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Conventional suture repair of peripheral nerves following injury is associated with several 
limitations such as technical difficulty, intra- and extra-neural scar formation, axonal escape 
and the leakage of neurotrophic factors. These limitations are particularly relevant following 
nerve grafting when regenerating axons must traverse two coaptation sites. Outcomes 
following suture repair are notoriously poor, providing large impetus for the development of 
alternative methods. Photochemical tissue bonding (PTB) uses visible light to create 
sutureless, non-thermal bonds between two closely apposed tissue surfaces stained with a 
photoactive dye. When used with a human amnion nerve wrap for end-to end nerve repair, 
this technique results in superior functional and histological outcomes in comparison to 
conventional epineurial suture. When initially applied to large gap injury and nerve grafting, 
outcomes were unsuccessful due to proteolytic degradation of amnion and photochemical 
bonds during extended periods of recovery. Chemical crosslinking of nerve wraps prior to 
PTB may improve wrap durability and efficacy of technique. This thesis provides a 
comprehensive three-phase assessment of the efficacy of this novel approach when applied to 
the repair of large gap injuries with nerve grafts. Phase 1 assesses the ex vivo biomechanical 
properties of nerve wraps and light activated bonds in addition to the in vivo performance of 
photochemically sealed crosslinked nerve wraps against several other clinically relevant 
fixation methods in a rodent sciatic nerve isograft model. Following major multi-limb injury 
and amputation, demand for autogenous nerve graft may exceed that which can be supplied 
by the patient. Acellular nerve allograft (ANA) is an alternative option in these circumstances 
although outcomes are typically inferior to autograft. Phase 2 assesses the performance of the 
optimum repair strategy from phase 1 against conventional epineurial suture when applied to 
	 11	
ANA. Most studies investigating the efficacy of novel repair techniques tend to perform 
repairs immediately following injury, a situation that rarely occurs clinically. Delays of 
weeks or months are not uncommon and have been shown to have a detrimental effect on 
regeneration and outcome. Phase 3 assesses the efficacy of PTB when applied to delayed 
nerve grafting.  
 
Additional work investigating a novel imaging technique for visualizing nerve 
revascularisation following injury and repair has been included. Optical frequency domain 
imaging (OFDI) uses low power infrared light to provide real time in vivo imaging of tissue 
microvasculature and flow characteristics. Originally applied to the study of tumour biology, 
this technique may prove useful for outcome assessment in preclinical research and 
eventually for the assessment of nerve viability in the clinical setting.  
 
Experiments investigating the early development of a brain body interface system (BBI) for 
upper limb reanimation following spinal cord injury (SCI) have also been included. The 
ultimate aim of this project is to restore autonomous motor control in a non-human primate 
(NHP) using cortically driven stimulation of peripheral nerves via implantable nerve cuffs. 
The experiments reported in this thesis detail the development of a selective, reversible 
paralysis model of elbow flexion in a NHP and demonstrate selective fascicular stimulation 
using acute and chronically implanted nerve cuffs in rodent and murine models.  
 
Methods: 
Phase 1: Three candidate nerve wraps (human amnion (HAM), crosslinked human amnion 
(xHAM), crosslinked swine intestinal sub-mucosa (xSIS)) and 3 fixation methods (suture, 
fibrin glue, PTB) were investigated. Crosslinking was performed using (1-ethyl-3-(3-
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dimethylaminopropyl) carbodiimide (EDC)/N-hydroxysuccinimide (NHS). Biomechanical 
tests were performed using a tensiometer. Ex vivo wrap durability was assessed using a type-
2 collagenase degradation assay. Under isoflurane anaesthesia, 110 inbred male Lewis rats 
had 15mm left sciatic nerve defects created and repaired with reversed isografts. 9 groups 
(n=10) had isografts secured by one of the aforementioned wrap/fixation combinations. PTB 
repairs had nerve wraps and nerve ends stained with photoactive dye (Rose Bengal) and, once 
nerve ends were apposed and wrapped circumferentially, the interface was illuminated with a 
532nm laser. Fibrin repairs had nerve ends apposed, wrapped circumferentially and secured 
with Tisseel fibrin glue. Suture repairs had nerve ends apposed, wrapped circumferentially 
and then secured with two 10-0 nylon sutures at each coaptation site (one either side of each 
repair). Positive and negative control groups (n=10) were repaired with graft+suture (10-0 
nylon) and no repair respectively. Phase 2: 20 sciatic nerves were harvested from Sprague 
Dawley rats and sent to AxoGen Inc. for decellularisation. An additional 20 male inbred 
Lewis rats were randomized into 2 groups (n=10). All rats had 15mm left sciatic nerve 
defects created and repaired with processed ANA. 1 group had nerves secured using 
conventional epineurial suture. The remaining group had ANA secured using 
photochemically sealed amnion wraps. Phase 3: 40 inbred male Lewis rats were randomized 
into 4 groups (n=10). All 40 rats had 15mm left sciatic nerve gaps created and reconstructed 
with reversed isografts harvested from donor Sprague Dawley rats. In groups 1 and 2, nerve 
gaps were repaired immediately with either conventional epineurial suture or 
photochemically sealed amnion wraps, respectively. In groups 3 and 4, repair took place 30-
days following injury using either conventional epineurial suture or photochemically sealed 
amnion wraps, respectively. All outcomes were assessed using walking track analysis and 
calculation of sciatic function index (SFI). Walking track analysis and SFI was performed 
pre-operatively, after the 30-day delay (phase 3) and at 30-day intervals following surgery. 
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Following sacrifice after 5-months, left (experimental) and right (control) gastrocnemius 
muscles were excised and weighed for calculation of muscle mass retention. Nerves were 
excised for histomorphometric analysis including axon count, fiber diameter, axon diameter, 
myelin thickness and G-ratio. For all in vivo experiments, statistical analysis was performed 
using ANOVA, repeated measures ANOVA and the post hoc Bonferroni test.  
 
Optical Frequency Domain Imaging (OFDI) pilot study: eight rodents were randomized 
into 4 groups (n=2): (1) crush injury, (2) transection and end-to-end repair, (3) transection 
and repair of 10mm nerve gap using contralateral autograft, (4) transection and repair of 
10mm nerve gap using ANA. Under ketamine/xylazine anaesthesia, all rodents had sciatic 
nerves exposed through hind limb dorsolateral incisions. Imaging was performed 
immediately pre-injury, immediately post-injury and on post-operative days 1, 3, 5 and 7. 
Rodents were secured firmly to polystyrene platforms in order to reduce movement artifact 
during imaging  
 
Brain-Body Interface (BBI) experiments: In the upper limb of a Rhesus macaque non-
human primate, the median nerve branch to brachialis and radial nerve branch to 
brachioradialis were transected, leaving elbow flexion entirely reliant on the 
musculocutaneous nerve. The musculocutaneous nerve was transposed into a subcutaneous 
position. Ultrasound guided nerve block resulted in a highly selective, reversible paralysis of 
elbow flexion.  
 
Under ketamine/xylazine anaesthesia, Sprague Dawley rats (n=5) and C57 Black 6 mice 
(n=5) had sciatic nerves exposed through dorsolateral, muscle splitting incisions. 8-channel 
stimulating cuff electrodes were wrapped around sciatic nerves and connected to a Tucker-
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Davies stimulation/recording system. Electromyography (EMG) needle electrodes were 
inserted into the tibialis anterior (TA) and gastrocnemius (G) muscles to record muscle 
activity. Single pulses and pulse trains were delivered to each animal whilst pulse parameters 
were systematically varied. In one survival rat, a stimulating nerve cuff and EMG recording 
electrodes were implanted chronically to assess equipment biocompatibility and recording 
stability.      
 
Results: 
Phase 1: Optimal tensile strength, photochemical bond strength and resistance to collagenase 
degradation were achieved using 4mM EDC/1mM NHS. Following sacrifice, crosslinked 
nerve wraps were still present. Un-crosslinked material was completely degraded. 
xHAM+PTB repairs  recovered greatest mean SFI although this was not statistically 
significant compared with standard repair (-67.9+/-1.6 vs -71.7+/-1.6 (mean+/-SEM)). 
xHAM+PTB repairs also recovered greatest muscle mass retention and this was significant in 
comparison to standard repair (67.3% +/- 1.4 vs 60.0% +/- 1.6; p=0.02). No significant 
difference in axon diameter existed between treatment groups. Fiber and axon diameter and 
myelin thickness were all significantly greater in the xHAM+PTB group in comparison to 
standard repair (6.87µm+/-0.04 vs. 5.47µm+/-0.03, p<0.0001; 4.51µm+/-0.04 vs. 3.50µm+/-
0.03, p<0.0001; 2.35µm+/-0.01 vs. 1.96µm+/-0.01, p<0.0001). Phase 2: Following sacrifice, 
all ANAs were in continuity and, on gross observation, showed evidence of regeneration. 
ANA repaired photochemically had less extraneural scar tissue formation in comparison to 
standard epineurial suture. SFI did not differ significantly between ANA+suture and 
ANA+PTB groups after 5-months follow up (-80.3+/-1.3 vs. -78.3+/-1.6 respectively; p=0.3). 
ANA+suture and ANA+PTB recovered significantly less SFI than corresponding 
isograft+suture and isograft+PTB. Gastrocnemius muscle mass retention did not differ 
	 15	
significantly between ANA+suture and ANA+PTB groups (53.3%+/-1.8 vs. 55.2%+/-1.6 
respectively; p=0.5). ANA+suture and ANA+PTB recovered significantly less muscle mass 
than isograft+suture and isograft+PTB, respectively. Muscle mass retention was statistically 
equivalent between ANA+PTB and isograft+suture (55.2+/-1.8% vs. 60+/-1.6%; p=0.22). 
With the exception of G-ratio, no significant differences existed between ANA+suture and 
ANA+PTB for any remaining histomorphometric parameter. ANA+PTB was statistically 
equivalent to isograft+suture for all histomorphometric parameters. Phase 3: After 5-months, 
in both immediate and delayed repairs, PTB resulted in greater mean SFI values but these 
results were not statistically significant (-72.3+/-1.5 vs. -68.5+/-1.5; p=0.4 and -80.1+/-1.4 vs. 
-77.3+/-1.5; p=1). Both suture and PTB fixation methods resulted in significantly greater 
recovery of SFI when performed immediately rather than after a 30-day delay after injury (-
72.3+/-1.5 vs. -80.1+/-1.4; p=0.003 and -68.5+/-1.5 vs. -77.3+/-1.5; p=0.002). Significantly 
greater muscle mass retention occurred following PTB fixation in both immediate and 
delayed repairs (64.9%+/-1.8 vs. 59.0%+/-1.1; p=0.03 and 60.2%+/-1.4 vs. 54.1%+/-1.7; 
p=0.04). No significant difference existed between immediate suture and delayed suture, or 
immediate PTB and delayed PTB groups. Muscle mass retention was not significantly 
different between immediate suture and delayed PTB (59.0+/-1.1% vs. 60.2+/-1.4%; p=1). 
No significant differences in axon count or density existed between groups. Fiber diameter, 
axon diameter, myelin thickness and G-ratio were not significantly different between 
immediate suture and delayed PTB. With the exception of G-ratio, all other 
histomorphometric parameter comparisons were significantly different between treatment 
groups, with immediate PTB achieving greatest recovery and delayed suture being poorest.  
 
OFDI: OFDI successfully provided real time images of nerve microvasculature. Vessels of 
the mesoneurial and epineurial longitudinal plexus were readily identifiable in uninjured 
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nerve. Marked tortuosity of these vessels was apparent. Different light scattering properties 
of muscle and nerve permitted easy differentiation between tissues. Injury sites were easily 
visible as areas of relative hypovascularity. Following crush injury, the longitudinal intrinsic 
plexus remained intact. Following end-to-end neurorrhaphy, although initially hypovascular, 
by post-operative day 7, a florid angiogenic response had occurred at the repair site. 
Following repair of 10mm autografts, the re-establishment of longitudinal vessels was 
apparent by day 4. Following repair of 10mm ANA, grafts remained relatively avascular. A 
predominance of inosculated longitudinal vessels existed with a relatively minor centripetal 
contribution from the surrounding muscle bed.  
 
BBI: Highly selective, reversible paralysis of non-human primate (NHP) elbow flexion was 
achieved. Application of nerve cuff electrodes around small animal sciatic nerves was 
technically simple and permitted muscle stimulation in all animals. Needle EMG electrodes 
successfully recorded muscle activity in all animals. In 9 animals, selective activation of 
tibial and common peroneal fascicles was possible, allowing the plotting of muscle 
recruitment curves as a function of stimulation amplitude. Following 6 months of chronic 
implantation, the nerve cuff and EMG electrodes were well tolerated and stimulation and 
recording was still possible.  
 
Conclusions  
PTB: Chemical crosslinking of biological nerve wraps improves tensile strength and in vivo 
resistance to biodegradation, whilst preserving the formation of light-activated bonds. Light 
activated sealing of crosslinked amnion around nerve isograft coaptation sites results in 
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significant improvements in muscle mass retention and nerve histomorphometry in 
comparison to conventional suture repair. SIS wraps were unsuitable for bonding around 
small diameter nerves although when applied to larger caliber nerves, may still be useful. 
Outcomes following ANA were inferior to those achieved following isograft reconstruction 
in phase 1. No significant difference was detected between photochemically sealed ANA and 
sutured ANA although the increase in mean values for muscle mass retention and 
histomorphometry were comparable to epineurial suture, the current standard of care. 
Immediate repairs performed significantly better than delayed repairs and light-activated 
repairs performed significantly better than sutured repairs. Delayed PTB repairs were 
statistically comparable to immediate suture. Light-activated sealing leads to superior 
outcomes in comparison to suture when applied to nerve isografts and may improve 
outcomes following the use of ANA and when repairs occur following a surgical delay.  
 
OFDI provides a real time, in vivo imaging modality for the assessment of nerve 
revascularisation following injury and repair. This has potential applications for pre-clinical 
outcome assessment in peripheral nerve research and also as a means of assessing peripheral 
nerve viability in the clinical setting.  
 
BBI: We have shown that selective fascicular stimulation of sub-1mm peripheral nerves can 
be achieved using implantable cuff electrodes. In combination with a highly selective and 
reversible paralysis of elbow extension in a non-human primate model, these cuffs will be 
used to deliver cortically recorded signals directly into upper limb nerves. Through operant 




Lay Summary  
Introduction and methods: 
The current standard of care for peripheral nerve repair involves re-joining nerve ends with 
suture. When gaps exist between nerve ends, other non-essential nerves in the injured patient 
can be used to bridge the gap. Suture repair of these injuries is limited by technical difficulty, 
scarring and the leakage of beneficial factors from the repair site. These limitations are 
amplified when gaps require nerve grafts because regenerating nerve fibers must cross two 
repair sites. Outcomes following suture repairs are notoriously poor, providing large impetus 
for the development of sutureless methods. Photochemical tissue bonding (PTB) uses visible 
light to create sutureless bonds between two closely apposed tissue surfaces that have been 
stained with a light activated dye. When dye-stained nerve ends are apposed and wrapped 
with dye stained nerve wraps, sutureless repair is possible and has been shown to result in 
superior outcomes in comparison to nerves that have been sutured. Previous application of 
this technique to large gap injuries requiring grafts was unsuccessful due to premature 
degradation of nerve wraps and bonds before nerve fibers reached the site of injury. One 
proposed solution to this problem is to treat nerve wraps with chemicals in order to make 
them last longer in the tissues and therefore prolong the strength of the bonds. This thesis 
tests how effective this approach is when applied to large nerve gap injury. Phase 1 tests how 
chemical concentration affects wrap strength and durability and whether the chemicals 
interfere with nerve bonding. In a rat model, the performance of light activated nerve bonding 
is compared to other nerve repair methods that are commonly used in the clinical setting, 
such as glue and suture. Following major injury, demand for nerve grafts may exceed that 
which is available from the patient. In these cases, acellular nerve allografts (ANA) can be 
used. These nerves are taken from cadaveric donors and are specially treated in order to 
	 19	
remove all cells whilst preserving internal structure. Without cells, ANA can be safely 
transplanted into different patients without fear of rejection. Unfortunately, ANA do not 
perform as well as nerves taken from the same patient. Phase 2 assesses the performance of 
light activated nerve bonding in ANA against conventionally sutured ANA in a rat model. 
Most studies investigating new repair techniques tend to perform nerve repair immediately 
following injury, a situation that rarely occurs clinically. Delays of weeks or months are not 
uncommon and have been shown to have a detrimental effect on outcome. Phase 3 assesses 
the efficacy of light activated nerve bonding when applied to delayed nerve grafting in a 
rodent model.  
 
Additional work has been included that investigates a novel imaging technique for 
visualizing the re-establishment of nerve blood supply in rat models of nerve crush injury, 
transection and suture, regular nerve grafting and following the use of acellular nerve graft. 
Optical frequency domain imaging (OFDI) uses infrared light to provide real time images of 
tissue blood vessels and blood flow. Originally applied to the study of tumours, this 
technique may prove useful for assessing the success of nerve regeneration in preclinical 
animal models and may also prove useful in the clinical setting by permitting intraoperative 
assessment of nerve viability following injury.  
 
Experiments investigating the early development of a brain body interface system (BBI) have 
also been included. This technology aims to help patients move paralysed limbs following 
spinal cord injury. Signals from the brain that control limb movement can be recorded and 
used to directly stimulate nerves and muscles, bypassing the injured spinal cord. The ultimate 
aim of this project is to demonstrate this in a non-human primate (NHP) model. This thesis 
reports preliminary experiments including the development of a technique permitting the 
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reversible paralysis of NHP elbow flexion. The ability of implantable stimulating nerve cuffs 
to activate very specific areas of rat peripheral nerve and therefore provide selective limb 
muscle activation is also demonstrated.  
 
Results and Conclusions  
Light activated nerve bonding: Chemical treatment of biological nerve wraps improves 
strength and durability, whilst preserving light activated bonding. Light activated bonding of 
nerve grafts results in superior outcomes in comparison to sutured grafts. When applied to 
ANA, no difference between sutured and bonded nerves was identified although outcomes in 
the bonded ANA group were equivalent to sutured nerve grafts in phase 1, the current 
standard of care. When performed after a surgical delay, light activated nerve bonding 
resulted in outcomes that were comparable to repairs that were performed immediately with 
suture. Overall, light-activated bonding is superior to gold standard suture when applied to 
conventional nerve grafts and may improve outcomes following the use of ANA and when 
repairs occur following a surgical delay.  
 
OFDI: This novel imaging modality provides real-time assessment of the re-establishment of 
nerve blood supply following injury and repair. This has potential applications for pre-
clinical outcome assessment in peripheral nerve research and also as a means of assessing 
peripheral nerve viability in the clinical setting.  
 
BBI: Surgical re-organisation of the NHP upper limb nerves allowed the development of a 
highly selective, reversible and repeatable paralysis of elbow flexion. Stimulating nerve cuff 
electrodes can be easily implanted and used to activate very specific areas of a nerve, 
permitting the selective activation of limb muscles. These techniques will be combined in 
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Section 1: Introduction 
1.1 The anatomy and physiology of peripheral nerves 
Peripheral nerves are extensions of the central nervous system. They provide motor and 
sympathetic output to the trunk and extremities and also provide afferent channels facilitating 
the perception of pain, temperature, pressure and joint position sense. Nerves contain huge 
collections of neurons, one of the fundamental cells of the nervous system. Such neurons are 
composed of a centrally located cell body, a peripherally extending axon, and its connection 
with a peripheral target. For example, cell bodies of motor neurons reside in the ventral horn 
of the spinal cord whereas sensory cell bodies are located in the dorsal root ganglion. Both 
project long axons into peripheral nerves that branch extensively until reaching their distal 
targets. The cell body contains structures consistent with other cells in the body such as a 
nucleus, mitochondria and endoplasmic reticulum. In common with other cells, RNA is 
transcribed in the nucleus of the neuron and is translated into protein from messenger RNA in 
the cytoplasm. In the neuron, the majority of cytoplasm is distributed within the axon where 
it is referred to as the axoplasm. Whilst some protein products are destined for local use 
within the cell body, others are required by the axon, often at relatively large distances from 
their site of synthesis.    
 
Axoplasm is continuously produced and contains multiple cytoskeletal elements such as 
microtubules that run the entire length of the axon(1). These cytoskeletal elements, in 
combination with motor proteins such as kinesin and dynein create axoplasmic transport, a 
bidirectional, fast or slow, transport and signaling mechanism allowing anterograde and 
retrograde transportation of cellular proteins(2). Anterograde flow transports proteins 
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manufactured in the cell body towards the periphery and is vital for the integrity of the distal 
axon. Retrograde transport allows movement of elements back towards the cell body from the 
periphery. Following injury, interruption of this transport heralds the onset of orthograde 
Wallerian degeneration. Retrograde transport of cellular debris from the site of injury is 
destined for lysosomal degradation and the influx of this material at the cell body is believed 
to form part of a feedback mechanism that upregulates cell body metabolism in preparation 
for regeneration(2).  
 
Although abundant, axons are only part of the volume of the nerve. The majority of the 
substance of the nerve is composed of connective tissue and supporting cells that provide the 
nerve with a high level of structural organization(3). This connective tissue is presented in 
layers and, from external to internal, includes (1) mesoneurium, (2) epineurium, (3) 
perineurium and (4) endoneurium. The mesoneurium is the outermost layer and is composed 
of loose areolar connective tissue. The mesoneurium carries with it a vascular supply and is 
believed to help tether nerves to surrounding structures such as muscle and fascia. The 
epineurium is a tough areolar layer composed of longitudinally orientated collagen and 
elastin fibers (figure 1)(4). The epineurium contains a dense network of vessels that form 
anastomoses with endoneurial vessles via connections that run obliquely through the 
perineurium. The epineurium extends internally to ensheath fascicles where it is known as the 
interfascicular epineurium.  
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The perineurium surrounds the fascicles of the nerve and is composed of oblique, 
longitudinal and circular collagen fibers, interspersed with perineurial cells (figure 1)(5). 
Fascicles vary in size and number depending on the nerve. The existence of tight junctions 
between perineurial cells creates a blood nerve barrier, preventing the intercellular transport 
of macromolecules. When injured, the breakdown of this barrier has a deleterious effect on 
axonal function(6). Demyelination and a loss of axon diameter can occur, all contributing to a 
loss of signal conduction. The perineurium also provides tensile strength to the nerve and is 
responsible for resisting the effects of longitudinal traction. In addition to providing strength, 
the perineurium also appears to maintain positive intrafascicular pressure. Disruption of this 
layer results in decompression and herniation of axons out-with the confines of the fascicle. 
The perineurial layer is the site of anastomotic connections between the epneurial vascular 








Figure 1. The anatomy of a peripheral nerve. The outermost connective tissue layer is the epineurium. This 
surrounds and contains fascicular groups. The tissue in between fascicular groups is referred to as the 
interfascicular epineurium. Individual fascicles contain bundles of axons and are surrounded by the perineurium. 
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Each axon is surrounded by the endoneurium that, in turn, surrounds basal lamina. All axons are accompanied 
by Schwann cells that may or may not produce myelin sheaths.        
 
The endoneurium is a matrix of predominantly longitudinally orientated collagen fibers that 
surround both myelinated and unmyelinated axons (figure 1)(4). Microvessels permeate the 
endoneurium and due to tight junctions between the endothelial cells of these vessels, they 
offer a further blood nerve barrier in addition to that of the perineurium. The permeability of 
these vessels increases following nerve injury, permitting the influx of inflammatory 
mediators into the endoneurial environment. The endoneurium also offers protection against 
longitudinal traction and, similar to the perineurium, also presents a relatively unyielding 
layer that results in positive pressures surrounding the axons.  
 
The fundamental role of the neuron is to generate and transmit electrical impulses known as 
action potentials. Action potentials are spikes of electrical activity that arise in excitable cells 
and play an integral role in cellular communication and the activation of many intracellular 
processes. As with any other cell, neurons possess a plasma membrane. In the axon, this is 
referred to as the axolemma. Within the plasma membrane exist many different proteins that 
serve many different roles. Some of these proteins are channels or carriers that facilitate the 
effects of diffusion or active transport. The flux of nutritional and waste products across the 
membrane is tightly regulated and maintains cell integrity in addition to allowing interaction 
with the surrounding environment. These channels are also responsible for the selective 
permeability of the membrane to ions. The unequal distribution of sodium (Na+) and 
potassium (K+) ions across the membrane sets up the transmembrane potential, the ionic 
concentration gradient and electrical charge difference across the cell. Resting membrane 
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potential varies between excitable cells and tissues but for the neurons, is approximately -
75mV. When the transmembrane potential becomes more negative, this is referred to as 
hyperpolarization. The generation of action potentials is the result of rapid depolarization, 
brought about by abrupt changes to the transmembrane conductance for Na+ and K+ ions 
through voltage gated ion channels. Following depolarization and action potential firing, the 
membrane is returned to its resting state through a period of repolarization. 
   
Axons are enveloped with Schwann cells (SCs). In turn, axons and their SCs are surrounded 
by basal lamina. In large myelinated fibers, SCs produce a lipoprotein rich electrical insulator 
called myelin that wraps circumferentially around segments of the axon, a feature that 
distinguishes the SC from other cells in the area. In smaller unmyelinated fibers, axons are 
surrounded by SCs and basal lamina, but lack myelin typical of larger myelinated fibers. In 
between adjacent SCs of myelinated fibers, myelin thickness is reduced. These areas of 
relative myelin thinning, known as nodes of Ranvier, contain an increased density of voltage-
gated ion channels in comparison to myelinated, internodal regions that are relatively lacking 
in ion channels, a finding that may be influenced by the Schwann cell(7). As a result, ion 
conductance and excitability are greater in these regions.  
 
Like any other electrical signal, action potentials travel down the path of least resistance. In 
the axon, this involves either continued propagation along the axon or leak through the 
membrane into the extracellular space. In unmyelinated axons, depolarization of contiguous 
sections of the membrane results in the activation of localised voltage-gated ion channels 
resulting in a continuous and complete depolarization of the entire axon membrane as the 
action potential is conducted away from the site of activation(8). This process is relatively 
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slow, due to time taken discharging and charging the membrane capacitance and, as a result, 
conduction velocities are also slow (0.1-2 ms-1). When sodium ions enter a node of Ranvier 
in a myelinated axon, the reduced capacitance of the myelin sheath ensures that 
depolarisation spreads rapidly to the next node. This process is referred to as saltatory 
conduction. It dramatically increases the impulse conduction velocity up to 1000 fold (>100 
ms-1)(8).  
 
In motor neurons, the arrival of action potentials at the neuromuscular junction results in 
depolarization of the presynaptic terminal and, through the exocytosis of synaptic vesicles, 
results in a flood of neurotransmitter release into the synaptic cleft(9, 10). The neurotransmitter 
released from the NMJ is acetylcholine (ACh) and, after binding to postsynaptic receptors on 
the sarcolemma of muscle fibres, results in further depolarisation and activation of muscle 
contraction. A single motor neuron may synapse with one or many muscle fibres, the 
combination of which is termed the motor unit(9, 10). 
 
Peripheral nerves are richly vascularized by two integrated but functionally distinct systems. 
The extrinsic system consists of segmental vessels originating from nearby large arteries and 
veins. These vessels are tortuous in appearance conveying a large degree of redundancy that 
allows extensive, unrestricted mobilization during movement. As these vessels approach the 
nerve, they arborize proximally and distally and run in the distinct, collateral, outermost 
mesoneurial layer. These nutrient vessels form anastomotic connections with the main 
longitudinal plexus of vessels situated at the level of the external epineurium and 
extrafascicular epineurium and marks the transition from extrinsic to intrinsic vascular 
systems(11). As previously discussed, epineurial vessels send branches obliquely through the 
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perineurium and intrafascicularly. These in turn send branches that infiltrate the substance of 
the endoneurim to supply axons(12). Although less relevant for uninjured nerve, following 
injury and repair, the nerve also receives an important vascular supply from the surrounding 
soft tissues, particularly muscle.  
 
1.2 Nerve injury 
1.2.1 The causes of nerve injury  
Traumatic nerve injury can occur by many different ways. Injury may be the result of 
penetrating or non-penetrating trauma, resulting in open or closed wounds respectively. 
Although open wounds are perceived as being more serious and destructive, in the context of 
nerve injury, they are often less problematic than closed injuries. Open injuries, with 
evidence of neurological deficit, warrant immediate intervention, involving decontamination, 
exploration and subsequent repair of nerves and other tissues. Diagnosis of nerve injury is 
rapid and plans for definitive reconstruction can be set in motion at an early stage. The 
freshly and sharply transected nerve following penetrating injury represents the ideal injury 
for repair and can result in a more predictable and successful functional outcome.  
 
Contrary to expectation however, the majority of penetrating injuries do not result in nerve 
transection. Instead, the nerve suffers from crushing or traction injury, both of which can 
result in varying degrees of intraneural damage. In contrast to open wound treatment, the 
closed, non-penetrating injury is usually managed expectantly, with the patient undergoing 
regular outpatient follow-up visits to assess and monitor signs of recovery. If after 3-months 
there are no signs of recovery, then surgical intervention is indicated. Partial transection 
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injury or a sufficiently severe crush or traction injury will result in intraneural scar tissue 
formation, a direct obstacle to axonal regeneration and recovery. The forces that a nerve 
endures during injury are not uniform and as a result, axonal injury tends to be heterogenous 
and dynamic. Classifying these injuries is useful for standardizing diagnosis, formulating 
management plans and assessing prognosis.   
 
1.2.2 The classification of nerve injury  
Several classification systems of nerve injuries have been proposed. According to all of these 
systems, nerve injuries fall into one of three general categories: neuropraxia, axonometsis and 
neurotomesis. This concept was introduced by Seddon(13), developed by Sunderland(14) and 
has most recently been contributed to by Mackinnon(15). These descriptive terms represent 
injuries of increasing severity.  
 
Neuropraxia represents Sunderland’s first-degree injury and describes a conduction block 
across a zone of injury. Although demyelination can occur, axons typically remain intact 
within their basal lamina tubes and Wallerian degeneration does not occur. Axons find 
themselves in a state of shock and are temporarily unable to transmit impulses down to distal 
targets. Conduction block exists exclusively at the site of injury with preserved transmission 
proximal and distal to the lesion. Larger motor fibers tend to be preferentially affected, in 
addition to those fibers serving touch and position sense. Smaller fibers including those 
responsible for the perception of pain can be preserved, explaining why, for some patients, 
these injuries are painful(16). Loss of function usually resolves within days although can last 
for many weeks. Full recovery is expected within 12 weeks. Neuropraxia often arises as a 
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result of compressive or stretching forces applied to the nerve. A common example is the 
“Saturday night” palsy which describes the temporary loss of radial nerve function, 
secondary to prolonged compression of the radial nerve between the arm of a chair and the 
humerus, typically after a patient falls asleep intoxicated.  
 
Axonotmesis represents Sunderland’s second-degree injury and usually occurs as a result of 
more severe crushing or stretching forces(14). This injury involves disruption in the continuity 
of the axon, resulting in Wallerian degeneration and demyelination. EMG recordings show 
fibrillations and denervation potentials in distal muscle targets. In contrast to neuropraxia, 
stimulation of the nerve several days after the injury is unable to elicit a muscle contraction. 
Wallerian degeneration occurs in the distal fiber and also, for a limited extent, in the proximal 
fiber. Recovery is determined by the success of regeneration and reinnervation. Regeneration 
occurs slowly and only after an initial period of delay as axons cross the injury site. Once 
they have negotiated the site of injury, regeneration proceeds distally at a variable rate. 
Regeneration rate tends to be more rapid, up to 3mm/day in a human, for injuries that are 
situated more proximally in relation to the cell body. When the level of injury is situated 
more distal, rates of regeneration of 0.5m/day are more typical(17). Additional delays also 
occur when axons reach their targets due to the physical re-establishment of distal 
connections. As with neuropraxia, the connective tissue layers, including basal lamina tubes, 
and fascicular architecture are preserved. As a result, axons, guided by SC Bands of Bungner, 
are able to mostly regenerate down the correct distal pathways. Due to the preservation of 
connective tissue layers, there is a relative absence of the typical proliferative, fibroplastic 
response and therefore a lack of disorganized, intervening scar tissue. Consequently, despite 
the loss of some axons, reinnervation of distal targets by those that survive is accurate, 
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leading to a relatively high level of functional recovery in comparison to neurotmesis, often 
obviating the requirement for surgical intervention.  
 
Neurotmesis is the most severe form of injury and encompasses third, fourth and fifth degree 
injuries in the Sunderland classification(14). These injuries involve interruption of the axon 
and various levels of connective tissue elements of the nerve. Neurometsis does not simply 
refer to transection of the nerve and more often than not, occurs without loss of continuity. 
Third degree injury involves disruption of the endoneurial layer and to a lesser extent, the 
perineurium. Part of the external fascicular anatomy is preserved and this remains a 
predominantly axonotmetic injury with some neurotmetic features. Fourth degree injury 
involves disruption of the axon, endoneurial and perineurial layers, leading to complete loss 
of fascicular architecture. The nerve remains in continuity at the epineurial level. A fifth 
degree injury represents total transection of the nerve. The sixth degree injury, as added by 
Mackinnon and Dellon, recognizes that injuries often do not fall conveniently into the above 
classifications and, across the cross section of the nerve, can include a mixture of 
axonotmetic and neurotmetic injury(15).  
 
The loss of nerve action potentials distal to the site of injury following neurotmesis, in 
addition to the muscle denervation changes detected by EMG, are consistent with those 
observed following simple axonotmesis. In contrast to axonotmesis however, the damaged 
endoneurial and perineurial layers result in a proliferative, fibroplastic response, leading to 
the formation of disorganized, intervening scar tissue. This, in addition to the loss of 
fascicular architecture can lead to axons becoming lost in the haphazard injury environment. 
In fourth degree injuries this may result in the formation of a neuroma in continuity. In fifth 
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degree, complete transections, failure of surgical intervention results in a proximal end-bulb 
neuroma. In third and fourth degree injuries, action potentials are unable to conduct through 
and distal to the injury site. Even if axons are able to negotiate the injury site and reach the 
distal stump, they are highly unlikely to reinnervate the correct basal lamina tubes. In mixed 
nerves, this may result in considerable sensory-motor mismatch. In addition, the intervening 
scar and prolonged denervation of the distal stump can have deleterious effects on axon 
diameter and myelination, further compromising the likelihood of successful reinnervation 
and recovery, regardless of whether the regenerating axon reaches their intended peripheral 
targets. Without surgically re-establishing accurate orientation of completely divided nerve 
ends, or resecting disorganized intervening scar and neuroma in continuity, successful 
regeneration and meaningful recovery does not normally occur. 
 
1.2.3 The neurobiology of nerve injury and regeneration 
Following nerve transection injury, a complex sequence of neurobiological events occurs in 
the cell body and in the proximal and distal nerve fiber. The interruption of axonal integrity 
leads to a rapid influx of ions at the site of injury and an electrophysiological response that 
propagates back towards the cell body signaling that a lesion has occurred(18). The retrograde 
transportation of local factors at the injury site such as leukocyte inhibitory factor (LIF), and 
the interruption of retrograde transport of neurotrophic factors such as nerve growth factor 
(NGF) results in chromatolysis(19, 20). Nissl bodies within the cell body undergo dissolution 
and the nucleus migrates to the periphery of the cell. Nissl bodies are composed of rough 
endoplasmic reticulum. The dissolution of this material is a consequence of a reduction in 
particle size towards the sub-microscopic scale rather than a loss of material. Although many 
survive, for some cell bodies this process heralds the onset of programmed cell death, 
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incurring an immediate and permanent loss of regenerative potential for the nerve. The 
proportion that is lost is believed to be greater in sensory neurons(20). Surviving cell bodies 
increase in size, associated with increased levels of RNA, and undergo major cytoskeletal 
restructuring. Upregulated expression of multiple regeneration-associated genes (RAGs) and 
protein synthesis prepares the neuron for the increased metabolic demands of regeneration 
and represents a temporary shift in function from impulse transmission to growth 
promotion(21-23). Interestingly, the changes occurring in the cell body are more pronounced 
with more proximal nerve injuries, implying that cell bodies can in some way detect the 
extent of regenerative support required for any given level of injury.  
 
The process of degeneration is rapid in most vertebrates, including rats. Within 12-15 hours, 
NMJs in axotomised rat muscle have begun to degenerate(24). Within 36 hours, the process of 
Wallerian degeneration ensues(25, 26). The activation of calcium dependent proteases results in 
proteolytic disintegration of axolemma and myelin sheaths, a process that continues to 
propagate bi-directionally over the following 72 hours(26, 27). Proximally, this process is 
usually limited to the first node of Ranvier although can vary depending on the severity of 
trauma(20). Denervated SCs in the distal stump undergo a temporary phenotypic transition, 
upregulating RAGs for growth promotion and down-regulating those genes associated with 
myelination(7). Over several days, transformed SCs and circulating myelomonocytic cells that 
have been recruited to the site of injury, phagocytose axon debris(28). The persistence of this 
regeneration-inhibiting material in the zone of injury, and its subsequent clearance, delays the 
onset of regeneration. Although the axon and its myelin sheath degenerate, basal lamina tubes 
remain. Within a few days of injury, SCs proliferate, de-differentiate and align themselves 
within basal lamina tubes where they are referred to as bands of Büngner. These scaffolding 
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columns form under the influence of neurotrophic factors and guide regenerating axons into 
distal basal lamina tubes(19, 23, 28, 29).  
 
Regeneration begins at the most distal, intact node of Ranvier and from each proximal axon 
stump, arise numerous sprouts(20). Each sprout is enlarged at its tip and gives rise to finger-
like projections known as filopodia(30). The regions in between projecting filopodia are called 
lamellipodia. Collectively these structures comprise the growth cone(30). The proteins 
necessary for growth cone formation and function such as actin, tubulin and growth 
associated protein-43 (GAP43) are manufactured in the cell body and must be transported to 
the site of regeneration(31, 32). The membrane surrounding filopodia contain many receptors 
and cell adhesion molecules that enable the advancing growth cone to respond to its 
immediate environment, rapidly changing direction and branching pattern in response to 
various stimuli(30). It is through this signaling that axons are attracted towards the distal stump 
and into basal lamina tubes. For this to be successful, divided nerve ends must be brought 
back into close apposition. Failure to do so will result in unsuccessful reinnervation of basal 
lamina tubes, SCs and distal targets. The lack of reinnervation not only has a profoundly 
detrimental impact on recovery but may also result in troublesome neuroma formation at the 
proximal stump.  
 
Neurotrophic factors play a key role in axonal regeneration. Several factors have been 
described such as nerve growth factor NGF, brain derived neurotrophic factor (BDNF), 
ciliary derived neurotrophic factor (CNTF), and p75(20, 33, 34). Following injury, the production 
of these factors is upregulated in both axotomised neuronal cell bodies and from denervated 
SCs in the distal nerve stump(34). The increases in production are distinctly different 
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depending on whether the injured axon is motor or sensory in origin. The period of increased 
neurotrophic factor production is finite and, after long delays between injury and repair, the 
number of axotomised neurons that are capable of regeneration and the ability of the distal 
fiber to support regeneration are reduced, both of which are related to the fall in neurotrophic 
factor release(35, 36). Investigators have taken several approaches in an attempt to increase the 
supply of neurotrophic factors. The injury site has been directly supplemented with 
neurotrophic factors(37-42). In addition, undifferentiated stem cells and stem cells that have 
been pre-differentiated into SC-like cells have also been added in order to augment 
regenerative support(43-77). Neurons have also been retrovirally infected in order to try and 
sustain neurotrophic factor production(78). 
 
Even following technically excellent nerve repair, the accuracy of reinnervation of distal 
targets is poor. Motor and sensory fibers are unlikely to find their exact basal lamina tubes 
and, due to extensive disorganization at the repair site, it is possible that sensory fibers 
inadvertently regenerate down motor pathways or vice versa. Signaling mechanisms can 
reduce the incidence of this happening and studies have shown that motor axons 
preferentially reinnervate motor axons in the distal stump(79-81). Those axons that regenerate 
down incorrect pathways are often pruned when they fail to form appropriate distal 
connections(82). To a certain extent, cortical plasticity can compensate for inappropriate 
innervation but there are limits to this(83). The power of cortical plasticity is regularly 
observed following nerve transfers in brachial plexus patients(84-86). Transferred nerves can 
power muscles that previously had non-synergistic or even antagonistic functions prior to 
injury.   
 
	 36	
Making the process of regeneration and reinnervation even more challenging is the inevitable 
formation of scar. Scarring is a natural feature of wound healing and although beneficial in 
many respects, following nerve injury, the proliferative reaction in epineurial, perineurial and 
endoneurial connective tissue layers has a detrimental impact on axonal regeneration(20). 
These effects tend to be worsened with increasing injury severity, the presence of tension at 
the repair site, the presence of suture material, and as a result of surgical dissection and 
manipulation of nerve ends(87). Importantly, as with healing and regenerative potential, the 
extent of scar tissue formation following nerve injury varies with animal species and is more 
pronounced in larger animals and humans in comparison to smaller animal models such as 
rats(88). This must be bore in mind when interpreting apparent scar reducing effects of an 
intervention and its clinical translatability. 
            
The formation of intraneural scar tissue is led by fibroblasts and influenced by a complex 
array of growth factors and cytokines. The three isoforms of the TGF-beta family of proteins 
(TGF beta 1, beta 2 and beta3) have a central role(89). TGF beta 1 is chemotactic to 
macrophages, stimulates angiogenesis and the formation of granulation tissue, promotes the 
synthesis of extracellular matrix formation and inhibits its degradation(90). TGF beta2 may act 
synergistically with TGF beta 1. In contrast, TGF beta 3, which is primarily synthesized by 
keratinocytes and fibroblasts, reduces macrophage and monocyte profile, reduces the 
deposition of fibronectin, collagen 1 and collagen 3, and is believed to be involved in the 
restoration of normal dermal architecture(90). All three isoforms of TGF beta have been 
isolated in SCs from uninjured and injured peripheral nerve. Following nerve injury, the 
epineurial levels of TGF beta 1 increase whilst those of TGF beta 3 fall(91, 92).  
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The presence of intraneural scar acts as a physical obstacle to regenerating axons(93). Axons 
that are forced to regenerate through this tissue are prone to deflection or complete 
obstruction. This not only compromises recovery, but also increases the likelihood of 
neuroma formation. Upon reaching the distal stump, axons have often taken a considerably 
more haphazard, tortuous and metabolically expensive route than normal and as a result, tend 
to be smaller in caliber and less myelinated(3, 94).  
 
1.3 Peripheral nerve repair 
1.3.1 Basic principles 
Traumatic injuries associated with open wounds are initially managed according to basic 
principles. In order of importance, life is preserved, the patient is stabilized, wounds are 
decontaminated and debrided and digits, limbs and soft tissues are revascularised, if required. 
Following on from this, the reconstruction of other tissues such as bone, tendon and nerve are 
performed. Nerve ends are inspected. If the nerve remains in continuity, management 
continues as it would for a closed injury. If injured nerves have been severed cleanly, they 
may only require minimal debridement of ragged ends. In these situations, simple end-to-end 
repair may be possible. If sections of nerve have been devitalized, this tissue must also be 
sharply debrided until healthy nerve is visualized. When nerve viability is in question, nerve 
ends can be tagged together with suture. A delayed procedure can be planned in order to 
more reliably assess nerve viability. At this point, sections of obviously scarred nerve can be 
identified, excised and formally reconstructed.  
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Successful outcome following nerve repair is dependent on multiple factors. Some of these 
relate to the cause of injury whilst others are specific to the patient and the surgical ability of 
the surgeon. The severity of injury is perhaps the most obvious of these. Repair of clean, 
guillotine-type injuries produce more favourable outcomes. Severe crush injuries or blast 
injuries resulting in loss of large segments of nerve have less favourable outcomes. Proximal 
injuries present greater regenerative distances and are also more problematic due to the 
longer periods of denervation of distal SCs and target muscle. Recovery following immediate 
repair, or repair performed after short delays, tend to outperform those injuries that occur 
after prolonged delays. This is also related to the duration of denervation, a topic that will be 
elaborated upon below. Nerve regeneration in elderly patients is less successful than in 
younger patients. The elderly also have a greater incidence of systemic conditions such as 
ischaemic heart disease, peripheral vascular disease and diabetes that can also compromise 
recovery from nerve injury. This demographic also more frequently take multiple 
medications and some of these, including steroids, can interfere with recovery.  
 
The skill of the operating surgeon is also of paramount importance. The qualified peripheral 
nerve surgeon has a deep understanding of the anatomy and physiology of nerves, the 
neurobiology of injury and repair and, with access to modern microsurgical equipment, is 
able to achieve the best possible results at present for the patient. Some basic principles 
regarding the approach to peripheral nerve repair must be adhered to.  
 
Thorough clinical examination precedes all other intervention following peripheral nerve 
injury. Quantitative assessment of motor and sensory function and comparison of these 
findings with the contralateral uninjured nerve allows the formulation of a differential 
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diagnosis and determines whether surgical intervention is warranted. This assessment must 
also be performed post-operatively in order to monitor recovery. As discussed, basic 
principles of wound management such as decontamination and debridement are essential to 
optimize the chances of successful regeneration. The use of microsurgical equipment and 
optical magnification is also essential. If a magnification of x4.0 is unavailable in the form of 
loupes, an operating microscope should be used. Immediate nerve repair is preferable to 
repair after a delay. However, in some situations, the patient’s condition or the nature of the 
injury preclude primary nerve repair. For example, when wounds are heavily contaminated 
and contain devitalized tissue, repair must be delayed so that wound toilet and debridement 
can occur. In this situation, nerve ends can be tagged or provisionally coapted in order to 
prevent significant retraction prior to reconstruction.  
 
The existence of tension between coapted nerve ends results in gapping and ischaemia, both 
of which exacerbate the formation of intraneural scar and have a deleterious effect on 
regeneration. If tensionless repair is unachievable, some form of bridging technique is 
indicated. Deciding when excessive tension exists can be difficult. Some have proposed that 
when nerve ends cannot be satisfactorily coapted with a single 8-0 suture, then excessive 
tension exists and nerve grafting should be performed. The experienced peripheral nerve 
surgeon will recognize that positional maneuvers should not be relied upon to reduce tension 
at the repair site. This practice is not only ineffective but it also introduces the possibility of 
joint stiffness and contractures. Conservative mobilization of the distal and proximal nerve 
ends in order to gain extra length is acceptable due to the robust intrinsic blood supply. If 
tensionless repair is not possible following conservative mobilization, then an interpositional 
graft should be used. As part of this decision making process, adjacent joints should be flexed 
and extended under anaesthetic in order to ensure that post-operative mobilization, as part of 
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a rehabilitation program, can be tolerated. If fascicular topography can be easily re-orientated 
then a group fascicular repair should be performed. If establishing fascicular orientation is 
not possible, then epineurial suturing should be performed. This may be due to a lack of 
specialized equipment or techniques or may be due to the fact that the injury is situated at a 
level where motor and sensory fibers are still mixed. Fascicular organization varies widely 
along the course of a nerve. Fascicles situated proximally tend to consist of fibers that serve a 
wide variety of distal functions. As these fascicles progress distally, a large amount of re-
organisation occurs. As a result, distally, fascicles have a high degree of organisation and 
functional differentiation, thus making group fascicular repair more feasible.  
 
Post-operatively, gentle mobilization should be initiated early in order to prevent the 
formation of encapsulating scar tissue around the nerve and subsequent traction injury. In 
addition to mobilization, sensory and motor re-education is also very important. Loss of 
function following repair is partly due to the reinnervation of different targets by axons. 
However, due to cortical plasticity, and with the appropriate intervention, the patient can be 
helped to adapt to the new connections.        
 
1.3.2 Timing of repair 
Early investigators postulated that delaying nerve repair until cell bodies had been 
metabolically primed and distal nerves had been sufficiently cleared of debris would translate 
into optimized regeneration and recovery. Similarly, others theorized that pre-degeneration of 
nerve grafts would also result in superior outcomes. Despite early promise, these predictions 
were not substantiated in animal models(95). Contemporary studies have highlighted the 
importance of expeditious nerve repair. Fu and Gordon observed that poor recovery was a 
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result of the combined effects of chronic axotomy and chronic denervation of the distal nerve 
and muscle and delineated the relative contributions played by each(35, 36). These and other 
studies subsequently confirmed that chronic denervation of the distal nerve and target muscle 
is the most important(35, 36, 96, 97). Denervated SCs are less able to support regenerating axons. 
Denervated muscle undergoes progressive, characteristic histological changes within a few 
weeks. The muscle atrophies, is less able to recover from this atrophy and has also been 
shown to impart a retrograde inhibitory influence on regenerating axons, the effects of which 
worsen with time(97). Although the effects of denervation atrophy can be reduced by artificial 
electrical stimulation, stimulation during prolonged denervation is unable to enhance muscle 
mass, force or motor function once muscles are subsequently reinnervated(98). With chronic, 
long-term denervation, particularly in combination with a lack of mobilization, denervated 
muscles are entirely replaced by fibrotic scar tissue or fat. Delays of up to 2-years can yield 
some recovery but after this time, the loss of functional muscle mass is often unsalvageable. 
Following major trauma, prolonged delays prior to the onset of definitive reconstruction are 
often unavoidable due to the requirement for patient stabilization, wound decontamination, 
and the presence of proximal injuries and large volume tissue loss. However, the importance 
of expeditious repair cannot be overemphasized.  
 
Maintaining a permissive regenerative environment following delayed repair may be possible 
through the supplementation of stem cells and neurotrophic factors(21, 34, 99, 100). However, 
delivery of these factors, and their temporal and spatial regulation, is far from being realized 
clinically. Inappropriately high concentrations of some neurotrophic factors can be inhibitory 
to regeneration and can even promote cell death(99, 100). Denervation times can be partially 
compensated for through external electrical stimulation of nerve repair sites(101, 102). This has 
been performed in animal models of immediate and delayed repair(103, 104) and most recently, 
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has facilitated full reinnervation of thenar muscles in humans with severe carpal tunnel 
syndrome(105). This effect has been linked to upregulation of RAG expression and elevated 
levels of neurotrophic factors(101, 102, 106). This technique perhaps represents one of the few 
clinically translatable solutions to date. 
 
1.3.3 End-to-end neurorrhaphy 
The use of loupe or microscope magnification is essential. Prior to repair, nerve ends are 
prepared by sharp transection using either straight scissors or a scalpel blade. The current 
standard of care for re-anastomosing involves the use of suture. The aim of suture placement 
is to accurately re-align, with minimum tension, not to create a perfect seal(107). Overly tight 
sutures may compromise vascularity and can result in bunching of the axons at the repair 
site(108). This leads to distortion of fascicular alignment and can increase the number of axons 
escaping extra-fascicularly. Herniation of axons out-with the repair site is sometimes 
unavoidable and in these situations, it is good practice to sharply transect these fibers and 
allow them to retract back inside the repair(15, 109, 110).  
 
Suture bites can be placed at the level of the epineurium, perineurium or can encompass both 
connective tissue layers. When nerves are small and monofascicular or when, in larger 
nerves, fascicular topography cannot be easily discerned and accurately re-established, 
epineurial suturing is performed. This approach is also preferred when injury occurs at more 
proximal levels where nerves are more often mono- or oligofascicular and considerable 
mixing of motor and sensory fibers exist. When fascicular topography can be easily 
distinguished, group fascicular repair can be performed in order to more accurately align 
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individual fascicles, reduce the incidence of sensory-motor mismatching and therefore 
improve outcome. Fascicular re-orientation can be aided by aligning epineurial blood vessels 
in the proximal and distal stumps. Although evidence exists suggesting a superiority of group 
fascicular repair over epineurial suturing in rodent models, evidence of this in higher order 
animals such as non-human primates is lacking(111-113). No well-controlled clinical trials have 
been performed. The main disadvantage of group fascicular repair is that the technique 
requires considerably more tissue handling, dissection and a higher suture burden in the 
nerve, all of which can lead to increased scar tissue formation and may compromise axonal 
regeneration. In addition, inadvertently coapting mis-matched fascicles together with perfect 
technique may be expected to have a more detrimental impact on recovery than a poorly 
performed epineurial repair.    
 
The identity of fascicles can be established by several techniques. Intraoperative stimulation 
of proximal and distal nerve stumps, in the case of transection, or along a segment of 
suspected fourth degree injury, can yield very useful information(114-117). With the patient 
awake, and with appropriate regional anaesthesia, stimulation of proximal motor fibers elicits 
a dull aching sensation whilst stimulation of sensory fibers results in a sharp pain in the 
distribution of the nerve. Initial dissection is performed under tourniquet although tourniquet 
time is limited to 30mins in order to avoid a neuropraxic injury that could interfere with 
stimulation and recording. In the acute setting following injury, if stimulated, the distal nerve 
stump will continue to produce muscle contractions for approximately 72-hours(107). Action 
potentials will also be detectable in sensory fibers for this duration(107). In cases of fourth 
degree injury, again with the patient awake, the surgeon can establish the extent of injury by 
stimulating systematically along the length of the nerve. Stimulation in an area of scarred, 
non-functioning nerve will obviously elicit no response. As stimulation moves proximally, 
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when healthy nerve is encountered, a sensory response will be detected. If stimulation occurs 
out with the critical 72-hour period, fascicles can be identified distally, distal to the point of 
anatomical segregation, and traced proximally to the point of injury.     
 
Intraoperative conduction studies can also provide information on the viability of injured 
nerve(107). Segments of nerve are assessed with stimulating and recording electrodes 
separated by a length of several centimeters. Stimulation pulses of increasing voltage 
amplitude are then used until an action potential is triggered. The proximal nerve, injured 
segment and distal nerve are sequentially evaluated. Lengths of adjacent, normal nerve can be 
activated and examined as a control and to ensure that the equipment is functioning 
satisfactorily. If no conduction exists across a segment of injured nerve and in the distal 
segment, this implies considerable neurotmetic injury and intraneural scar requiring excision 
and grafting of the involved segment. If high stimulating amplitudes are required for 
conduction but conduction remains intact, this suggests a first to third degree Sunderland 
injury. Neurolysis may be all that is required. Poorer conduction may require careful 
examination of individual fascicles. This technique is of particular relevance when 
confronted with a sixth degree Mackinnon injury. This pattern of injury is typified by a 
neuroma-in-continuity and may consist of a spectrum of axonotmetic and neurotmetic 
injuries. It is recommended in these situations that dissection in the area of scar or neuroma is 
avoided in order to reduce the chances of injuring healthy, recovering fibers. By considering 
the information gained from clinical examination and electrical testing, those fascicles that 
are irreparably damaged are excised and grafted whilst those that are free from scar and have 
intact conduction are preserved. 
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Histological methods for distinguishing motor from sensor fascicles have existed for many 
years(118, 119). These techniques rely on the detection of cholinesterase enzymes in motor 
fascicles and carbonic anhydrase in sensory fascicles. Although originally the process took 
24-hours, currently results can be returned to the surgeon within one hour. In common with 
electrical stimulation of the distal nerve stump following injury, staining of enzymes is only 
possible for 5-days following injury. As a result, in a large proportion of cases, useful 
topographic information can only be obtained for the proximal stump. Additional limitations 
are that it requires biopsy of the nerve, is time consuming and it requires a costly, dedicated 
histology service. Some report superior outcomes but due to the limitations of the technique, 
it has not been widely adopted.  
 
1.3.4 The nerve gap 
A nerve gap is the distance between two injured nerve ends and can result from primary loss 
of tissue following severe trauma or can result from the surgical resection of nerve. Resection 
may occur acutely as part of a debridement, sub-acutely after 2-3 weeks when the extent of 
injury is not immediately apparent, or may be performed following a longer delay for lesions 
in continuity when it becomes obvious that recovery is not progressing. In the latter two 
examples, the scarred segments are often different in appearance and consistency in 
comparison to healthy nerve. Under loupe or microscopic examination, the sectioned nerve 
end that lies within the area of scar tends to be a homogenous block resembling ground glass 
with complete loss of fascicular organization. With serial sectioning, the re-appearance of 
healthy bulging endoneurium and fascicular arrangement becomes apparent(107). These 
observations are relied upon, in addition to the electrophysiological techniques previously 
discussed, in order to accurately determine the amount of nerve that requires removal prior to 
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reconstruction(107). Added to the gap caused by loss of actual nerve tissue is the distance that 
proximal and distal nerve ends retract. This can be substantial, particularly after prolonged 
periods of delay between injury and reconstruction.  
 
The current standard of care for reconstructing nerve gaps uses autologous nerve as an 
interpositional graft. However, the use of autografts necessitates the harvest of an 
“expendable” donor nerve and is associated with prolonged operating time, additional 
scarring, sensory loss and increased risk of neuroma formation. In cases of major trauma 
associated with substantial tissue loss, the demand for autograft may exceed that which can 
be harvested from the patient. Although rare in civilian practice, this scenario has become 
more frequent in recent years following the return of wounded warfighters from Iraq and 
Afghanistan who have sustained major nerve injury and limb amputations, often secondary to 
injuries caused by improvised explosive devices. In these challenging patients, alternative 
strategies must be employed for nerve reconstruction. Alternatives to nerve autograft include 
nerve allografts and nerve guidance conduits, although regeneration through these materials 
has typically been unable to match that of the autograft. As a result, research into improving 
regeneration through these products has intensified in recent years.  
 
1.3.4.1 Nerve autograft  
Although, in theory, any nerve can serve as a donor, a limited few are used routinely. In order 
to be suitable for use as a donor, nerves must be of sufficiently small caliber in order to 
ensure that revascularisation is not problematic and they must be “expendable” in the sense 
that the resulting loss of function is inconsequential for the patient. The commonly used 
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nerves are all sensory and include the sural nerve, medial and lateral antebrachial cutaneous 
nerves, the superficial, sensory branch of the radial nerve and the saphenous nerve. 
Ultimately, the choice is dictated by what nerve has been injured and the extent of the gap 
that requires bridging. For digital nerves, a reasonable size match can be achieved by using 
single cables of one of the above nerves. If a smaller caliber nerve is required then branches 
of the main nerves can also be used. For the reconstruction of larger, multifascicular nerves 
such as the median and ulnar nerves, several cables may be required. Once the gap length and 
the number of fascicles that required grafting are known, the length of required donor nerve 
can be estimated. Once grafts are harvested, they are stored in cool, moist gauze until ready 
for use. Analogous to blood vessels, nerves branch as they move distally. In order to reduce 
the proportion of axons that are lost down these branches, nerve grafts are reversed prior to 
suturing. This essentially creates a funnel of convergence for the axons as they move towards 
the distal stump. At the distal neurorrhaphy site, the epineurium or perineurium of the distal 
stump can be sutured so that it overlaps that layer of the graft, further improving axonal 
capture. The number of sutures used for each cable graft is kept to a minimum, often two or 
three 9-0 or 10-0 nylon. In order to further reduce the reliance on sutures, the strength of the 
repair site can be augmented with fibrin glue. Fibrin glue also helps reduce tension and 
gapping at the repair site, the formation of which results in the deposition of scar(120).       
 
In light of the aforementioned centripetal vascular supply of nerve grafts, it would seem 
logical that the use of vascularized nerve grafts would be preferable to conventional, non-
vascularized grafts. This would be of particular relevance in severely scarred, poorly 
vascularized wound beds. Initially, vascularized grafts included an axial vessel with the 
nerve. More recently, the use of pedicled nerve grafts has largely been supplanted by 
microsurgical techniques(121). Many preclinical comparisons between vascularized and non-
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vascularized grafts have been performed and have provided support for(122-126) and against(127-
130) vascularization. In spite of these reports, there is a dearth of well-designed, randomized 
controlled trials showing a clear clinical benefit. In addition, very few studies have 
investigated the efficacy of these grafts in poorly vascularized, clinically relevant scenarios. 
Clinically, the use of non-vascularized grafts is limited to small caliber sensory nerves as 
previously discussed. If indicated, the use of larger, motor nerves requires vascularization in 
order to avoid central avascular necrosis.  
 
1.3.4.2 Nerve allograft  
Nerve allografts provide the most accurate representation of intraneural architecture and 
axonal guidance. Initially, allografts were fresh and cellularized, requiring 
immunosuppression to overcome rejection and preserve donor SC viability over the course of 
recovery. Early experiments in immunosuppressed rats and non-human primates produced 
outcomes that were comparable to autograft(131-135). These observations were partly related to 
the pro-regenerative effect of immunosuppressant therapy. However, due to the risk of 
infective and neoplastic disease, this approach has been disfavored and has driven the 
development of decellularization protocols and the use of acellular nerve allograft (ANA). 
Initial attempts at decellularization involved thermal and chemical processing and, although 
technically successful, produced poor regenerative outcomes as a result of inadequate 
preservation of extracellular matrix (ECM) components and insufficient removal of cellular 
debris (136, 137). In 2004, Hudson et al described an optimized detergent-based protocol that 
resulted in superior histological outcomes in comparison to those previously described 
methods (138). In 2007, human ANA (Avance, AxoGen Inc), processed by a modified 
detergent-based method, was approved for clinical use (139).   
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Although obviating the requirement and risks of immunosuppression, decellularization 
removes SCs and other pro-regenerative components. The detrimental impact this has on the 
extent and rate of regeneration in comparison to conventional autograft has been consistently 
demonstrated in animal models of large gap injury (136, 140). This long-standing impasse has 
prevented widespread clinical acceptance of ANA. Leaders in the field reserve ANA for 
small diameter, non-critical sensory nerve defects of less than 4cm, for restoring autograft 
donor site sensation, for nerve supercharging and for end-to-side nerve transfers in the hand. 
The use of ANA for the reconstruction of motor nerves, large diameter nerves, critical 
sensory nerves and sensory nerves greater than 4cm in length has been discouraged(141). This 
practice has been based on the scarcity of good quality clinical evidence and the fact that 
existing evidence is often compounded by small sample sizes, the inclusion of sensory nerves 
only, small nerve gaps and the lack of autograft control groups (142-144). However, in 2012, 
Brooks et al published results from the first comprehensive multi-centre trial and showed that 
Avance was safe and resulted in “meaningful” recovery in 87% of those cases recording 
quantitative outcomes (139).  Cho et al have also reported results from the RANGER study and 
conclude that, for gaps between 5-50mm, ANAs can produce motor and sensory outcomes 
that are comparable to autograft and superior to hollow conduits (145). 
 
Broadening the clinical application of ANAs and ultimately supplanting autograft provides 
strong impetus to improve regeneration through ANAs. Recent efforts have focused on the 
supplementation of ANA with neurotrophic factors, SCs and stem cells. Although 
conceptually exciting, preclinical experience has been disappointing. Although a tissue 
engineered or cell-based solution is far from being realized, addressing other, technical 
aspects of conventional suture coaptation may offer a more simplistic and rapidly translatable 
solution.  
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1.3.4.3 Nerve conduits  
Nerve conduits can be broadly classified into either natural or synthetic. Natural conduits 
obtained from autologous sources such as bone, artery, vein, muscle and tendon have been 
used clinically for well over one hundred years(146, 147). The use of small superficial veins 
represents an expendable and widely available autologous source and has been shown by 
many to result in meaningful recovery of function when used for small gaps involving 
sensory nerves. Due to the flimsy nature of small veins, luminal collapse and obstruction to 
regeneration can be problematic. Prevention of this has been attempted by including small 
amounts of nerve or muscle tissue within the lumen of the vein(148-151). In addition to physical 
support, nerve and muscle tissue also provide ECM proteins, SCs and neurotrophic factors 
that may provide biochemical and architectural support to regenerating axons. Another 
autogenous material that has shown some efficacy is tendon. As with vein grafts filled with 
luminal support, tendons consists of parallel arrays of collagen fibrils and ECM proteins that 
can act as guidance channels supporting axonal regeneration. Several investigators have 
shown promising results with these materials but none have been shown to be superior to the 
nerve autograft(152, 153). The main disincentive with using autogenous material as a nerve 
conduit is the morbidity of harvest. The harvest of autogenous artery, vein or tendon can 
involve a second surgical site, compounding the risks of bleeding, infection, abnormal or 
painful scarring and wound breakdown. These factors have driven the search for a suitable 
synthetic alternative.      
 
Several different synthetic materials have been used to manufacture guidance channels, some 
of which are approved for clinical use. Synthetic conduits can be further categorized into 
either non-absorbable or absorbable. Silicone is perhaps the most well known example of a 
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non-absorbable conduit material. Although initially popular, these products suffered a high 
incidence of nerve compression, local immunoreactivity and patient discomfort, necessitating 
explantation in many cases(154). Recently, an alternative non-absorbable conduit composed of 
a biocompatible polyvinyl alcohol (PVA) hydrogel has been FDA approved. Currently, 
insufficient experience with this product exists to permit robust assessment. It remains to be 
seen whether this product offers any significant advantage over previous non-absorbable 
materials or indeed, other absorbable alternatives, or whether it suffers from similar 
aforementioned limitations of compression and immunoreactivity(155). As a result of these 
limitations, the majority of products now FDA approved and clinically available, are 
composed of absorbable materials. Examples of these include type-I collagen, polyglycolic 
acid (PGA) and poly-DL-lactide-caprolactone (PLCL). Success with other materials such as 
fibrin(156, 157), poly-3-hydroxybutyrate (PHB)(158) and chitosan(159) has also been described. 
Conduits manufactured from components of the ECM such as collagen and fibrin may have 
superior cell adhesion characteristics and a more predictable, non-toxic degradation in 
comparison to other artificial conduits. Organic polymers such as polypyrrole or electrically 
poled poly(vinylidene fluoride) are good electrical conductors. Conduits composed of these 
materials that are subsequently stimulated with low frequency electrical currents have been 
shown to improve rates of axonal regeneration(160).      
 
It is generally accepted that the application of inert, hollow nerve conduits is limited to short 
gaps (<3cm)(161). Nevertheless, optimizing regeneration through these products has important 
clinical implications and as a result, huge efforts have been focused on this subject. 
Researchers have manipulated physical properties such as conduit material, flexibility, 
strength, permeability, luminal profile, diameter and internal architecture(155). In recognition 
of the importance of axonal guidance, the design and manufacture of increasingly elaborate 
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intraluminal architecture has been attempted to recreate native intraneural conditions(155). 
Likewise, conduits have been supplemented with SCs, stem cells, extracellular matrix 
proteins and neurotrophic factors in an attempt to recreate the optimal biochemical conditions 
found following simple transection and end-to-end repair(146, 155). However, the temporal and 
spatial regulation of cells and biochemical mediators is an incredibly complex and 
incompletely understood process and, at this time, it is uncertain whether this goal is 
realistically achievable. Advances in the fields of biotechnology and tissue engineering, and 
the application of these approaches to the development of “bioartificial” guidance channels, 
may eventually provide a conduit that can supplant the nerve autograft.   
 
1.3.5 Sutureless approaches to peripheral nerve repair 
The use of suture for neurorrhaphy has several well-known limitations. Excessive 
manipulation of nerve ends and needle passage through tissues results in iatrogenic trauma. 
Although inert, suture material is inflammatory, resulting in fibrosis and intra and extra-
neural scar tissue formation(162). Scar tissue not only presents a direct obstacle to regenerating 
axons but can also lead to tethering, traction neuritis and external compression, all of which 
can compromise outcome. Even under high magnification and with meticulous technique, 
coaptation sites are imperfect. Leakage of growth promoting factors and mis-guided axons 
into adjacent tissues further compromises outcome and likely contributes to neuroma 
formation(163-165). These effects may be exacerbated in the context of gap injury and nerve 
grafting when axons must traverse two coaptation sites. Reducing the suture burden at the 
repair site or, ideally, obviating the requirement for suture completely, is a logical solution to 
try and improve regeneration and outcomes following repair.   
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Several sutureless methods of nerve repair have been thoroughly investigated. Fibrin sealants 
and laser-assisted techniques represent two of the most extensively studied(166-168). Fibrin 
sealants rely on the combination of fibrinogen and thrombin to form a fibrin clot. Although 
originally designed for hemostasis, “off-label” application as an adhesive for peripheral nerve 
repair dates back to the 1940s(169). Proponents claim that fibrin glue can be rapidly applied, 
results in less scar tissue formation, and can improve outcomes(166, 170-174). In contrast, others 
have reported excessive fibrosis, inferior bond strength and high rates of dehiscence(175-178). 
Introduced in the 1980s, laser welding of peripheral nerves has generally been performed 
using carbon dioxide and argon lasers(167). A photothermal reaction at the repair site creates a 
bond from the coagulum of denatured protein. Proposed advantages include shorter repair 
times, reduced incidence of inflammation, scarring and neuroma. In one rodent model, laser 
welding was found to be at least as effective as fibrin glue and epineurial suture(167, 179). 
However, due to thermal damage, poor bond strength and high rates of dehiscence, the 
technique has not been clinically adopted(180-185). The introduction of biological solder such as 
fascia or bovine albumin promised to enhance bond strength and limit thermal damage but 
interest in its potential has largely been abandoned(167, 185, 186).  
 
The role of non-penetrating clips and anastomotic couplers has become commonplace in 
micro- and macrovascular anastomoses. The application of these techniques to the repair of 
peripheral nerves has also been investigated(187-189). Anastomotic couplers rely on the 
insertion of divided nerve ends through two separate but closely apposed rings connected by 
a spring-mounted hinge. The opposing sides of each ring possess spikes. Once vessel or 
nerve ends are inserted through the rings, vessel wall or epineurium is everted over the 
spikes. As the hinge is closed, the spikes interlock and the coapted nerve or vessel can be 
detached from the device. Studies have shown that the technique is faster than conventional 
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suture anastomosis although no clear functional or histological benefit has been 
demonstrated(190). One study showed that nerves repaired using a coupler device showed 
evidence of compression at the repair site due to fibrous tissue ingrowth although this did not 
appear to have a detrimental impact on outcomes. In the same study, axonal escape from the 
repair site into the surrounding tissues was considerably less in comparison to suture 
repairs(189). Non-penetrating vascular closure staples (VCS) are made from titanium and are 
inert. They aim to grip and appose only the epineurium and have been shown to be a more 
rapid method of nerve coaptation than conventional suture. However, as with anastomotic 
couplers, functional and histological outcomes following the use of these staples have not 
been shown to be significantly better than suture(187, 188).  
     
Photochemical tissue bonding (PTB) is a recently developed platform technology that offers 
an additional alternative to conventional suture. The technique differs from laser welding as it 
uses visible light to create bonds between apposed tissues that have been pre-stained with a 
non-toxic, photoactive dye. Dye photoactivation results in the liberation of reactive species 
from tissue proteins, covalent bond formation between amino acid residues and the formation 
of a protective seal with no thermal damage(191-194). The absence of collateral thermal damage 
is a distinct advantage over laser welding. When applied to peripheral nerve repair, this light 
activated technique can be used to bond transected nerves together. A biological nerve wrap 
is stained with photoactive dye and is wrapped circumferentially around dye-stained coapted 
nerve ends. Subsequent illumination of the nerve wrap interface results in bond formation 
between the epineurium of nerve ends and the bridging wrap. In order to allow light to 
penetrate through the nerve wrap, the biological material in question must be very thin and 
transparent. Materials that have shown success include chitosan and human amnion(195, 196).  
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1.4 Human amnion as a biomaterial  
1.4.1 History  
Prior to the realization of its medical and surgical applications, human amnion was the focus 
of myth, legend and superstition(197). Being born with the fetal membranes or “caul” intact 
was considered extremely lucky. In addition to good fortune, it was believed children were 
gifted with life-long happiness, the ability to see spirits, and protection from death by arms 
and drowning. The magical powers of the caul were not confined to the original bearer and 
could be transferred by inheritance or by legitimate sale. As a result, the trade of caul amulets 
became extremely popular, particularly between seafaring men during the 1800s at the time 
of the Napoleonic War(197). In the early 1900s, amnion was found to be an effective dressing 
for wounds of multiple aetiologies(198, 199). Investigators claimed that time to healing and 
infections were reduced when using fetal membranes. Over the last 100 years, the therapeutic 
benefits of amnion have been observed following application for burns, chronic vascular and 
diabetic ulcers, dural defects, intra-abdominal adhesions, peritoneal reconstruction, genital 
reconstruction, hip arthroplasty, tendon repair, microvascular repair, corneal repair, intra-oral 
reconstruction and reconstruction of the nasal lining and tympanic membrane(198, 199). More 
recently amnion has been shown to be a viable source of stem cells with a potentially exciting 
future in regenerative medicine(200-203).  
 
1.4.2 The anatomy and physiology of human amnion 
Amnion forms during the transition of the morula into the blastocyst at approximately 7-days 
following fertilization(204). The amnion is between 0.02-0.05mm thick and consists of five 
distinct layers: (1) epithelium, (2) basement membrane, (3) compact layer, (4) fibroblast 
layer, (5) spongy layer (figure 2). The epithelium is the innermost layer, consists of a single 
layer of cells and is in direct contact with the amniotic fluid. The free border of the cell is 
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covered with microvilli. The basement membrane border of the cells contains blunt 
projections that inter-digitate with similar processes in the basement membrane, forming a 
densely adherent bond. The basement membrane is a thin layer composed of reticular fibers. 
The compact, fibroblast and spongy layers are collectively referred to as the amniotic 
mesenchyme and originate from the primary extra-embryonic mesoderm of the blastocyst. 
The mesenchyme contains collagen I-VII,  
 
 
Figure 2. Schematic of the layers of human amniotic membrane. The amniotic epithelium lies adjacent to 
the amniotic fluid. The histological layers lying external to the epithelium include the basement membrane, 
compact layer, fibroblast layer and the spongy layer. The compact, fibroblast and spongy layers are collectively 
referred to as the amniotic mesenchyme and form an interface between the epithelium and the chorion.   
 
elastin, laminin and fibronectin. The compact layer is composed of a dense network of fibers 
and is almost entirely free from cells. The majority of the tensile strength originates from this 
layer. The fibroblast layer is the thickest amniotic layer and is composed of a loose fibroblast 
network within a matrix of reticulin. The outermost spongy layer represents the transitional 
layer between amnion and chorion and is composed of bundles of reticulin within a 
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background of mucin. The two layers are loosely adherent, allowing a degree of gliding 
during gestation and easy separation by blunt dissection during harvest(199). During the course 
of gestation, the structure and composition of these layers changes.  
 
The amnion protects the fetus from mechanical stress and desiccation. Uniaxial tensile 
strength is due to abundant type-1 and 2 collagen and elastin within the mesenchyme. 
Elasticity is related to type-3 collagen content(205). The presence of microvilli at the apical 
surface of amniotic epithelial cells is thought to play an important role in the production and 
regulation of amniotic fluid homeostasis(198). 
 
Amnion lacks vascularity and receives oxygen and nutrients by diffusion from adjacent 
amniotic fluid and chorionic vasculature(199). In spite of this, amnion is metabolically active 
and is responsible for the production of multiple vasoactive peptides, growth factors and 
cytokines(205). The mesenchyme accumulates these growth factors and may act as a reservoir 
from which the amnion exerts its beneficial effects following transplantation. 
 
Amniotic epithelium has been shown to be a source of prostaglandins, particularly 
prostaglandin-E2, and is thought to play an important role in the initiation and maintenance 
of uterine contractions during parturition(206). The epithelium also contains human chorionic 
gonadotrophin receptors that have a role in the regulation of prostaglandin production and 
activity.   
 
1.4.3 Collection, processing and storage of human amnion 
Elective cesarean section donors undergo rigorous serological screening for HIV-1/2 (human 
immunodeficiency virus-1/2), Hepatitis B, Hepatitis C, HTLV (human T-cell lymphotrophic 
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virus), syphilis, CMV (cytomegalovirus), and TB (tuberculosis)(207). Following delivery, 
amnion is separated from the placenta by blunt dissection (figure 3). Once gross 
contaminants are removed, amnion is usually de-epithelialised to limit immunogenicity, 
sterilised to reduce risks of disease transmission, and preserved to improve longevity and 
convenience for storage. Improvements in processing have focused on preserving membrane 
architecture and growth factor content in order to optimise therapeutic effect(198, 207, 208). 
 
 
Figure 3. Blunt separation of amniotic membrane from placenta. Using aseptic technique, amniotic 
membrane is peeled off the placenta. Due to the loose adherence between the amniotic mesenchyme and the 
chorion, separation is easily achieved using blunt dissection.  
 
De-epithelialisation can be performed by mechanical scraping or exposure to chemicals(207). 
It is uncertain how these protocols affect the levels of growth factors and ECM proteins. 
Koizumi et al showed that, although amnion denuded of its epithelium contained EGF, TGF-
α, KGF, HGF, bFGF, TGF-β1, and TGF-β2, protein levels were reduced in comparison to 
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samples with intact epithelium(209). Whether this is clinically significant is uncertain. 
Neurotransmitters, neurotrophic factors and neuropeptides are concentrated in the epithelium 
and therefore amnion with intact epithelium may be superior when applied to neural 
injury(210). In contrast, denuded amnion results in superior cell adhesion, migration and 
proliferation and therefore may be preferable when applied to acute and chronic wounds(211). 
As the majority of clinical applications concern wound healing, the use of denuded amnion 
has greater representation in the literature.   
  
Developed in the late 1980s, cryopreservation in glycerol is the most widely used 
preservation technique. Anti-bacterials and anti-fungals are often added before freezing at -
80°C. Cells are devitalised although not sterilized(212). Viable bacteria and viruses can be 
present following several months of storage(213). The effect on biological properties is 
uncertain. Thomasen et al reported no detrimental impact on sterility, histological integrity or 
the availability of biological mediators. Amnion cryopreserved in 50% glycerol/DMEM 
(Dulbecco’s Modified Eagle’s Medium) at -80 degrees for 1-month contained epidermal 
growth factor (EGF), transforming growth factor-α (TGF-α), TGF-β1, -β2, -β3, keratinocyte 
growth factor (KGF), hepatocyte growth factor (HGF), basic fibroblast growth factor (bFGF), 
keratinocyte growth factor receptor (KGFR) and hepatocyte growth factor receptor 
(HGFR)(208). Cryopreservation requires expensive equipment that may be unavailable for 
some institutions, particularly in developing nations.  
 
Lyophilisation is an alternative technique allowing storage of amnion at room temperature, 
obviating the requirement for deep freeze facilities and increasing surgeon convenience. 
Lyophilised membranes are commonly sterilised with gamma irradiation. Concerns exist 
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regarding detrimental changes to membrane architecture and growth factor levels. Nakamura 
et al reported no significant difference in tensile properties, tissue structure or ECM 
composition between lyophilised, gamma-irradiated and cryopreserved membrane(214). Lim et 
al showed that lyophilisation reduced the levels of several growth factors and ECM proteins 
although there was no appreciable difference in clinical performance when compared with 
cryopreserved samples(215). Other methods of preservation and sterilisation exist although 
these are less well accepted.  
 
The variation in processing within the literature makes it difficult to draw definitive 
conclusions on the optimal method. Variation also exists amongst commercially available 
products. Independent of processing technique, several donor specific factors can influence 
the biochemical composition of amniotic membrane. Lopez-Valladares et al showed that in 
fresh, cryopreserved and lyophilised amnion, levels of bFGF, HGF, KGF and TGF-β1 were 
significantly lower in those membranes of greater gestational and maternal age(216). Velez et 
al found significant differences in cytokine profiles between African Americans and 
Caucasians(217). Membrane architecture and growth factor profile can also vary depending on 
what area of amnion a specimen originates from(218). As a result, standardisation of collection 
and processing may be essential if consistent therapeutic results are to be achieved. If 
consistent relationships between donor variables and biochemical profile exist, it may 





1.4.4 Proposed biotherapeutic effects of amnion on healing and regeneration 
1.4.4.1 Non-immunogenicity:  
A fundamental requirement of any implantable material is non-immunogenicity. Conflicting 
reports exist in the literature regarding the presence or absence of human leukocyte antigens 
(HLA) in human amnion cells. Several investigators conclude that human amniotic epithelial 
cells and mesenchymal stromal cells lack HLA class A, B, DR and co-stimulatory molecules 
CD-40, CD-80 and CD-86(219). In contrast, other studies have shown the presence of class-1 
and class-1b antigens in epithelial cells, mesenchymal cells and fibroblasts(220). Other 
radiobiological studies have suggested that although amnion cells retain the ability to 
synthesize HLA, they do not express HLA-A, B, C or DR antigens of β-2 microglobulin on 
the cell surface(221). As the widespread technique of cryopreservation in glycerol renders 
amniotic cells non-viable, this issue is perhaps of little consequence. Regardless of the 
presence or absence of these antigens, it is widely reported that transplantation into 
immunocompetent hosts results in a negligible immune response(198, 199). Mesenchymal 
stromal cells may also inhibit the maturation of peripheral blood monocytes into antigen-
presenting dendritic cells(222).  
 
1.4.4.2 Anti-inflammatory: 
Amnion cells have been shown to express a number of anti-inflammatory mediators. 
Interleukin-10 (IL-10) has been shown to be present in amniotic epithelial cells(223). IL-10 
down-regulates the expression of Th1 cytokines, major histocompatibility complex (MHC) 
class II antigens and co-stimulatory molecules on macrophages(224). It also enhances B-cell 
survival, proliferation and antibody production. IL-10 has also been shown to inhibit the 
production of pro-inflammatory cytokines such as interferon-γ, IL-2, IL-3, tumour necrosis 
factor-α (TNF-α), and granulocyte macrophage colony stimulating factor (GM-CSF) 
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produced by macrophages and regulatory T-cells(224). Other anti-inflammatory mediators 
such as IL-1 receptor antagonist and tissue inhibitors of metalloproteinase-1, 2, 3, 4 (TIMPs) 
have also been found in amnion cells(198, 225-227).  
 
1.4.4.3 Antibacterial  
The presence of infection is detrimental to any healing tissue, resulting in an exacerbated 
inflammatory response and scar tissue formation. Amniotic fluid contains lysozymes and a 
variety of immunoglobulins(228). Although it is uncertain whether these factors are retained 
within amnion cells, many studies have described the antibacterial effect of the amniotic 
membrane. In vitro experiments have shown reduced viability of group-A and group-B 
Streptococcus, Staphylococcus aureus and Staphylococcus saprophyticus in the presence of 
amnion(229). The antibacterial effect is likely mediated by a paracrine-like mechanism rather 
than cell-cell contact. Amnion has also been shown to produce human-beta-3-defensin, an 
antimicrobial peptide(230). Amnion epithelial cells can also be induced to express intercellular 
adhesion molecule-1 (ICAM-1) by pro-inflammatory cytokines such as tumour necrosis 
factor-α (TNF-α) and IL-1β(231). ICAM-1 has a recognized role in the attraction and adhesion 
of leukocytes and may also have a role in signal transduction in pro-inflammatory pathways 
resulting in the recruitment of inflammatory mediators such as macrophages and 
granulocytes(232).  
  
1.4.4.4 Inhibition of fibrosis and scar: 
TGF-β1, β2, β3 are partially responsible for the proliferation of fibroblasts and thus the 
synthesis and deposition of extracellular matrix proteins by increasing the generation of 
protease inhibitors, cellular adhesion molecules and by inhibiting the production of matrix 
degrading proteases(233). Hyaluronic acid within the amniotic mesenchymal layer may inhibit 
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TGF- β and therefore the over-activity of fibroblasts, their conversion into myofibroblasts 
and ultimately the generation of fibrosis and excessive scar(209). The inhibition of intraneural 
and extraneural scar tissue formation could result in greater numbers of axons regenerating 
across the repair site and also reduced rates of post-operative tethering and traction neuritis 
respectively.   
 
1.4.4.5 Regulation of angiogenesis: 
Early reports attributed the beneficial effects of amnion on wound healing to a promotion of 
angiogenesis(234). The presence of platelet derived growth factor (PDGF) and vascular 
endothelial derived growth factor (VEGF) are suggestive of a pro-angiogenic role(235). In 
addition, bFGF has been shown to have an even greater pro-angiogenic influence than PDGF 
and VEGF and is responsible for the proliferation of fibroblasts forming granulation 
tissue(235). The presence and supplementation of pro-angiogenic factors during nerve 
regeneration, particularly when using de-vascularised nerve grafts, could potentially result in 
expedited and improved regeneration and therefore outcomes following repair.  
 
1.4.5 The application of human amnion to the repair of peripheral nerves 
Amnion is very thin and transparent and has zero inherent elastic memory. These features 
make it a potentially favourable material for use as a nerve wrap. Even when applied to very 
small nerves with a diameter of 1mm or less, amnion readily wraps circumferentially and is 
adherent upon itself. As with other nerve wraps amnion is believed to provide a protective 
barrier at the neurorrhaphy site. In one study, amnion was used to wrap autografts following 
the repair of 10mm sciatic nerve gaps. Amnion treated nerves had reduced scar tissue 
formation, a finding believed to result in reduced obstruction to regenerating axons and the 
prevention of nerve tethering, traction injury and ischemia(236). In addition to acting as a 
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barrier, amnion has also been shown to be useful for the manufacture of nerve conduits(237-
240). In one study, amnion conduits resulted in outcomes that were comparable to autograft 
and superior to that achieved with silicone conduits(238). The authors concluded that amnion 
represented an ideal conduit material based on the fact that it is biodegradable, non-
immunogenic, readily available, semi-flexible, is easily manufactured into different lengths 
and diameters and may contain important neurotrophic factors. The same group also showed 
that amnion conduits were also suitable for the inclusion of a hyaluronic acid/nerve growth 
factor media and showed that the combination of media and amnion wrap resulted in superior 
outcomes in comparison to amnion wraps alone(239). Although the aforementioned studies 
report superior outcomes in comparison to conventional nerve autograft at early time points, 
at the end of follow-up, early advantages were often lost. The demonstration of initial 
equivalency with autograft was encouraging although the ultimate goal of surpassing 
outcomes achieved with conventional suture and autograft remain unmet.  
 
It is possible that amnion fixation with suture causes a detrimental impact on regeneration. In 
recent years, collaborative work between the Plastic Surgery Research Laboratory and the 
Wellman Centre for Photomedicine at The Massachusetts General Hospital has demonstrated 
that amnion nerve wraps can be photochemically bonded to the epineurium of nerves. Light-
activated sealing of nerve coaptation sites obviates the requirement for suture fixation and has 
been shown to result in superior functional and histological outcomes in comparison to 
conventional techniques(240-243). As has been highlighted in previous studies, it is likely that 
these observations are related to a reduction in scar tissue formation, the prevention of axonal 
escape, and the presence of growth promoting and anti-fibrotic factors within amniotic 
membrane. Unique to the process of photochemical bonding, it is believed that the creation of 
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a protective seal may enclose and prevent the leakage of beneficial neuro-regenerative 
factors.  
 
Photochemical bonding has also been used to seal amnion conduits and has been shown to 
support regeneration across short nerve gaps(240). Despite early success with rodent models of 
end-to-end nerve repair, subsequent application of this technique in a rabbit model of large 
gap injury led to high rates of dehiscence at the distal coaptation sites. These observations 
were thought to be a consequence of proteolytic degradation of amnion nerve wraps, and 
light-activated bonds, prior to the arrival of regenerating axons during long periods of 
recovery (unpublished results, Plastic Surgery Research Laboratory, The Massachusetts 
General Hospital, Boston). Studies specifically investigating the in vivo degradation of 
human amnion are lacking. Rapid proteolytic degradation within one week has been observed 
when untreated amnion is applied to the treatment of corneal ulcers(244). Glutaraldehyde 
treated human amnion microvascular interposition grafts were still present after 4 weeks of 
implantation in a rodent model(245). Untreated human amnion nerve conduits were completely 
degraded after four months in a rodent model of sciatic nerve repair(238). In another similar 
study, amnion conduits were still present after three months, although these had been photo-
crosslinked prior to implantation(240). It is uncertain from these reports exactly how long 
amnion persists in vivo although it is possible that, with pre-implantation crosslinking, the 
material can survive for several months.    
 
Cross-linking of biomaterials reduces enzymatic degradation and improved durability and 
can be readily applied to the collagen matrix of amnion. Chemicals such as glutaraldehyde 
and physical methods such as gamma and electron beam irradiation are common crosslinking 
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methods but are limited in this application by toxicity issues and inconsistent cross-linking 
density respectively(246-250). The water soluble carbodiimide, 1-ethyl-3-(3-
dimethylamionopropyl) carbodiimide hydrochloride (EDC), is an alternative non-toxic agent 
resulting in carboxyl-to-amine cross-linking between proteins. Often used in combination 
with N-hydroxysuccinimide (NHS), EDC has been successfully used to improve 
biomechanical strength and resistance to degradation of several collagen-based biomaterials, 
including amnion(251-255).  
 
1.5 Aims and Hypothesis 
The work presented in this thesis aimed at improving outcomes that typically follow large 
gap peripheral nerve repair. Although, fundamentally, recovery is limited by large 
regenerative distance and slow rates of regeneration, refinements to the technical aspects of 
repair have the ability to improve outcomes in comparison to conventional suture repair. 
Building on previous success with PTB in end-to-end repair, this work assesses efficacy 
when reconstructing large gaps. This assessment takes place over three phases. In recognition 
of previous observations that amnion and light activated bonds undergo proteolytic 
degradation over long periods of recovery, phase 1 aimed to show that chemical crosslinking 
of amnion nerve wraps could improve strength and durability. Several ex-vivo biomechanical 
tests exploring parameters such as maximum load to failure, Young’s modulus and 
photochemical bond strength were performed. To facilitate clinical translation, these tests 
were also performed on a commercially available swine intestinal submucosa (SIS) that is 
approved for human implantation and is already used to manufacture nerve wraps. Following 
on from these tests, a comprehensive assessment of the optimal nerve wrap and fixation 
method was performed in an in-vivo rodent model of large gap injury. Different combinations 
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of three different nerve wraps (untreated amnion (HAM), crosslinked amnion (xHAM) and 
crosslnked SIS (xSIS)) and three different fixation methods (suture, fibrin glue and PTB) 
were used to repair 15mm rat sciatic nerve gaps with isografts and were assessed against 
positive (epineurial suture) and negative (no repair) controls. An attempt was made to 
disprove the null hypothesis that photochemical sealing of nerve graft coaptation sites with 
crosslinked amnion nerve wraps would result in outcomes that were not significantly 
different than those achieved with conventional epineurial suture.   
 
Phase 2 assessed whether light-activated sealing of crosslinked amnion nerve wraps remains 
efficacious when applied to ANA. This phase of the study was incorporated due to the fact 
that following major trauma involving tissue loss and amputation, the demand for autograft 
may exceed that which can be realistically supplied by the patient. Outcomes following the 
use of ANA are typically inferior to that of autografts due to the absence of SCs and 
neurotrophic factors. Improving the performance of these grafts has the potential to improve 
outcomes following these challenging injuries and may avoid the morbidity associated with 
autologous harvest. In an identical animal model to phase 1, ANAs were used to reconstruct 
15mm rat sciatic nerve gaps. Light activated sealing of ANA using crosslinked amnion was 
assessed against gold standard sutured ANA. This phase aimed to disprove the null 
hypothesis that light activated sealing offers no significant advantage over conventional 
suture when applied to ANA.           
    
Previous studies and the initial two phases of this thesis assessed the performance of light 
activated sealing for nerve repair performed immediately following injury. This rarely occurs 
clinically, with repairs occurring days, weeks, months and even years following injury. 
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Unavoidable delays may simply be due to timing of patient presentation although are often 
enforced due to the nature of the injury or the clinical condition of the patient. Significant 
delays between injury and repair have a detrimental impact on regeneration, distal target 
reinnervation and recovery and as a result, the third and final aim of this thesis was to assess 
the efficacy of light activated sealing following a clinically relevant delay in repair. Isografts 
were repaired with photochemically sealed crosslinked amnion or gold standard epineurial 
suture either immediately or following a 30-day delay. This phase aimed to disprove the null 
hypothesis that light activated sealing offers no significant advantage over conventional 











Section 2: Methods 
2.1 Generic Methods  
2.1.1 Nerve wrap biomaterials 
2.1.1.1 Human amniotic membrane (HAM) harvest and processing 
HAM was obtained from elective caesarean section patients who had been screened 
serologically for HIV-1/2, Hepatitis B, Hepatitis C, HTLV, syphilis, CMV, and TB. 
Following delivery, amnion was bluntly removed from the placenta and washed liberally with 
phosphate buffered saline (PBS; Sigma-Aldrich, Co., St Louis, Mo). Membranes were 
mechanically de-epithelialized using a cell scraper, cut into strips, wrapped around 
nitrocellulose paper and placed in a storage solution containing a 1:1 mix of 100% sterile 
glycerol and Dulbeccos modified Eagles medium (DMEM; Gibco, Grand Island, NY), 
penicillin-streptomycin-neomycin (PSN; Gibco, Grand Island, NY) and amphotericin B 
(figure 4). HAM was stored at -80°C until required. Following thawing, HAM was mounted 
onto nitrocellulose paper before being dried and cut into 1cm x 1cm sections (figure 5).  
 
2.1.1.2 Commercially available nerve wraps  
Prior to the use of SIS nerve wraps for in-vivo studies, several commercially available nerve 
wraps and biomaterials were investigated. Collagen based products included: NeuraGen 
(Integra), NeuraWrap (Integra), Tenoglide (Integra), NeuraMend (Stryker), Neuromatrix 











Figure 4. De-epithelialised amnion wrapped around nitrocellulose paper. Amnion is immersed in a storage 
medium consisting of a 1:1 mix of 100% sterile glycerol and DMEM, penicillin-streptomycin-neomycin and 
amphotericin B. Amnion is frozen at -80°C and thawed prior to use.  
 
materials included a mutli-layer product (AxoGuard by AxoGen) and a single layer product 
(Oasis wound dressing by HealthPoint Biotherapeutics). All products were studied under the 
operating microscope to assess their suitability for photochemical bonding and use in the in 
vivo phase of the study. Particular attention was paid to the assessment of material thickness, 
material stiffness, memory and the ability to wrap around the small diameter rodent sciatic 
nerve, and the transparency of the material. In order to ensure close apposition between wrap 
and nerve, the material had to be extremely thin and lack any inherent memory preventing 
circumferential wrapping. The material also needed to be transparent to allow light 
penetration for bonding. Any materials not satisfying these strict inclusion criteria were 
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dismissed from further assessment. A thorough biomechanical assessment was performed 
only on those materials selected for in vivo experiments.   
 
Figure 5. Desiccated and rehydrated amnion wraps. Once thawed, amnion was spread out onto nitrocellulose 
paper and allowed to dry. Once dry, amnion was cut into 10x10mm squares. Amnion wraps were stored in the 











Figure 6. Desiccated and rehydrated SIS wraps. SIS was taken directly from sealed packet and cut into 
10x10mm squares. As with amnion, note the transparency of the material following rehydration, an important 
characteristic facilitating light penetration.  
 
2.1.1.3 Swine intestinal submucosa (SIS) 
Single layer SIS material was obtained from HealthPoint Biotherapeutics Ltd. (Fort Worth, 
TX). This dehydrated material was removed from packaging and cut into 1x1cm sections 
prior to use (figure 6).  
 
2.1.2 Nerve wrap crosslinking  
A 0.05M stock solution of 2-(N-morpholino) ethanesulfonic acid (MES; Sigma-Aldrich, Co., 
St Louis, Mo) buffer was made by adding 9.76g of MES to 1L distilled water. To this buffer, 
EDC EDC (1-ethyl-3-(3-dimethylaminopropyl) carbodiimide/NHS (N-hydroxysuccinimide)) 
(Sigma-Aldrich, Co., St Louis, Mo) and NHS (Sigma-Aldrich, Co., St Louis, Mo) were added 
to arrive at four different crosslinker concentrations: 1mM EDC/0.25mM NHS, 2mM 
EDC/0.5mM NHS, 4mM EDC/1mM NHS, 8mM EDC/1mM NHS. Thawed amnion was 
washed thoroughly as described above in order to remove all trace of storage medium. 
Segments of amnion were added to separate petri dishes containing each crosslinking 
solution and were left on a platform shaker for 1-hour. Following crosslinking, the segments 
of amnion were washed three times with PBS and placed onto nitrocellulose paper to dry 
(figure 7). Once dry, the crosslinked amnion was cut into 1x1cm squares in preparation for 








Figure 7. Crosslinked amniotic membrane.  After immersion in EDC/NHS, amnion was grossly different. 
Amnion became more opaque and on palpation, the material felt stronger than untreated, rehydrated amnion.    
 
2.1.3 In vivo rodent sciatic nerve injury and reconstruction 
The Institutional Animal Care and Use Committee (IACUC) at the Massachusetts General 
Hospital and the Animal Care and Use Review Office (ACURO) at the United States Army 
Medical Research and Command (USAMRC) approved all procedures. Male, inbred Lewis 
rats weighing 250-300g were used for all experiments. This breed was selected in order to 
permit immunotolerant isograft exchange between rodents for nerve gap reconstruction. 
Induction and maintenance anesthesia was achieved using isoflurane (Baxter Healthcare 
Corp. Deerfield IL; 5% induction/2-3% maintenance). Two surgeons performed all 
procedures together. The lead surgeon (N.G.F) was a senior plastic surgery trainee 
experienced in microsurgical technique. The second surgeon was a general surgical trainee 
(J.N.G) who received microsurgical training prior to rodent surgeries. A dorsolateral, muscle-
splitting incision was made on the left hindquarter of each animal. Under the operating 
microscope, the sciatic nerve was mobilized along its length and marked 5mm proximal to 
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the trifurcation. Using digital calipers, nerve grafts measuring 15mm proximal to this mark 
were excised, reversed and exchanged between two simultaneously anesthetized animals 










Figure 8. Rodent sciatic nerve exposure and exchange of nerve grafts. (A) Dorsolateral incision on hindlimb 
of rodent. (B) Muscle splitting incision and freeing of sciatic nerve from investing connective tissue. (C) 
Excison of 15mm length of sciatic nerve from a point 5mm proximal to trifurcation of nerve. (D) reversal of 
nerve harvested nerve graft and transfer into wound of adjacent simultaneously anaesthetised rodent.  
 
For reconstructions using ANA, sections of excised sciatic nerve were simply discarded. For 
experiments involving delayed reconstruction, sections of nerve were discarded and proximal 
nerve ends buried into adjacent muscle. In these cases, reconstruction following surgical 
delay was performed using freshly harvested donor sciatic nerves from Sprague Dawley rats. 
All wounds were closed with 4.0 vicryl (muscle and deep dermal) and 4.0 monocryl 
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(subcuticular). Topical antibacterial ointment was applied to wounds in order to reduce the 
incidence of post-operative infection and bitter apple sprayed onto ipsilateral feet to reduce 
the incidence of automutilation. Rodents were housed in the Massachusetts General Hospital 
small animal facility and had access to food and water ad libitum. 
 
2.2 Experiment specific Methods 
2.2.1 Experiment 1: Ex vivo biomechanical assessment of nerve wrap biomaterials 
Maximum load to failure and Young’s modulus of amnion was measured using a horizontal 
tensiometer (MTESTQuattro, ADMET, Norwood Ma) equipped with a 10N load cell (figure 
9). 10x10mm sections of untreated and crosslinked amnion (n=5) and SIS were rehydrated 
and secured between tensiometer crossheads. Crossheads consisted of parallel grips mounted 
with sandpaper to aid nerve wrap gripping. Crossheads were separated at a rate of 2mm per 
minute until material failure occurred. Material thickness was assumed to be 50µm for 
amnion and 100µm for SIS. This information was entered into tensiometer data fields in 
order to allow MTEST Quattro software to calculate material cross-sectional area, stress, 
strain and Youngs modulus. During testing, hydration of samples was maintained by 












Figure 9. ADMET MTESTQuattro tensiometer. Biological wraps and photochemically bonded nerve/wrap 
interfaces were placed in between opposing crossheads. One crosshead was mounted to a 10N load cell. Tissues 
were secured using mounted plates screwed in placed. Emery paper provided additional traction.     
 
2.2.2 Experiment 2: Type-2 collagenase degradation of nerve wrap biomaterials 
2.2.2.1 Gross degradation test  
Samples of crosslinked amnion and SIS material of uniform weight were prepared and 
digested in 15mls 0.1% type-2 (Clostridium histolyticum) collagenase (Worthington 
Biochemical Corp., Lakewood, NJ). Samples were grossly observed every 15 minutes until 
complete digestion had occurred or it became apparent that digestion was not going to occur 
within 24 hours.  
 
2.2.2.2 Fluorescamine degradation assay 
Samples of crosslinked amnion and SIS of uniform weight were prepared and digested in 
0.1% type 2 (Clostridium histolyticum) collagenase (Worthington Biochemical Corp., 
Lakewood, NJ). At sequential predetermined time points, 100µL of each sample solution was 
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diluted to 1:100. 50µL of each diluted digestion solution was then added to wells on a 96 well 
plate. To each well was added 160µL of 10mM NaBO4. After the addition of 90µL of 0.25% 
fluorescamine (in acetonitrile), sample excitation was achieved by irradiating each well with 
a 405nm light source. Fluorescence intensity was detected in a plate reader at 470nm. From 
this data, micromolar mass of liberated protein per 1mg of amnion and SIS was calculated by 
computer software associated with the plate reader. Untreated samples were not investigated 
by fluorescamine degradation due to the very rapid degradation identified on gross 
observation tests.   
 
2.2.3 Experiment 3: Ex vivo uniaxial bond strength between rat sciatic nerve and 
candidate nerve wraps 
Rat sciatic nerves were harvested from 300g adult male Sprague Dawley rats (Charles River 
Laboratories, Wilmington Ma). Nerves were cut into 1cm sections. 1x1cm sections of 
candidate nerve wraps were stained with 0.1% (w/v) Rose Bengal (RB) (Sigma-Aldrich, Co., 
St Louis, Mo) for 60 seconds. Under 3.2x loupe magnification, RB-stained wraps were 
wrapped circumferentially around RB-stained rat sciatic nerves ensuring that a minimum of 
5mm overlap existed (figure 10). The area of overlap was irradiated for 1 minute using a 
532nm KTP laser (Laserscope, Orchard Dr, San Jose, Ca) at an irradiance of 0.5W/cm2 
(figure 11A). After 60 seconds, the nerve/wrap overlap was rotated 180° in order to irradiate 
the back wall for an additional 60 seconds. Following irradiation, nerve/wrap specimens were 
placed between tensiometer crossheads and distracted until bond failure, as described above 
(figure 11B). Load to failure was also assessed for uninjured rat sciatic nerves and also for 
nerves that had undergone clinically relevant repairs using fibrin glue and epineurial suturing 
using both four and six 10-0 ethilon sutures.   
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Figure 10. RB-stained amnion wrap and circumferential wrapping around RB-stained rat sciatic nerve 
    
Figure 11. KTP laser unit and assessment of uniaxial bond strength of nerve/wrap bonds. (A) Light was 
delivered from the laser unit through an optical fiber. Power output was manually set on the laser unit and the 
actual output from the fiber measured by a power meter. Periodically, the optical fiber had its external cladding 
stripped and was cut in order to ensure that a uniform beam of light was emitted. (B) Following light activated 
sealing, the nerve/wrap preparation was placed in between tensiometer crossheads and was distracted as 




2.2.4 Experiment 4: The effects of amniotic membrane surface (epithelial or chorionic 
surface) on photochemical bonding  
Rodent sciatic nerves and amnion were prepared as described above. Under loupe 
magnification, two groups of nerves (n=5) had amnion bonded either with the epithelial 
surface or the chorionic surface. The nerve/wrap interface was illuminated using the 
parameters described above and bond strengths were assessed by distraction in the 
tensiometer.  
 
2.2.5 Experiment 5: Assessment of laser fluence dose response on photochemical bonding   
Rodent sciatic nerves and amnion wraps were prepared as described above. Under loupe 
magnification, amnion was wrapped circumferentially around nerves and was illuminated as 
described above. Four groups of nerves (n=5) were bonded using a laser fluence of 0, 30, 60, 
120 and 240 J/cm2. Bond strength was evaluated by distracting each repair in the tensiometer 
as described above. A fluence of zero (no illumination) was tested with and without RB 
staining.  
 
2.2.6 Experiment 6: In vivo evaluation of optimal nerve wrap and fixation method for 
reconstruction of large gap rodent sciatic nerve repair 
Nerve wrap biomaterials were prepared as described. 110 rodents were randomized into 11 
groups (n=10). Two groups served as positive (6-epineurial sutures) and negative (no repair) 
controls. The remaining nine groups had nerves reconstructed using different combinations of 
the three different nerve wraps and three different fixation methods (figure 12).   
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Figure 12. Schematic of treatment groups for in vivo isograft phase. Positive controls had 15mm nerve 
isografts repaired using conventional 10-0 epineurial suture. Negative controls had nerve sections excised and 
proximal ends buried into muscle. Distal ends were left free. The remaining nine treatment groups had isografts 
secured using different combinations of the three different nerve wraps and three different fixation methods.  
 
2.2.6.1 Group 1: Negative control (n=10) 
Following the creation of nerve defects, a small incision was made in adjacent muscle. 
Proximal nerve ends were sutured into muscle pockets using two 10.0 Ethilon sutures 






2.2.6.2 Group 2: Positive control (n=10) 
Following nerve exchange, grafts were secured with six 10.0 epineurial sutures at each 
neurorrhaphy site. Following repair, any axons protruding from the repair site were trimmed 
(figure 13).  
 
Figure 13. Control groups. Negative control group had nerve sections excised and proximal ends buried into 
adjacent muscle. Positive control group had 15mm reversed isografts secured with six 10-0 epineurial sutures.  
 
2.2.6.3 Suture fixation (n=10) – groups 3, 4, 5 
Candidate nerve wraps were prepared as described. Following nerve graft exchange, each 
graft was secured into the defect using two 10.0 nylon sutures at each end. Nerve wraps were 
rehydrated for 60 seconds in PBS before being removed from nitrocellulose paper and 
transferred into the surgical field. Once applied circumferentially at each repair site, wraps 
were secured with one proximal and one distal 10.0 suture (figure 14). Great care was taken 




2.2.6.4 Fibrin glue fixation (n=10) – groups 6, 7, 8 
Wraps were prepared and nerve grafts tacked into place as described above. Following wrap 
application, Tisseel fibrin glue (Baxter Healthcare Corp. Deerfield IL) was applied to each 
nerve wrap interface, ensuring that the entire wrap was covered in glue (figure 14). 
 
Figure 14. Methods of nerve wrap fixation. Wraps secured with suture had two tacking sutures placed either 
side of each coaptation site. Wraps secured with fibrin had glue applied all around coaptation sites, ensuring that 
the entire wrap was covered. Bonded wraps had amnion wrapped and sealed as described in the text   
 
2.2.6.5 PTB fixation (n=10) – groups 9, 10, 11 
Wraps were prepared and nerve grafts tacked into place as described above. Prior to transfer 
into the surgical field, wraps and neurorrhaphy sites were stained with 0.1% (w/v) RB for 60 
seconds. After 60 seconds, excess dye was removed. RB-stained wraps were removed from 
nitrocellulose paper and wrapped circumferentially around sciatic nerves, ensuring that a 
minimum of 5mm overlap existed (figure 14 and 15). The area of overlap was irradiated for 
60-seconds using the same laser parameters as previously described. The nerve/wrap was 





Figure 15. Schematic of light-activated sealing technique. Transected nerve ends are apposed. Two 10-0 
tacking sutures are used to overcome any tension between nerve ends. Nerve ends are stained with RB 
photoactive dye for 60 seconds. 10x10mm nerve wrap is also stained with RB for 60 seconds. Circumferential 
wrapping of biomaterial is followed by illumination with 532nm KTP laser. Once the anterior wall has been 
illuminated for 60 seconds, the nerve is rotated 180° and the posterior wall is illuminated for 60 seconds.     
 
2.2.7 Experiment 7: In vivo light-activated sealing of nerve graft coaptation sites using 
acellular nerve allograft (ANA) 
2.2.7.1 Nerve allograft preparation 
Sprague Dawley rats provided donor sciatic nerves. The entire length of nerve from sciatic 
notch to distal trifurcation was harvested. Over-dissection of the nerve was avoided to 
prevent inadvertent structural damage.  Following harvest, nerves were cleaned of gross 
contaminants, placed in PBS and stored at -80°C before being shipped to AxoGen 
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Laboratories for detergent-based decellularization and sterilization. Once processed, nerves 
were returned and stored at -80°C until the day of surgery.  
 
2.2.7.2 Sciatic nerve injury and reconstruction 
Twenty male inbred Lewis rats weighing 250-300g were randomized into two groups (figure 
16). In 1 group (n=10), nerve gaps were repaired using allografts secured with conventional 
epineurial suture. In the remaining group (n=10), nerves were repaired using allografts 





Figure 16. Schematic of treatment groups for in vivo ANA phase. 15mm sections of rat sciatic nerve were 
excised. These gaps were bridged with 15mm ANA. ANA was secured with either conventional 10-0 epineurial 





2.2.7.3 Group 1- ANA+epineurial suture 
Prior to anesthesia, allografts were thawed in a 37°C water bath. Following the excision of 
15mm of sciatic nerve, allografts were placed into the field and cut to length. Grafts were 
secured with six 10.0 epineurial sutures at each site. Following repair, any protruding axons 













Figure 17 Conventional suture fixation of ANA. (A) ANA was in excess of 15mm. (B) Note the brilliant 
white appearance of freshly thawed ANA in comparison to normal nerve. (C) ANA trimmed to 15mm. (D) 




2.2.7.4 Group 2 - ANA+PTB 
Crosslinked amnion and nerve allografts were prepared as described above. Nerve grafts 
were tacked into place using two 10.0 epineurial sutures at each coaptation site. Prior to 
transfer into the surgical field, wraps and coaptation sites were stained with 0.1% RB for 60 
seconds. After 60 seconds, excess dye was removed. RB-stained wraps were wrapped 
circumferentially around sciatic nerves, creating a 5mm overlap either side of the coaptation. 
The area of overlap was irradiated for 60-seconds using the same light source and parameters 
previously described. The nerve/wrap was then rotated 180° in order to irradiate the back 







Figure 18. Light activated sealing of ANA with amnion nerve wrap. ANA grafts before and after light 





2.2.8 Experiment 8: Immediate versus delayed repair of large gap peripheral nerve injury 
using light-activated sealing of human amnion nerve wraps around nerve graft coaptation 
sites  
2.2.8.1 Sciatic nerve injury and reconstruction 
Forty inbred Lewis rats weighing 250-300g were randomized to one of four experimental 
groups described below. A further ten Lewis rats were used as isograft donors. Groups 1 and 
2 had nerve gaps repaired immediately whereas groups 3 and 4 had nerve gaps repaired 
following a 30-day delay (figure 19).  
 
Figure 19. Schematic of treatment groups for immediate versus delayed isograft phase. 15mm gaps were 
created in rat sciatic nerves. These gaps were repaired using isografts either immediately or after a 30-day delay. 
Isografts were secured using either conventional 10-0 epineurial suture or light activated sealing 
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2.2.8.2 Immediate repair: Groups 1 and 2 
Two rodents were anaesthetized simultaneously. Following the excision of 15mm segments 
of sciatic nerve, nerves were reversed and immediately exchanged as isografts between 
animals. In group 1, isografts were secured using six 10.0 Ethilon suture (Ethicon, 
Sommerville, NJ), representing the current standard of care. Following repair, any protruding 
axons were trimmed and allowed to retract within the coaptation site. In Group 2, isografts 
were secured using photochemical sealing. Amnion nerve wraps were prepared as described 
above.  
 
2.2.8.3 Delayed Repair: Groups 3 and 4 
Following the creation of 15mm sciatic nerve defects, a small incision was made in adjacent 
muscle and proximal nerve ends were buried and secured using two 10.0 Ethilon sutures. 
Distal nerve ends were left free. Wounds were closed as described and the animal returned to 
the animal facility. After 30-days, animals were re-anaesthetised. Wounds were re-opened 
and nerve ends dissected and mobilized. Simultaneously, fresh isografts were harvested from 
donor Lewis rats and immediately reversed and transferred into the nerve gap. In group 3, 
isografts were secured with 10.0 Ethilon suture and in group 4, isografts were sealed 






2.3 Outcome assessment 
2.3.1 Walking track analysis  
Walking track analysis was performed immediately prior to surgery for baseline SFI. 
Following surgery, walking track analysis was performed at 30-day intervals. After dipping 
both hind paws in water soluble ink, rats were encouraged to walk up a 10 x 60 cm, partially 
enclosed ramp lined with white paper and set at an incline of 30° to horizontal. 
Measurements of print length, toe spread and intermediary toe spread were measured from 
the resulting prints using digital calipers (figure 20). Mean values from three normal and 
experimental prints were entered into the SFI formula described by Bain and colleagues(256). 
 
Figure 20. Walking track analysis and calculation of SFI. Rodent hindpaws that have been dipped in 
indelible ink leave foot prints. Both experimental (E) and normal (N) prints have toe spread (TS), intermediary 
toe (IT) spread and print length (PL) measured. These values are entered into the above equation to give SFI. 
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2.3.2 Muscle weight retention  
All rodents were sacrificed 150-days post-operatively by carbon dioxide inhalation. Left and 
right gastrocnemius muscles were harvested. Wet weights were recorded immediately and 







     
 
 
Figure 21. Gastrocnemius muscle mass retention. Normal right and experimental left-sided gastrocnemius 
muscles were excised following sacrifice. Muscle weight was measured immediately following harvest and a 
percentage muscle mass retention calculated. Note the obvious reduced muscle bulk in the left sided 
gastrocnemius.  
 
2.3.3 Histology and histomorphometric analysis 
Following sacrifice, nerves were harvested 5mm proximal and 5mm distal to the graft. In 
phase 1, contralateral sciatic nerves from one rat in each treatment group (n=11) were 
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harvested in the same region as distal graft coaptation sites. This permitted interpretation of 
histomorphometric results in relation to what is “normal”. Nerves were immediately fixed in 
a mixture of 2% glutaraldehyde/2% paraformaldehyde (Electron Microscopy Sciences, 
Hatfield, PA). After 48 hours, fixed nerves were washed in sodium cacodylate buffer (0.1M; 
pH=7.4) and post-fixed in 2% osmium tetroxide (Electron Microscopy Sciences, Hatfield, 
PA) for 2 hours. Following further washing in sodium cacodylate buffer, specimens were 
dehydrated in increasing concentrations of ethanol (25%, 50%, 75%, 95%, 100%). Following 
dehydration, all specimens were washed with propylene oxide (Electron Microscopy 
Sciences, Hatfield, PA). Specimens were then placed in increasing concentrations of Epoxy 
resin (DDSA (dodecyl succinic anyhydrides 98+%; Free Acid 2%)/tEPON-812 (Epoxy 
Resin)/NMA Ultrapure (methyl-5-norbornene-2,3-dicarboxylic anhydride)/DMP-30 (2,4,6-tri 
(dimethylaminomethyl) phenol (Tousimis Research Corporation, Rockville, MD) before 
being baked overnight in an oven at 60°C. Using a diamond blade, 1µm sections were cut 
5mm distal to the graft. The lead surgeon (N.G.F) and the laboratory technician (A.M) were 
responsible for all fixation steps and the majority of EPON embedding. Final embedding in 
100% EPON, oven baking, microtome cutting, slide mounting and staining were performed 
by the pathology staff.    
 
Histology slides were digitized using a Hamamatsu NanoZoomer 2.0-HT slide scanner 
(Meyer Instruments, Houston TX) and read using NDP.com software (Hamamatsu Corp. 
Bridgewater, NJ). Images were numbered and their identity concealed during analysis. A 
blinded technician (A.M) manually selected in a random fashion five 400x images from each 
40x slide. All 40x and 400x images were converted into JPEGs and imported into Adobe 
Photoshop (figure 22 and 23). Two blinded researchers (N.G.F and A.M) manually measured 
nerve cross sectional area from 40x images and counted axons from each 400x image. Total 
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counts were entered into a randomization website (randomizer.org) in order to obtain 50 
random numbers. Numbered axons were then identified on each 400x image, from which 
fiber diameter and axon diameter were manually measured using the Photoshop measurement 
tool. These measurements were entered into an excel spreadsheet from which myelin 
thickness (fibre diameter – axon diameter) and G-ratio (axon diameter/fibre diameter) were 
calculated from automated formulas. This provided measurements for 250 axons per distal 
nerve section.   
 
Figure 22. 40x image of isograft cross-section. From these proximal and distal images, total nerve cross 
sectional area was calculated and five randomly selected 400x images were taken. These images were used for 
axon counting and measurement of fiber and axon diameter.   
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Figure 23. Randomly selected 400x images of isograft cross-sections. Images were imported into Adobe 
Photoshop. All axons within each image were counted. Fifty randomly selected axons then had fiber (outer 
diameter) and axon diameters (inner diameter) measured. Myelin thickness was calculated by subtracting axon 
diameter from fiber diameter.   
 
2.3.4 Statistical analysis 
All data has been expressed as mean+/- SEM. Statistical analysis was performed using 
KaleidaGraph for Windows v4.1 (Synergy Software, Reading, PA). For ex vivo, 
biomechanical data, a regression analysis was used to test for the effect that increasing 
crosslinker concentration had on maximum load to failure and Youngs modulus. Analysis of 
variance (ANOVA) was used to assess fluorescamine degradation and photochemical bond 
strengths. Statistical significance was set at p<0.05. For in vivo data, repeated measures 
analysis of variance and the post hoc Bonferroni test was applied to monthly SFI data. Mean 
values across all time points in each group were compared in order to test for the existence of 
significant differences over time. ANOVA and post hoc Bonferroni were also used to analyse 
muscle mass retention and histomorphometric variables. Statistical significance was set at 
p<0.05. In some comparisons, 95% confidence intervals were examined to assess for the 
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possible existence of type 2 statistical errors. Assistance with the data analysis was provided 
by Mr. Douglas Hayden (Harvard Catalyst) and Dr Rob Elton (University of Edinburgh).   
 
2.3.4.1 Comparative analysis of ANA vs Isograft  
In phase two, the efficacy of light activated sealing when applied to ANA is assessed. In 
addition to comparing light activated sealing to conventional suture as a method of fixation, a 
comparison is made between the performance of ANA against gold standard isograft by 
including data from phase one in the statistical analysis. The inclusion of isograft+PTB 
(n=10) and isograft+suture (n=10) groups represents historical controls from phase one and 
helps extend the clinical relevance of this study.  
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Section 3: Results 
3.1 Generic results 
3.1.1 Selection of commercially available nerve wrap biomaterial 
All commercially available nerve wraps (AxoGuard, NeuraGen, NeuraWrap, NeuraMend and 
NeuraMatrix) were unsuitable for use with the rodent sciatic nerve (figure 24). Likewise, 
other materials such as TenoGlide (used to wrap tendon repairs), Colafilm, AmnioFix and 
SurgiMend (acellular collagen matrices used for wound dressings and soft tissue 
reconstruction) were also unsuitable. Single layer SIS material was found to be the most 
suitable product for use as a nerve wrap and was selected for in vivo experiments as a 









Figure 24. Example of a commercially available nerve wrap (AxoGuard). Excessive thickness, stiffness and 
elastic memory prevented satisfactory circumferential wrapping.  
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3.2 Experiment specific results 
3.2.1 Experiment 1: Ex vivo biomechanical assessment of nerve wrap biomaterials 
Mean maximum load to failure of untreated amnion was 0.46+/-0.05N. Maximum load to 
failure increased with increasing crosslinker concentration to a maximum of 0.83+/-0.06N 
and this result was statistically significant on regression analysis (p=0.03; table 1). Maximum 
load to failure for untreated SIS was 2.80+/-0.21N. With increasing crosslinker concentration, 
maximum load to failure increased to a maximum of 4.58+/-0.58N. This was not statistically 
significant on regression analysis (p=0.21; table 1). Mean Youngs modulus for untreated 
amnion was 4.47+/-0.55MPa and this increased with increasing crosslinker concentration to a 
maximum of 9.82+/-0.97 MPa. This was statistically significant on regression analysis 
(p<0.001; table 1). Mean Youngs modulus for untreated SIS was 16.35+/-1.33 MPa. With 
increasing crosslinker concentration, this increased to a maximum of 31.0+/-3.40 MPa. These 
results were statistically significant on regression analysis (p=0.006; table 1). No significant 
differences in photochemical bond strength were observed between untreated, 1mM EDC, 
2mM EDC and 4mM EDC treated amnion. When EDC concentration was increased to 8mM, 
a significant fall in photochemical bond strength was observed (p=0.04; table 1). Due to this 
finding, a maximum concentration of 4mM was selected for in vivo experiments. Bond 
strengths using SIS were not significantly different between untreated samples and those that 
had been crosslinked with 1mM and 4mM EDC (table 1).   





 Nerve wrap material 
 HAM SIS 
Crosslinker 
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Table 1. Maximum load to failure, Young’s modulus and uniaxial nerve/wrap bond strength for amnion 
and SIS nerve wraps. Each biomechanical test took place in n=5 rats. All data expressed as mean+/-SEM. 
A=control sample (uncrosslinked), B=1mM EDC, C=2mM EDC, D=4mM EDC, E=8mM EDC. Assessment of 
effect of crosslinking on maximum load to failure and Youngs modulus performed using regression analysis. 
Bond strengths assessed using ANOVA and post hoc Bonferroni test. *statistically significant in comparison to 
untreated material (p<0.05).     
 
3.2.2 Experiment 2: Type-2 collagenase degradation of nerve wrap biomaterials 
3.2.2.1 Gross degradation test 
Untreated amnion had completely degraded within 30-45 minutes. Untreated SIS had 
completely degraded within 6hrs 15 minutes. All crosslinked samples were still present after 





3.2.2.2 Fluorescamine degradation assay 
Chemical crosslinking of amnion and SIS resulted in significant reductions in type-2 
collagenase degradation and protein liberation. Table 2 shows liberated protein 
concentrations for both amnion and SIS samples following 24 hours digestion. There was no 
significant difference in degradation between those samples of amnion treated with 4mM 
EDC/1mM NHS and 8mM EDC/2mM NHS. Significant reductions in degradation were 
observed at all concentrations of crosslinked SIS (Table 2; figure 25). 
Material EDC (mM) Liberated protein concentration (µM per 1mg amnion +/- 
SEM) 
2hr 4hr 24hr 
HAM 1 ------ 7.44+/-0.30 15.76+/-0.17 
 2 ------ 2.03+/-0.19 6.60+/-0.31 
 4 ------ 1.86+/-0.19 3.00+/-0.36 
 8 ------ 1.33+/-0.30 3.36+/-0.29 
SIS 1 1.98+/-0.14 2.95+/-0.12 4.95+/-0.10 
 2 1.80+/-0.20 2.64+/-0.01 4.64+/-0.29 
 4 1.06+/-0.06 2.04+/-0.02 3.04+/-0.07 
 8 0.35+/-0.15 0.62+/-0.03 1.57+/-0.25 
 
Table 2. Protein liberation from amnion and SIS when exposed to increasing concentrations of EDC. 
increasing EDC concentration from 1mM to 2mM led to a significant reduction in protein liberation (p<0.0001). 
Increasing from 2mM to 4mM also led to a significant reduction in protein liberation (p<0.0001). Increasing 
EDC concentration to 8mM had no further effect on protein liberation. For SIS material, no significant 
reduction in protein liberation was observed between 1mM and 2mM EDC. Protein liberation was significantly 
reduced between 2mM and 4mM (p<0.0001) and between 4mM and 8mM EDC (p<0.0001). ANOVA+post hoc 








Figure 23.  
 
Fig 25. Fluorescamine degradation assay for amnion and SIS. Different colours in the graphs refer to 
different concentrations of EDC: red (1mM),  blue (2mM), green (4mM), black (8mM). With amnion, 
increasing EDC concentration from 1mM to 2mM led to a significant reduction in protein liberation (p<0.0001). 
Increasing from 2mM to 4mM also led to a significant reduction in protein liberation (p<0.0001). Increasing 
EDC concentration to 8mM had no further effect on protein liberation. For SIS material, no significant 
reduction in protein liberation was observed between 1mM and 2mM EDC. Protein liberation was significantly 
reduced between 2mM and 4mM (p<0.0001) and between 4mM and 8mM EDC (p<0.0001). Plotted data 
represent mean+/-SEM. ANOVA + post hoc bonferroni testing used for analysis (p<0.05).     
 
3.2.3 Experiment 3: Ex vivo uniaxial bond strength between rat sciatic nerve and 
candidate nerve wraps 
Freshly harvested, uninjured rat sciatic nerves failed under a distractive force of 3.31+/-
0.55N. Sciatic nerve transections repaired exclusively with fibrin glue failed at 0.17+/-0.01N. 
Repairs performed using four and six 10-0 epineurial sutures failed at 0.74+/-0.03N and 
1.19+/-0.08N respectively. Maximum load to failure of nerves repaired using 
photochemically sealed untreated amnion was 0.61+/-0.06N. No significant difference in 
bond strength existed when amnion was  
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crosslinked with 1mM, 2mM or 4mM EDC. Bond strength of photochemcially sealed amnion 
crosslinked with 8mM EDC was 0.34+/-0.05N and this was a significant fall in comparison 
to those bonds created using untreated amnion (p=0.01). Bond strength of repairs using 
photochemically sealed untreated SIS were 0.96+/-0.04N. This was significantly higher than 
bonds created with untreated amnion (p=0.003). No significant difference existed between 
those performed using SIS wraps crosslinked with 1mM or 4mM EDC. Bond strengths for all 
light activated bonds tested using amnion or SIS were all significantly poorer than repairs 
using six 10-0 epineurial sutures, with the exception of 4mM EDC treated SIS which was 











Figure 26. Mean bond strength of experimental and conventional repair methods. Clinically, nerves of 
1mm diameter (digital nerves in the fingers) are usually repaired with 4-6 epineurial sutures. In comparison to 
the tensile strength of suture repairs using six 10-0 epineurial sutures, fibrin glue and all photochemical repairs 
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using crosslinked amnion resulted in weaker bonds. Bonds created with 4mM crosslinked SIS had bond 
strengths that were comparable to 6-suture repairs. In comparison to untreated amnion, EDC crosslinking had no 
significant effect on bond strength up to a maximum concentration of 4mM. Crosslinking with 8mM EDC led to 
a significant fall in bond strength (p=0.01). Bond strength of untreated SIS was significantly greater than 
untreated amnion (p=0.04). No significant difference existed between untreated amnion and 1mM xSIS. Bonds 
using 4mM xSIS were significantly stronger than untreated amnion (p=0.001) and 4mM xHAM (p=0.001). Data 
presented as mean+/-SEM. *indicates statistical significance in relation to 6-suture repair. **indicates statistical 
significance in relation to untreated HAM. Analysis performed using ANOVA and post hoc Bonferroni test; 
p=<0.05.   
 
3.2.4 Experiment 4: The effects of amniotic membrane surface (epithelial or chorionic 
surface) on photochemical bonding 
Mean bond strength when amnion wraps were bonded to sciatic nerve epineurium using the 
epithelial surface was 0.64+/-0.04N. Mean bond strength when amnion was bonded to 
epineurium using the chorionic surface was 0.62+/-0.08N. No significant difference existed 









Figure 27. The influence of amnion surface on photochemical bond formation. Sciatic nerves were wrapped 
with amniotic membrane with either the epithelial (n=5) or chorionic (n=5) surface in apposition with 
epineurium. Following illumination, uniaxial bond strengths were assessed using the tensiometer. There was no 
significant difference in bond strength between the two options.   
 
3.2.5 Experiment 5: Assessment of laser fluence dose response on photochemical bonding 
When laser fluence is zero, bond formation does not occur. This was confirmed by 
tensiometer distraction of repairs that were treated with or without RB and were not 
illuminated with the 532nm light source (0.03+/-0.005N and 0.02+/-0.006N respectively). 
When laser fluence was 30J/cm2, maximum load to failure was 0.68+/-0.03N. When fluence 
was increased to 60J/cm2, maximum load to failure was 0.92+/-0.08N and this was 
significantly greater than bond strength obtained with 30J/cm2 (p=0.04). Further increases of 
fluence to 120J/cm2 and 240J/cm2 had a significantly detrimental impact on the formation of 
photochemical bonds in comparison to 60J/cm2 (0.69+/-0.02N (p=0.04) and 0.42+/-0.03N 













Figure 28. The effect of KTP laser fluence on the formation of photochemical bonds. Bond formation was 
unsuccessful with a fluence of zero. RB had no effect on the formation of bonds in the absence of illumination. 
Greatest bond strength was achieved when using a fluence of 60J/cm2. This was significantly greater than that 
achieved with 30J/cm2 
 
3.2.6 Experiment 6: In vivo light-activated sealing of nerve graft coaptation sites improves 
outcome following large gap peripheral nerve injury. 
3.2.6.1 Gross observations following sacrifice  
Following sacrifice, two rodents from the xSIS+PTB group were found to have dehisced 
repairs. All other nerve repairs were intact. Crosslinked amnion and SIS nerve wraps that had 
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been stained with RB, although not fully intact, were identifiable (figure 29C). No evidence 
of untreated nerve wraps could be found in any of the fixation groups (figure 29B). Although 
not quantitatively assessed, those nerves repaired photochemically were found to have 
considerably less extraneural scar tissue formation in comparison to standard graft+suture 
(figure 29C vs. 29A respectively)  
 
Figure 29. Gross observations of isografts following sacrifice. (A) Typical observation in isograft+suture 
group. Note the prominent extran-neural adhesions surrounding proximal and distal neurorrhaphy sites. (B) 
Typical result in the HAM+PTB group. No evidence of RB-stained amnion was found. Note the relative 
absence of extra-neural adhesion formation. (C) Typical observation in xHAM+PTB group. RB-stained nerve 
wraps still intact.  
 
3.2.6.2 Sciatic function Index 
All repairs experienced some degree of functional recovery. After 5-months follow-up, 
nerves repaired with xHAM+PTB showed greatest mean SFI although this was not 
statistically significant in comparison to graft+suture (-67.9+/-5.1 vs -71.7+/-4.8; table 3, 
figure 30). SIS+suture and SIS+PTB groups experienced significantly poorer functional 
recovery in comparison to positive controls (-80.3+/-3.2 and -85.0+/-6.0 vs -71.7+/-4.8 
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respectively; p<0.01). There were no other significant differences between any of the 




1-month 2-month 3-month 4-month 5-month 
No Repair -89.0+/-1.2 -94.2+/-1.6* -89.8+/-1.6* -89.3+/-1.5* -96.2+/-1.2*Ψ 
Standard  
Graft + Suture 
-87.6+/-1.6 -81.1+/-1.4 -71.8+/-2.3 -74.7+/-2.4 -71.7+/-1.6 
HAM+suture -90.3+/-1.6 -85.7+/-3.1 -80.6+/-1.1* -79.7+/-2.0 -77.9+/-2.2Ψ 
HAM+fibrin -89.2+/-1.3 -81.6+/-1.3 -80.4+/-2.3* -79.4+/-1.5 -75.2+/-1.6 
HAM+PTB -90.0+/-1.6 -81.2+/-0.8 -72.8+/-1.5 -75.6+/-1.0 -74.5+/-1.4 
xHAM+suture -96.6+/-2.4 -82.4+/-1.5 -80.0+/-1.3* -81.4+/-1.7 -76.8+/-1.0Ψ 
xHAM+fibrin -90.9+/-1.0 -84.1+/-1.1 -79.8+/-1.1* -81.2+/-1.0 -75.0+/-1.3Ψ 
xHAM+PTB -88.2+/-1.2 -80.3+/-1.2 -67.2+/-1.1 -71.6+/-1.7 -67.9+/-1.6 
xSIS+suture -94.7+/-1.3 -85.6+/-1.4 -82.5+/-1.4* -81.4+/-1.6 -80.3+/-1.1*Ψ 
xSIS+fibrin -93.2+/-1.5 -84.7+/-1.6 -82.0+/-1.2* -81.5+/-1.4 -78.8+/-1.4Ψ 
xSIS+PTB -92.5+/-0.7 -84.7+/-1.6 -84.3+/-1.2* -85.3+/-2.1* -85.0+/-1.9*Ψ 
 
Table 3. Monthly mean SFI. After 5-months follow-up, xHAM+PTB recovered greatest SFI although this was 
not statistically significant in comparison to graft+suture. No repair, xSIS+suture and xSIS+PTB groups 
performed significantly worse that standard graft+suture, with no significant difference existing between 
remaining groups. When adjusting for time and, in comparison to standard graft+suture, mean SFI values across 
the entire 5-months follow-up period were significantly worse in the no repair, HAM+suture, xHAM+fibrin, 
xSIS+suture, xSIS+fibrin and xSIS+PTB groups. No other significant differences in time-adjusted SFI existed 
for remaining groups. (*denotes statistically significant at 5-month time point in comparison to standard 
graft+suture; Ψdenotes statistically significant mean SFI over entire 5-months in comparison to standard 
graft+suture). Analysis performed using ANOVA, repeated meausures ANOVA (to test for differences across 












Figure 30. Mean SFI for select treatment groups over 5-month follow-up period. In the interests of clarity, 
only a select number of treatment groups have been included. Those nerve repaired using xHAM+PTB 
recovered greatest SFI although this was not statistically significant compared with standard graft+suture 
(67.9+/-1.6 vs -71.7+/-1.6; mean+/-SEM). Mean SFI in the HAM+PTB was less than xHAM+PTB and standard 
graft+suture although this was not statistically significant (table 3). xSIS+PTB performed least well out of all 
treatment groups and was significantly worse than standard repair. Analysis performed using ANOVA, repeated 
meausures ANOVA (to test for differences across 5-month follow-up) and post hoc Bonferroni test; p<0.05.  
  
 3.2.6.3 Gastrocnemius muscle mass retention 
Nerves repaired with xHAM+PTB experienced a small (<10%) but statistically significant 
improvement in muscle mass retention compared with graft+suture (67.3%+/-1.4 vs 
60.0%+/-1.6; p=0.02). There were no other significant differences between remaining 
treatment groups and graft+suture controls (table 4; figure 31). Repairs using crosslinked 
amnion recovered greater mean values than untreated amnion although these were not 
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significant. Comparisons of HAM+suture vs. xHAM+suture, HAM+fibrin vs. xHAM+fibrin 
and HAM+PTB vs. xHAM+PTB yielded 95% confidence intervals (CI) of -13.35 to 0.35, -
9.75 to 3.95, and -11.65 to 2.05, respectively. These wide ranges contain potentially 
important effect sizes and as a result, the occurrence of a type-2 statistical error cannot be 
excluded. Amnion wraps secured with PTB and fibrin glue recovered greater mean muscle 
mass in comparison to wraps secured with suture (greater suture burden) although these 
results were not statistically significant. Comparison of HAM+suture vs. HAM+PTB, 
HAM+suture vs. HAM+fibrin, xHAM+suture vs. xHAM+PTB, and xHAM+suture vs. 
xHAM+fibrin yielded 95% CI of -13.35 to 0.35, -10.65 to 3.05, -11.65 to 2.05, and -7.05 to 
6.65 respectively. As with the aforementioned effect of crosslinking, with the exception of 
the last comparison, the wide ranges contain potentially important effect sizes and a type-2 
error cannot be excluded.    
Experimental group Mean left gastrocnemius 
muscle mass retention 
(%) 
SEM P value* 
No Repair 9.2 0.3 <0.0001 
Standard Graft + Suture 60.0 1.6 1 
HAM+suture 56.0 1.8 1 
HAM+fibrin 59.8 1.7 1 
HAM+PTB 62.5 1.3 1 
xHAM+suture 57.7 1.3 1 
xHAM+fibrin 62.7 1.4 1 
xHAM+PTB 67.3* 1.4 0.02 
xSIS+suture 54.9 1.4 0.68 
xSIS+fibrin 58.5 1.7 1 
xSIS+PTB 54.1 1.1 0.37 
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Table 4. Left gastrocnemius muscle mass retention. Those nerves repaired using xHAM+PTB recovered 
greatest gastrocnemius muscle mass retention. This result was statistically significant. Those nerves repaired 
using xSIS+suture and xSIS+PTB recovered least gastrocnemius muscle mass. *Statistically significant 
improvement in comparison to standard graft+suture. Analysis performed using ANOVA and post hoc 












Figure 31. Left gastrocnemius muscle mass retention. All repairs using amnion and SIS resulted in 
significantly greater recovery in comparison to the no repair group. Nerves repaired using xHAM+PTB resulted 
in a small (7.3%) but significant improvement in gastrocnemius muscle mass in comparison to graft+suture 
(67.3+/-1.4 vs 60.0+/-1.6; p=0.02; Mean+/-SEM). Those methods of repair using least suture (PTB and fibrin) 
recovered greater mean values although, other than that observed for xHAM+PTB, these differences were not 
significant. This was also observed for crosslinked wraps in comparison to untreated wraps, with the exception 
of xSIS, which performed least well out of all treatment groups. Photochemically sealed HAM and xHAM both 
performed significantly better than photochemically sealed SIS (p=0.008 and p<0.0001 respectively). Other 
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differences between amnion and SIS were marginal. Red line represents graft+suture. Analysis performed using 
ANOVA and post hoc Bonferroni test; p<0.05.    
 
3.2.6.4 Nerve counts and histomorphometry 
All distal nerve sections were populated with axons (figure 32). In comparison to uninjured 
nerve, mean distal axon counts were greater in all treatment groups (with the exception of no 
repair). This was significant for HAM+suture (p=0.005), xHAM+suture (p=0.02), 
HAM+fibrin (p=0.003), xHAM+fibrin (p=0.001) and xHAM+PTB (p=0.03). As expected, 
axon counts in the no repair group were significantly lower than all repair groups. Distal axon 
counts in the remaining treatment groups did not differ significantly in comparison to 
graft+suture (table 5). Nerve fiber diameter, axon diameter and myelin thickness were 
significantly lower in all treatment groups in comparison to uninjured nerve. xHAM+PTB 
recovered 80% of uninjured nerve fibre diameter, 81% axon fibre diameter and 78% of 
myelin thickness. Nerve fiber diameter, axon diameter and myelin thickness were 
significantly increased in the xHAM+PTB group in comparison to graft+suture repair (table 












Table 5 . Histomorphometric analysis of distal nerve sections. Axon count in uninjured nerve was 
significantly lower than that found in HAM+suture (p=0.005), xHAM+suture (p=0.02), HAM+fibrin (p=0.003), 
xHAM+fibrin (p=0.001), and xHAM+PTB (p=0.03). Mean axon count did not differ significantly between 
treatment groups. Fiber diameter, axon diameter and myelin thickness were significantly greater in uninjured 
nerve in comparison to all treatment groups. Fiber diameter, axon diameter and myelin thickness were 
significantly greater in those nerves repaired using xHAM+PTB in comparison to graft+suture. All values 
expressed as mean+/-SEM. *Denotes statistically significant improvement in comparison to standard 
graft+suture. Analysis performed using ANOVA and post hoc Bonferroni test; p<0.05.  




















Uninjured nerve  4.66+/-0.50 14.11+/-0.39 8.55+/-0.04 5.55+/-0.03 3.00+/-0.01 0.64+/-0.01 
No repair 0.04+/-0.02 0.48+/-0.19 4.14+/-0.07 3.13+/-0.07 1.01+/-0.03 0.744+/-0.007 
Standard Graft+ 
Suture 
7.61+/-1.08 29.36+/-5.72 5.47+-0.03 3.50+/-0.03 1.96+/-0.01 0.624+/-0.002 
HAM+suture 10.41+/-1.33 28.85+/-6.20 5.07+/-0.03 3.44+/-0.03 1.63+/-0.01 0.666+/-0.004 
HAM+fibrin 10.42+/-0.49 29.95+/-4.43 5.22+/-0.03 3.44+/-0.03 1.78+/-0.01 0.643+/-0.002 
HAM+PTB 9.31+/-1.32 30.70+/-2.83 5.19+/-0.04 3.47+/-0.03 1.72+/-0.01 0.649+/-0.002 
xHAM+suture 9.79+/-1.06 27.12+/-2.92 5.14+/-0.03 3.54+/-0.03 1.59+/-0.01 0.673+/-0.002 
xHAM+fibrin 10.87+/-1.37 32.12+/-6.41 5.24+/-0.03 3.52+/-0.03 1.72+/-0.01 0.659+/-0.002 
xHAM+PTB 9.66+/-0.98 30.73+/-4.66 6.87+/-0.04* 4.51+/-0.04* 2.35+/-0.01* 0.642+/-0.002 
xSIS+suture 9.36+/-0.76 30.30+/-5.20 4.83+/-0.03 3.31+/0.03 1.52+/-0.01 0.672+/-0.002 
xSIS+fibrin 6.91+/-0.83 31.55+/-4.23 5.18+/-0.03 3.58+/-0.03 1.59+/-0.01 0.684+/-0.002 
















Figure 32. Histology slides from distal isograft section site. Those nerves that were not repaired lacked axons. 
All treatment groups regenerated axons distal to isografts with the exception of those nerves that dehisced in the 
xSIS+PTB group. Axons in the xHAM+PTB group had statistically larger fiber diameter, axon diameter and 




Figure 33. Schematic representation of fibre diameter, axon diameter and myelin thickness for select 
treatment groups. The data in this schematic represents mean values for fibre diameter, axon diameter and 
myelin thickness taken from table 5. SEM has been omitted for clarity. The red box highlights the significant 
increase in diameters in the xHAM+PTB group. Analysis was performed using ANOVA and post hoc 




3.2.7 Experiment 7: In vivo light-activated sealing of nerve graft coaptation sites using 
acellular nerve allograft (ANA) 
3.2.7.1 Gross observation following sacrifice 
There were no cases of nerve dehiscence in either ANA group and no animals suffered from 
foot ulceration or automutilation. In those nerves repaired photochemically, remnants of the 
RB-stained amnion nerve wraps were evident. As with previous studies, extra-neural scar 
tissue formation was obvious in those nerves repaired using conventional suture and was 
qualitatively less in photochemically bonded nerves (figure 34). Qualitatively, allografts were 
of smaller diameter than isografts.  
 
Figure 34. Gross observations of ANA following sacrifice. Nerves from isograft phase have been included for 
comparison. All nerves were found to be intact and showed evidence of regeneration across ANA. Qualitatively, 
as with sutured isografts (A), sutured ANA (D) had greater adhesion formation around coaptation sites. As with 
photochemically sealed isografts (B), photochemically sealed ANA (C) showed remnants of RB stained amnion 
wraps. Qualitatively, sutured ANA diameter was noticeably reduced in comparison to isograft, an observation 





3.2.7.2 Sciatic function index 
Isograft+PTB from phase 1 recovered greatest mean SFI after 5-months follow-up (table 6; 
figure 35). This was not statistically significant in comparison to isograft+suture. Likewise, 
photochemically sealed ANA recovered greater mean SFI values in comparison to sutured 
ANA although this was not statistically significant (-78.3+/-1.6 vs. -80.3+/-1.3; p=1; 95% CI 
-8.15 to 3.86; table 6 and 9; Fig 35). ANA+suture performed significantly worse than 
isograft+suture (-80.3+/-1.3 vs. -71.7+/-1.6; p=0.0019; table 6 and 9). SFI was also 




Sciatic Function Index (Mean+/-SEM) 
1-month 2-month 3-month 4-month 5-month 
Isograft+suture -87.6+/-1.6 -81.1+/-1.4 -71.8+/-2.3 -74.7+/-2.4 -71.7+/-1.6 
Isograft+PTB -88.2+/-1.2 -80.3+/-1.2 -67.2+/-1.1 -71.6+/-1.7 -67.9+/-1.6 
ANA+suture -95.4+/-0.79 -90.3+/-3.3 -87.9+/-1.3 -84.1+/-1.0 -80.3+/-1.3* 
ANA+PTB -93.4+/-1.1 -91.1+/-1.7 -88.9+/-1.7 -83.4+/-1.5 -78.3+/-1.6* 
 
Table 6. Mean SFI for all treatment groups (n=10) over 5-month follow-up. At each time point throughout 
recovery, no significant differences existed within each of the isograft and ANA groups. Recovery of SFI over 
the entire 5-month follow-up period was statistically poorer for both sutured and photochemically sealed ANA 
in comparison to sutured and photochemically sealed isografts (*p<0.001). All data expressed as mean+/-SEM. 





Figure 35. Mean SFI of ANA and isograft treatment groups (n=10). Data points represent mean+/-SEM 
from table 6. After 5-months follow-up, no significant difference existed within either isograft or ANA groups. 
ANA+suture and ANA+PTB groups recovered statistically less SFI in comparison to sutured and bonded 
isografts respectively (p<0.001). Analysis performed using repeated measures ANOVA and post hoc Bonferroni 
test.  
 
3.2.7.3 Gastrocnemius muscle mass retention 
Isograft+PTB recovered greatest gastrocnemius muscle mass retention and this was 
statistically significant in comparison to all other groups (table 7; figure 36). Mean muscle 
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mass retention values were higher for ANA+PTB but these were not significantly different to 
ANA+suture (55.2+/-1.8% vs. 52.9+/-1.5%; p=1; 95% CI -8.50 to 3.97; table 7, figure 36). 
Muscle mass recovery was significantly poorer in ANA+suture group in comparison to 
isograft+suture group. Likewise, recovery of ANA+PTB was significantly poorer than 
isograft+PTB. Muscle mass retention in the ANA+PTB group was statistically comparable to 
that achieved using isograft+suture, the current standard of care. 
Experimental group Mean left gastrocnemius 
muscle mass retention (%) 
SEM P value 
Isograft+suture 60.0 1.6 ---- 
Isograft+PTB 67.3 1.4 0.01 
ANA+suture 52.9 1.5 0.02 
ANA+PTB 55.2 1.8 0.22 
 
Table 7. Gastrocnemius muscle mass retention for all groups. Isograft+PTB recovered a small but 
significantly greater muscle mass in comparison to isograft+suture (p=0.01). Muscle mass retention was 
significantly poorer in the ANA+suture group in comparison to isograft+suture (p=0.02). Retention in the 
ANA+PTB group was comparable to isograft+suture. P-values are in relation to isograft+suture.  Analysis 




Figure 36. Gastrocnemius Muscle Mass Retention for ANA and isograft treatment groups. Isografts sealed 
photochemically with crosslinked amnion recovered significantly greater muscle mass than all remaining 
groups. No significant difference existed between sutured and photochemically sealed ANA. ANA+suture 
recovered significantly less muscle mass than isograft+suture but there was no significant difference between 
isograft+suture and ANA+PTB. *Denotes statistically significant improvement in comparison to 
isograft+suture; p=0.01. **Denotes statistically significant reduction in muscle mass retention in comparison to 





3.2.7.4 Nerve counts and histomorphometry 
Axon counts in the distal nerve stump were significantly greater for isograft+PTB in 
comparison to ANA+suture. No other significant differences in axon counts or axon density 
existed between treatment groups. Isograft+PTB recovered the greatest fiber diameter, axon 
diameter and myelin thickness and this was statistically significant in comparison to all other 
groups (table 8 and 9; figure 37). Histomorphometric recovery was poorest in the 
ANA+suture group and this was statistically significant in comparison to isograft+suture and 
isograft+PTB. Mean values for fiber diameter, axon diameter and myelin thickness were less 
for ANA+suture in comparison to ANA+PTB but these were not significantly different 
(5.26+/-0.03 vs. 5.38+/-0.02, p=0.07, 95% CI -0.250 to 0.007; 3.30+/-0.02 vs. 3.41+/-0.02, 
p=0.06, 95% CI -0.211 to 0.003; 1.95+/-0.01 vs. 1.97+/-0.01, p=1, 95% CI -0065 to 0.030, 
respectively. There was no significant difference between ANA+PTB and isograft+suture, 
the current standard of care (table 8 and 9 figure 37)  
 
Table 8. Histomorphometric analysis for all groups. Results from uninjured rat sciatic nerve in phase 1 
included for reference. Isograft+PTB recovered significantly greater fibre diameter, axon diameter and myelin 
thickness than all other groups. With the exception of G-ratio, no significant differences existed between 


















Uninjured nerve 4.66+/-0.50 14.11+/-0.39 8.55+/-0.04 5.55+/-0.03 3.00+/-0.01 0.64+/-0.01 
Isograft+Suture 7.61+/-1.08 29.36+/-5.72 5.47+-0.03 3.50+/-0.03 1.96+/-0.01 0.625+/-0.002 
Isograft+PTB 9.66+/-0.98 30.73+/-4.66 6.87+/-0.04* 4.51+/-0.04* 2.35+/-0.01* 0.642+/-0.002 
ANA+suture 5.04+/-0.86 21.50+/-0.85 5.26+/-0.03 3.30+/-0.02 1.95+/-0.01 0.621+/-0.002 
ANA+PTB 6.04+/-1.01 22.03+/-1.63 5.38+/-0.02 3.41+/-0.02 1.97+/0.01 0.631+/-0.002 
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ANA+suture and ANA+PTB. ANA+suture recovered significantly less fibre diameter and axon diameter than 
isograft+suture. There was no difference in axon count, myelin thickness and G-ratio between these groups. 
ANA+PTB was statistically comparable to isograft+suture for all histomorphometric parameters (see Bonferroni 
all-pairs comparison (Table 4)). *Statistically significant improvement in comparison to isograft+suture. 
Analysis performed using ANOVA and post hoc Bonferroni test (p<0.05)  
 
Table 9. Bonferroni all-pairs comparison for all groups. In comparison to isograft +suture, isograft+PTB 
results in statistically significant improvements in muscle mass retention, fibre diameter, axon diameter and 
myelin thickness. ANA+suture had significantly poorer recovery of SFI, muscle mass retention, fibre diameter 
and axon diameter. With the exception of G-ratio, there was no significant difference between ANA+suture and 
ANA+PTB for any of the outcomes measured. There was no significant difference in muscle mass retention, 
axon count, fibre diameter, axon diameter, myelin thickness and G-ratio between ANA+PTB and 
isograft+suture. *Derived from repeated measures ANOVA. 















0.22 0.01 0.90 < 0.0001 < 0.0001 < 0.0001 < 0.0001 
Isograft+suture vs 
ANA+suture 
<0.001 0.02 0.47 < 0.0001 < 0.0001 1 1 
Isograft+suture vs 
ANA+PTB 
<0.001 0.22 1 0.27 0.08 1 0.21 
Isograft+PTB vs 
ANA+suture 
< 0.001 < 0.0001 0.02 < 0.0001 < 0.0001 < 0.0001 < 0.0001 
Isograft+PTB vs 
ANA+PTB 
<0.001 < 0.0001 0.08 < 0.0001 < 0.0001 < 0.0001 0.0005 
ANA+suture vs 
ANA+PTB 
1 1 1 0.07 0.06 1 0.0062 
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Figure 37. Examples of distal ANA histology and schematic representation of histomorphometric 
measurements. Isograft+PTB recovered significantly greater fibre diameter, axon diameter and myelin 
thickness in comparison to remaining groups (see table 9 for Bonferroni all pairs comparison). These outcomes 
were not significantly different between sutured isografts and photochemically sealed ANA. Analysis was 





3.2.8 Experiment 8: Immediate versus delayed repair of large gap peripheral nerve injury 
using light-activated sealing of human amnion nerve wraps around nerve graft coaptation 
sites 
3.2.8.1 Gross observations following sacrifice  
Two rodents in the delayed PTB group had to be sacrificed prematurely due to intractable 
foot ulcers. Unfortunately one of these animals was disposed of before necropsy could be 
performed. In the remaining rodent, the isograft was found to be in continuity but had 








Figure 38. Gross observations of immediate and delayed isograft groups following sacrifice. Two animals 
in the isograft+PTB group required sacrifice prior to the completion of 150-days follow-up due to intractable 
foot ulcers. Necropsy of one animal showed intact photochemical bonds but a severely atrophied graft. The 
remaining animal was disposed of before examination could take place (A). Amnion wraps were found to be 
present, evidence of successful retardation of proteolytic degradation (B). Qualitatively, isograft+PTB nerves 
had less extraneural scar tissue formation than isograft+suture groups (C+D).   
No other episodes of dehiscence occurred in the remaining groups with all nerves showing 
evidence of regeneration. Crosslinked amnion nerve wraps were identifiable following 
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sacrifice in all groups showing that crosslinking protects enzymatic degradation for a 
minimum of 5-months (figure 38). Extra-neural scarring appeared qualitatively reduced in 
those nerves repaired photochemically, an observation consistent with previous studies 
(figure 38). 
 
3.2.8.2 Sciatic Function Index 
After 5-months follow-up, greatest recovery of SFI occurred in the immediate PTB group. 
This result was not statistically significant in comparison to immediate suture although was 
significantly better than that of the delayed PTB group (-68.5+/-1.5 vs. -72.3+/-1.5; p=0.41 
and -68.5+/-1.5 vs. -77.3+/-1.5; p=0.002 respectively). Recovery in the immediate suture 
group was significantly better than delayed suture, which performed poorest out of all groups 
(-72.3+/-1.5 vs. -80.1+/-1.4). There was no significant difference between immediate suture 
and delayed PTB (-72.3+/-1.5 vs. -77.3+/-1.5; table 10 and 13).  
 
3.2.8.3 Gastrocnemius Muscle Mass Retention 
Muscle mass retention was greatest in the immediate PTB group and this was statistically 
significant in comparison to the immediate suture group (64.9+/-1.8% vs. 59.0+/-1.1%; 
p=0.02). A similar small (<10%) significant improvement was also observed in the delayed 
PTB group in comparison to delayed suture (60.2+/-1.4% vs. 54.1+/-1.7%; p=0.03). With 
regards to the surgical delay, no significant difference existed between immediate suture and 
delayed suture, or immediate PTB and delayed PTB groups. Muscle mass retention was not 
significantly different between immediate suture and delayed PTB (59.0+/-1.1% vs. 60.2+/-
1.4%; p=1; table 11 and 13).  
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Table 10. Mean SFI for all treatment groups over 5-month follow-up period. All data expressed as mean+/-
SEM. Immediate isograft+PTB recovered greatest mean SFI after 5-months although this was not statistically 
significant in comparison to immediate suture. Similarly, No significant difference existed between delayed 
PTB and delayed suture. SFI in the immediate suture group was significantly better than the delayed suture 
group (p=0.003). Likewise immediate PTB recovered a significantly greater SFI in comparison to delayed PTB 
(0.002). Immediate PTB was significantly better than delayed suture, which performed poorest out of all groups 
(p<0.0001). No significant difference existed between immediate suture and delayed PTB. Analysis was 
performed using repeated measures ANOVA and post hoc Bonferroni test. 
Experimental group Mean left gastroc. muscle 
mass retention (%) 
SEM P value 
Immediate suture 59.0 1.1 ----- 
Immediate PTB 64.9* 1.8 0.02 
Delayed suture 54.1 1.7 0.10 
Delayed PTB 60.2 1.4 1 
 
Table 11. Gastrocnemius muscle mass retention for all groups. Groups compared statistically to immediate 
suture. Immediate PTB group recovered significantly greater muscle mass than immediate suture (p=0.02). 




1-month 2-month 3-month 4-month 5-month 



































13 for Bonferroni all-pairs comparison. Analysis performed using ANOVA and post hoc Bonferroni test; 
p<0.05.    
 
3.2.8.4 Nerve counts and histomorphometry      
No significant differences in axon counts existed between any of the treatment groups. The 
immediate PTB group recovered significantly greater fiber diameter, axon diameter, myelin 
thickness and G-ratio in comparison to immediate suture group. This equates to increases in 
fibre diameter, axon diameter and myelin thickness of 10%, 7% and 11% respectively. 
Recovery of fibre diameter, axon diameter and myelin thickness in relation to uninjured 
nerve was 74%, 80% and 62% respectively. With the exception of G-ratio, all measurements 
were significantly greater in the delayed PTB group in comparison to the delayed suture 
group. Fibre diameter, axon diameter and myelin thickness were improved by 8%, 9% and 
4% respectively. Recovery of these variables in relation to uninjured nerve was 68%, 76% 
and 53% respectively. With regards to surgical delay, fiber diameter, axon diameter and 
myelin thickness were significantly greater in the immediate suture group in comparison to 
the delayed suture group (figure 39). No significant difference in G-ratio was detected. All 
measurements in the immediate PTB group were significantly better in comparison to the 
delayed PTB group. No significant difference in any histomorphometric measurement existed 



























4.66+/-0.50 14.11+/-0.39 8.55+/-0.04 5.55+/-0.03 3.00+/-0.01 0.64+/-0.01 
Immediate 
Suture 
7.34+/-1.39 24.83+/-1.34 5.75+/-0.03 4.15+/-0.03 1.60+/-0.01 0.715+/-0.001 
Immediate 
PTB 
7.29+/-1.46 23.25+/-0.71 6.30+/-0.03* 4.45+/-0.03* 1.85+/-0.01* 0.703+/-0.001* 
Delayed suture 4.04+/-0.45 24.17+/-0.86 5.40+/-0.03 3.88+/-0.02 1.53+/-0.01 0.716+/-0.001 
Delayed PTB 5.77+/-0.46 23.00+/-0.84 5.81+/-0.03 4.22+/-0.03 1.59+/-0.01 0.721+/-0.001 
	
Table 12. Histomorphometric analysis for all groups. Results from uninjured nerve in phase 1 included for 
reference. Although mean axon counts were considerably greater in immediate repair groups, due to large  
standard deviation, these values were not significantly different. All histomorphometric measurements were 
greater in the immediate PTB group in comparison to immediate suture (*denotes statistically significant 
improvement in comparison to immediate suture). Table 13 provides detailed cross-pairs comparison. Analysis 






Table 13. Bonferroni all-pairs comparison for all groups. No significant differences in SFI were detected  
between immediate suture and immediate PTB or delayed suture and delayed PTB. Significant differences were 
detected between immediate and delayed suture and immediate and delayed PTB highlighting the detrimental 
impact of delay. No significant difference existed between immediate suture and delayed PTB. Muscle mass 
retention was significantly improved following PTB repair in both immediate and delayed groups. The effects 
of delay were not significantly different for suture or PTB fixation. As with SFI, immediate suture was not 
significantly different in comparison to delayed PTB. No significant differences existed in axon count or density 
existed between groups. Fiber diameter, axon diameter and myelin thickness and G-ratio were not significantly 
different between immediate suture and delayed PTB. With the exception of G-ratio, all other 
histomorphometric parameter comparisons were significantly different between treatment groups, with 
immediate PTB achieving greatest recovery and delayed suture being poorest 
 













Immediate suture vs 
Immediate PTB 
0.41 0.02 1 < 0.0001 < 0.0001 < 0.0001 < 0.0001 
Immediate suture vs 
Delayed suture 
0.003 0.10 0.23 < 0.0001 < 0.0001 < 0.0001 1 
Immediate suture vs 
Delayed PTB 
0.17 1 1 1 0.35 1 0.06 
Immediate PTB vs 
Delayed suture 
< 0.0001 < 0.0001 0.24 < 0.0001 < 0.0001 < 0.0001 < 0.0001 
Immediate PTB vs 
Delayed PTB 
0.002 0.16 1 < 0.0001 < 0.0001 < 0.0001 < 0.0001 
Delayed suture vs 
Delayed PTB 
1 0.03 1 < 0.0001 < 0.0001 0.001 0.12 
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Figure 39. Examples of distal isograft histology and schematic representation of histomorphometric 
measurements. Sections taken 5mm distal to the distal isograft coaptation site. With the exception of the two 
rodents that were sacrificed prematurely, all rodents successfully regenerated axons through isografts into the 
distal nerve stump after 5-months. No significant differences in total axon counts between groups were detected. 
Histomorphometric measurements were generally greater in immediate repairs versus delayed repairs and in 
those repairs performed photochemically versus suture. No significant differences existed between immediate 







Section 4: Discussion 
 Main findings  
Phase 1 experiments show that photochemical sealing of nerve graft coaptation sites using 
crosslinked human amnion results in statistically significant improvements in muscle mass 
retention and histomorphometric outcomes compared with standard graft+suture. With the 
exception of xSIS groups having significantly poorer SFI, no other significant differences 
existed between treatment groups. However, mean values for all outcome measures tended to 
be higher in those groups repaired with crosslinked nerve wraps. The observed 95% 
confidence intervals cannot exclude the existence of a type-2 statistical error and a larger 
sample size may have identified a significant correlation. Although in vivo nerve wrap 
degradation was not formally assessed throughout the regenerative period, there was visible 
evidence of persisting crosslinked RB-stained wraps following sacrifice (figure 29C). In 
contrast, untreated wraps were completely degraded (figure 29B). The prevention of 
premature wrap degradation before the arrival of regenerating axons appears to maintain a 
protective growth permissive seal that lasts longer. Partial degradation of crosslinked material 
did occur. Although EDC successfully protects against collagenase degradation, it may be 
unable to offer protection against other proteolytic enzymes.  
 
Likewise, although not significant, mean values for all outcome measures tended to be higher 
when suture burden was reduced (fibrin glue and PTB). Again, the reported 95% confidence 
intervals raise the possibility that greater sample sizes may have identified this as a 
significant effect. These observations are consistent with widely accepted tenets regarding the 
detrimental, pro-inflammatory effect of suture. Although mean outcome values following 
photochemical sealing were greater than those achieved using fibrin glue, only those nerves 
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repaired with photochemically-sealed crosslinked amnion showed significant improvements 
in muscle mass retention and histomorphometry in comparison to standard graft+suture. This 
suggests that the effects of reduced suture burden and photochemical sealing may be additive. 
The lack of significant improvement in those repairs photochemically sealed with untreated 
amnion supports the claim that sealing of nerve grafts in large deficit injuries is only 
efficacious if amnion can resist proteolytic degradation over extended periods of recovery. It 
may be that the added burden of revascularisation, which the graft must undergo to survive, 
compromises its ability to support axonal re-growth, or it may be that benefits manifest 
themselves only if photochemical seals are preserved long enough for axons to cross through 
distal coaptation sites.  
 
In isolation, fibrin glue provides insufficient bond strength for nerve repair although 
favourable outcomes have been reported when used to augment suture(166, 170-174). Fibrin 
bonds have also been shown to degrade within three weeks(257). As a result, the suitability of 
fibrin glue for wrap fixation was questionable. In spite of these concerns, no dehiscence 
occurred in this group and recovery was comparable to standard graft+suture. This verifies 
that fibrin glue, in combination with epineurial tacking sutures, provides sufficient support 
and is a useful alternative for repair.  
 
When applied to ANA in phase 2, no significant differences between light-activated sealing 
and conventional suture were detected. Whilst ANA+suture had significantly poorer 
outcomes in comparison to isograft+suture, the current standard of care, the improved mean 
values observed in the ANA+PTB group were statistically equivalent to isograft+suture. 
When comparing ANA+PTB with ANA+suture, fibre diameter and axon diameter had 
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narrow 95% CI, not including zero, and p-values that approached significance. Although 
attenuated, the effect of photochemical sealing when applied to ANA may result in small 
improvements in regeneration that can rival the current standard of care. This may have 
important clinical implications in human subjects, who have a limited regenerative capacity, 
when severe injury, complicated by limb loss, precludes the use of autograft.  
 
Although the presence of basal lamina elements such as fibronectin and laminin in ANA can 
promote neurite outgrowth and support axonal regeneration in the absence of SCs(258-265), 
with increasing graft length, successful regeneration is reliant on graft re-population by 
resident SCs(266, 267). Studies have shown diminishing regenerative return with increasing 
graft length(136). Evidence suggests a finite migratory and proliferative capacity of SCs and 
shows that repopulation of increasingly long ANAs by recipient SCs can lead to SC 
senescence(268). The current study did not assess SC re-population but it is possible that 
photochemical sealing of the intraneural mileu may augment SC migration and regeneration 
through ANAs. Assessing SC repopulation in ANAs of varying length may form the basis of 
future study. Perhaps combining this approach with cell-based therapy may have a synergistic 
effect. 
 
The method of ANA decellularisation can influence outcome(269). Comparative analysis 
between allografts and xenografts from various animal species has also detected significant 
differences in outcome(270). Although the use of human cadaveric Avance® would have had 
greater clinical relevance, investigators have shown that in rodent models, regeneration 
through Avance® is inferior to rodent ANA(271). This is believed to be due to a xenograft-
induced subclinical inflammatory response. The use of Sprague Dawley ANA in favour of 
	 132	
Avance® in the current study aimed to reduce any detrimental effect of cross species 
immunoreactivity.  
 
Phase 3 experiments verify that photochemical sealing remains superior to conventional 
suture, both when performed immediately and after a clinically relevant delay. Although this 
relationship was not significant for SFI, mean values were greater for photochemical sealing. 
Both muscle mass retention and nerve histomorphometry were significantly improved in 
immediate and delayed groups, suggesting that this may be a more sensitive measure than 
SFI in detecting a difference in regeneration. SFI and histomorphometric outcomes between 
immediately sutured nerves and delayed, photochemical repairs were not significantly 
different. This suggests that photochemical sealing may have the ability to ameliorate the 
poorer outcomes expected following a surgical delay using standard microsurgical repair.  
 
The delay of 30-days in this study had a deleterious impact on recovery, regardless of 
whether isografts were secured using conventional suture or photochemical sealing. This is 
consistent with the tenet that increasing periods of axotomy and denervation result in a 
reduction in regenerating axons, reduced regenerative support in the distal fibre and reduced 
motor unit reinnervation in muscle targets. Curiously, this effect was not evident from the 
analysis of muscle mass retention. Gordon et al showed that freshly axotomized axons were 
able to recover full muscle mass and force of contraction when periods of distal fibre and 
muscle denervation were less than 50 days(97). This was also observed when chronically 
axotomised nerve regenerated down freshly denervated distal nerve and muscle, reflecting 
compensatory increases in motor unit size(97). A lack of significant difference in regenerative 
outcomes with shorter periods of delay has been reported by others(272). Although mean 
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muscle mass retention was greater in immediate repair groups in this study, it is possible that 
the lack of statistical significance reflects an element of compensation through increased 
innervation ratio. Significant differences in SFI between immediate and delayed groups 
suggests that compensatory increases in innervation ratio, whilst sufficient to maintain 
muscle mass of the lower limb, may be unable to compensate for poor reinnervation of 
intrinsic musculature of the foot and sensory loss, both essential components for coordinated 
motor control. 
 
The inclusion of histomorphometric data for normal, uninjured nerve allows assessment of 
recovery of treatment groups not only against the current standard of care for nerve gap 
repair, but also against that of normal, uninjured nerve. This data was subsequently included 
in histomorphometric data tables in phase 2 and 3. It was felt unnecessary to repeat sampling 
of uninjured nerve in these groups as all experiments used 250-300g male Lewis rats. Mean 
axon counts in the distal nerve fibre were significantly higher in several treatment groups in 
comparison to uninjured nerve. Wolthers et al showed that after 100 days, the total number of 
myelinated fibres was almost twice that found in control, uninjured nerve following crush 
and transection and repair(273). This may be partly explained by the observation that following 
injury, transected axons give rise to many daughter axons(274). These misleadingly high axon 
numbers do not accurately reflect the number of neurons successfully regenerating and is a 
major limitation of this outcome measure(275). Wolthers et al reported a mean fibre diameter 
of 8.20+/-0.04 in control rat sciatic nerves which is comparable to our results(273). Mean fibre 
diameter after transection and repair was 6.70+/-0.05 which, although is also comparable to 
our results, is following end-to-end repair rather than nerve grafting(273). Reports of the 
morphometric outcomes following nerve grafts are less well studied and more conflicting. 
Axon counts were found to be reduced in distal stumps following regeneration through 
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mouse sciatic nerve gaps(276). Declines in axon number in the distal nerve have also been 
observed in rabbit median nerve grafts(129). Contrastingly in a monkey median nerve graft 
model, significant increases in myelinated axon number distal to nerve grafts were reported, 
in comparison to normal controls. Significant reductions in fibre diameter and increases in G-
ratio (less remyelination) were also observed suggesting that regeneration through these 
grafts was consistent with that observed following end-to-end neurorrhaphy(277).  
 
In phase 3, G-ratio, or the extent of remyelination, was significantly better in the immediate 
PTB group. This was consistent with the other significantly greater histomorphometric 
variables in this group, in keeping with this being the optimal method of nerve repair 
observed in earlier experiments. However, in phase 2, G-ratio was significantly better in 
isograft+suture in comparison to isograft+PTB and was actually statistically comparable to 
ANA+suture. These observations imply that re-myelination is less effective following 
photochemical sealing and is not affected by decellularisation. A similar finding was found in 
phase 1 where G-ratio was significantly better in the standard isograft+suture group in 
comparison to xHAM+PTB and other remaining groups. These observations are contrary to 
the majority of muscle mass retention and histomorphometric data observed throughout this 
thesis and to the conclusion that light activated sealing is the optimal repair strategy for nerve 
gap injury. They are also not consistent with the extensive body of literature supporting the 
conclusion that regeneration through nerve grafts, particularly those that have been 
decellularised, has a detrimental impact on remyelination. The explanation for these 
observations is unclear.           
 
	 135	
The mechanisms behind the observed beneficial effects of light activated sealing are largely 
unknown. Suture material causes foreign body reaction, granuloma formation and the 
formation of intraneural scar(87). The relative absence of suture may lead to a less tumultuous 
repair environment, expediting the regeneration of axons across coaptation sites. Protection 
of the repair site may reduce the effects of extraneural scar and may also reduce the escape of 
axons extra-fascicularly, therefore reducing the formation of neuroma. Those nerves repaired 
photochemically tended to have less extraneural adhesions in comparison to standard 
graft+suture (figure 29, 34, 38). Although insufficient data was collected to allow robust 
assessment of this observation, this is a finding consistent with previous studies(243). 
Phototherapy has been shown to inhibit fibroblast and myofibroblast activity and causes 
massive neurite sprouting and SC proliferation in vitro(278-280). This effect may also explain 
recently demonstrated reductions in implant capsule formation and capsular contracture by 
tissues pre-treated with photochemical tissue passivation(281). Furthermore, the anti-fibrotic 
effects of transplanted amnion have been well reported(199, 282).  
 
Following injury, neurotrophic rich fluid leaks from nerve ends and can be physically 
collected(283-285). Techniques that capture and enclose this fluid at the repair site have resulted 
in superior outcome(283). ANA are devoid of SCs and neurotrophic factors. The observation 
that light activated sealing is less effective when applied to ANA suggests that sealing the 
repair sites with a durable bond may help contain SCs and fluid and preserve a neurotrophic 
rich milieu.  
 
Following denervation, SCs in the distal nerve upregulate RAGs and the expression of 
neurotrophic factors. With increasing denervation time, this expression progressively declines 
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and SCs become dormant, diminishing their ability to support regeneration(21). The 
observation that outcomes using light-activated sealing following a delay can match 
conventional suture performed immediately suggests that sealing with durable bonds may 
help maintain neurotrophic levels and may also retard SC dormancy by preventing the loss of 
mitogenic stimuli released from fresh nerve grafts. The uncertainty surrounding these 
mechanisms will provide impetus for further study.  
 
Limitations of the study   
Rodent animal models are invaluable research tools that have helped facilitate the clinical 
translation of many peripheral nerve repair techniques that are in use today. Nevertheless, 
there are several general limitations associated with the use of rats that are also applicable to 
this thesis. In comparison to humans, rats have a superior ability to regenerate axons. 
Lunborg et al showed that without any intervention, axons regenerated through a silicone 
tube, across a 6mm rat sciatic nerve gap, regardless of whether the distal end was included in 
the conduit(286). When the gap was increased to 10mm, complete regeneration was possible 
only if the distal nerve end was included in the conduit. If the distal ends were excluded, little 
or no axons regenerated. Through 15mm conduits, regeneration was nonexistent, regardless 
of whether distal ends were included or not. Based on these experiments, the regenerative 
limit or “critical gap” in rodents was accepted as being 15mm(285-287). Subsequent studies 
showed that this upper regenerative limit could be increased to 20mm if conduit lumens were 
filled with dialysed plasma(288), glycosaminoglycan matrix, laminin, and collagen matrix(289, 
290). Studies by Mackinnon et al suggested that this may be an underestimation. After 
complete excision of the sciatic nerve at the sciatic notch and 5-months follow-up, 
regeneration was observed over a mean length of 23.7+/-6.4mm(291). The critical gap varies 
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between animal species, being approximately 3cm in rabbits and 4cm in humans(88). This 
variation is believed to be due to differences in rates of fibrin cable degradation between 
proximal and distal nerve ends rather than major differences in rates of regeneration. SCs use 
these fibrin guidance matrices to form the bands of Büngner(88).  
 
Photochemical bonding required clear access 5mm proximal and distal to the coaptation site. 
As a result, the maximum achievable nerve gap before sciatic trifurcation was 15mm. 
Although significant improvements in outcome were detected with the use of 
photochemically bonded crosslinked amnion in phase 1, these differences were small. It is 
possible that the use of this “limited” large nerve gap coupled with the superior regenerative 
ability of rats may have interfered with our ability to detect differences between groups. In 
other words, regeneration was good regardless of intervention. The lack of significant 
differences between light-activated sealing and suture when applied to ANA may also reflect 
this. Whitlock et al reported no significant difference in outcome between isograft and rodent 
allograft across a 14mm sciatic nerve gap after 12 weeks. However, a significant difference 
was detected after 16 weeks when the gap was extended to 28mm(292). Nevertheless, in our 
experiments, ANA+suture performed significantly poorer than isograft+suture over a 15mm 
nerve gap. Further studies using larger nerve gaps are planned. It is possible that the small 
improvements detected will be more pronounced when performed in larger animals and 
humans.  
 
Although the observations in phase 1, 2 and 3 showed evidence of reduced intraneural and 
extraneural scarring, this was not objectively tested. Histological assessment and objective, 
blinded scoring of nerve scarring at sacrifice would have helped substantiate this claim. The 
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potential scar reducing effects of PTB remains conjecture. A possible confounding factor in 
the future assessment of nerve scarring and PTB is that, in comparison to humans, rats scar to 
a much lesser extent(293). The formation of abnormal scars is very much a human disorder. 
The presence of the panniculus carnosus in animals such as the rat leads to rapid contraction 
and minimal scarring following injury to the skin(293). In light of the increasing propensity for 
scar tissue formation in humans, it is possible that any real scar reducing effect identified in 
this thesis could be even more pronounced when applied to human nerve repair. 
   
The performance of light activated sealing was assessed against isograft+suture, the current 
standard of care. Outcomes in this positive control group are comparable to other studies(292, 
294). However, some have reported more successful outcomes with sutured isografts. 
Methodological discrepancies between studies commonly exist, making meaningful 
comparisons difficult. Nonetheless, poorer outcomes may be due to technical aspects of 
repair and microsurgical experience. The lead surgeon in this study was a senior plastic 
surgery trainee (N.G.F) with experience in microsurgical repair. It is possible that if repairs 
had been performed by an “expert” microsurgeon, outcomes following isograft+suture may 
have been improved, nullifying the observed superiority of light-activated sealing. However 
the technical demands of microsurgical repair are a fundamental limitation. Expertise and 
equipment may not be available clinically. An advantage of light-activated sealing is that 
surgeons without microsurgical training can readily adopt the technique.  
 
Due to the exchange of isografts between rodents, tensionless repair was impossible. The 
insertion of two tacking sutures at coaptation sites was necessary to permit photochemical 
sealing. As a result, repairs were not truly “sutureless”. A solution to this problem would 
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have been to use additional rats purely as nerve donors and to simply transect the sciatic 
nerve prior to nerve graft interposition, rather than excising a length of nerve. However this 
would have had major financial implications. In the clinical arena, nerve autografts and 
allografts can be oversized to eliminate tension, obviating the requirement for sutures. Whilst 
tacking sutures may still be necessary for group fascicular repair and cable grafting, 
subsequent wrapping of the entire gap still offers the benefit of sealing and containment of 
neurotrophic-rich fluid. 
 
In phase 2, the use of Isograft+suture and Isograft+PTB groups as historical controls 
introduced an element of selection bias. An assumption was made that the outcomes in these 
groups achieved in phase 1 would have been replicated had they been repeated. The use of 
this data was justified in light of the fact that the same surgeons (N.G.F and J.N.G) performed 
all experiments, the same methods of repair were used (other than the use of ANA in place of 
isograft in phase 1), the same researchers were involved in outcome assessment (N.G.F and 
A.M) and the animals received the same post-operative care by the same animal facility team. 
The experiments also took place sequentially with very little delay between phases 1 and 2. 
Although methodologically “cleaner”, the inclusion of new isograft groups would have 
resulted in unnecessary animal morbidity and cost.  
 
In phase 3, the period of surgical delay may have been insufficient. Gordon et al showed that 
the deleterious effects of prolonged axotomy and denervation were maximal following 
considerably longer surgical delays than found in this study. However, the exponential 
decline of motor unit reinnervation was evident with delays of less than 50 days(97). In 
addition to surgical delay, denervation time is further extended by slow rates of regeneration. 
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Although rates are commonly quoted as 1-3mm/day, Brushart et al explained that this 
referred to only the fastest growing sensory axons(102). Large numbers of axons can take 
many days and weeks to traverse coaptation sites. This “staggered regeneration” is the result 
of the physical obstacle presented by suture repairs, the arborisation of daughter axons and 
the rationing of raw materials from the cell body, and sensory-motor mismatching leading to 
pruning(102). These effects are exacerbated in the context of nerve grafting when axons must 
negotiate two copatation sites. Gordon et al estimated that regeneration of all motorneurons 
across an injury site can take 1-month and by extension, regeneration through a 15mm 
autograft may take in the region of 10 weeks(97, 295). The deleterious effects of chronic 
axotomy and denervation are also exacerbated with grafting(35, 36, 97). Clinically, denervation 
times may typically exceed that which has been tested in this study. Nevertheless, the 30-day 
delay led to a deleterious and detectable impact on regeneration and has allowed significant 
differences to be detected between treatment groups. 
 
The limitations of current functional and histological outcome assessment for peripheral 
nerve research in rodent models have been well reported(296-299). The use of walking track 
analysis and SFI is arguably the most problematic of these. SFI uses inked prints to measure 
parameters such as print length, toe spread and intermediary toe spread. Entering these values 
into the validated Bain-Mackinnon-Hunter equation gives results between zero and -100, 
with -100 representing complete dysfunction and zero representing either a normal, uninjured 
nerve or a completely recovered nerve(256). The coefficients associated with print length, toe 
spread and intermediary toe spread are derived from regression analyses on data from large 
volumes of rats and represent the significance and weighted contribution of each 
measurements on the index formula(256). The importance of narrowed toe spread is reflected 
by a significantly weighted coefficient.  
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SFI aims to provide an assessment of integrated motor recovery that is reliant on appropriate 
sensory and motor target reinnervation and minimization of axonal misdirection. Whilst 
providing useful information on the success of regeneration, histomorphometry provides little 
information on the appropriateness of reinnervation. Regenerating axons re-innervate 
muscles non-selectively and as a result, regeneration, remyelination and reinnervation may be 
successful but may not translate into successful functional recovery if reinnervated targets are 
inappropriate. This can account for good recovery of muscle mass and histomorphometry, 
with relatively poor recovery of SFI, as observed in this thesis. Sensitivity and selectivity of 
SFI is poorly reported but many have highlighted concerns with the use of SFI. When using 
SFI to assess recovery across a 1cm nerve gap, Shenaq et al were unable to distinguish 
between unrepaired nerves and nerves repaired with autograft, amnion conduits and silicone 
conduits, showing no correlation between SFI and histomorphometry(300). Urbanchek et al 
found a lack of correlation between SFI and muscle forces(301), an observation most likely 
related to abnormal muscle activation patterns during locomotion due to non-selective 
reinnervation(302). Others have also suggested that significant cortical re-organisation of 
sensory-motor maps occurs following nerve injury, further interfering with the reliability of 
SFI(303). Other reported limitations of SFI relate to practical issues. Due to non-compliance, 
often several attempts are required to obtain satisfactory walking tracks to measure from. 
Some prints may be uninterpretable due to foot dragging, contractures and automutilation. 
Significant variations in print parameters can occur with changes in velocity and 
compensatory weight shift to the contralateral limb secondary to the injury(304, 305). Perhaps 
most importantly, the act of print measurement is a subjective one. The use of other objective 
outcome measures, such as electrophysiology and immunohistochemistry would have added 
depth to this thesis and will be considered for future studies. Despite these limitations, 
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walking track analysis and SFI provide a non-invasive assessment of integrated motor 
function.  
 
As has already been discussed, the use of axon counts can be problematic. Transected axons 
give rise to multiple daughter axons that form part of the regenerating front(274). As a result, 
axon counts can be misleadingly high distal to the site of repair and do not necessarily reflect 
the number of neurons that have successfully regenerated axons(275). Axon counts were 
significantly greater than that seen in uninjured sciatic nerve in many treatment groups 
throughout this thesis. Several others have commented on the inconsistences between distal 
axon counts and neuron counts(306). Alternative methods of analysis that can overcome this 
issue include retrograde labeling of cell bodies(275). 
 
The loss of two animals in the delayed+PTB group and the unsuccessful regeneration in one 
of these rodents was a concern. It is uncertain what caused this although the excessive 
delivery of energy from the light source is most likely. The light used in this study was 
delivered by means of a divergent beam. As a result, small, inadvertent reductions in the 
distance between nerve and light source during bonding may have resulted in the delivery of 
excessive energy. Although not apparent at the time of bonding, subtle thermal damage to the 
internal architecture of nerve stumps and grafts may have compromised axonal regeneration 
and revascularisation. Collimation of the beam would be a simple, easily achievable solution 
that would standardise spot size and energy delivery and improve safety for clinical 
translation.    
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How the results fit into the current field of peripheral nerve repair 
Photochemical sealing of peripheral nerves offers an alternative method of repair to 
conventional microsuture. In order for the technique to translate clinically, the technique 
must be safe and the materials involved must be biocompatible and approved for use in 
humans. Amnion has emerged as a very useful biological membrane that bridges coaptation 
sites and facilitates the formation of photochemical bonds between nerve ends. Amnion is 
very thin and has no elastic memory, allowing easy wrapping around the circumference of 
small diameter nerves. The translucency of the membrane allows easy light penetration, a 
critical feature during bond formation.  
 
Ex vivo testing confirmed that amnion is strong and elastic with biomechanical properties 
consistent with those reported in the literature(160). Amnion bonds to nerve epineurium 
equally well whether using the chorionic or epithelial surface, a finding consistent with 
previous studies(307). Maximum load to failure, Youngs modulus and resistance to collagenase 
degradation all increased significantly when crosslinked with EDC. Crosslinking up to a 
maximum concentration of 4mM EDC had no detrimental impact on the formation of 
photochemical bonds and as a result, this value was selected for in vivo testing. Crosslinking 
beyond 4mM EDC led to a significant fall in uniaxial photochemical bond strength. This may 
have been related to excessive material stiffness, impaired circumferential wrapping and the 
presence of microfractures in the material. Chemical crosslinking and photocrosslinking 
occur by discrete mechanisms and as a result, it is also possible that the observed drop in 
bond strength at high EDC concentrations may be due to a critical fall in the number of sites 
that are available for photo-crosslinking and bond formation. Ex vivo bond strength between 
rat sciatic nerve and photochemically bonded crosslinked amnion was comparable to 
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conventional epineurial suture using four 10-0 ethilon sutures, typically what is used 
clinically for nerves of this size.  
  
Although several other commercially available nerve wraps were tested, the majority of these 
products were excessively thick (150-200µm) and stiff, with pre-determined internal 
diameters. The elastic “memory” could not be overcome and as a result, circumferential 
wrapping was problematic. The loose fit and lack of adherence between wrap and epineurium 
made light activated sealing impossible. Based on ex vivo tests, single layer SIS 
(manufactured by Cook Medical and distributed by HealthPoint Biotherapeutics as Oasis® 
wound dressing) was a suitable alternative. SIS had a thickness of 100µm and once 
rehydrated, had very little memory, allowing circumferential wrapping, adherence and 
photochemical bonding. Tensile strength, resistance to collagenase degradation and bond 
strength were superior to amnion. However, in vivo use was problematic. Increased thickness 
of SIS (100µm vs. 20-50µm for amnion) impaired adherence and circumferential wrapping. 
As a result, photochemical bonding was sub-optimal leading to two cases of nerve dehiscence 
in the xSIS+PTB group. Although ineffective in this setting, it is possible this material may 
still be suitable for larger caliber nerves in humans. 
 
Rose Bengal has been used for several biological applications. Historically, it has perhaps 
been most commonly used as a conjunctival stain in the field of ophthalmology to diagnose 
conditions such as kerataconjunctivitis sicca(308). In addition to its use as a tissue stain it has 
found several other biological applications due to its photo-reactivity. The mechanism of 
action of Rose Bengal is still relatively unknown although it is postulated that when activated 
by 532nm laser light, photons of light absorbed by RB result in the creation of free radical 
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species. The generation of free radicals is usually synonymous with cellular toxicity and this 
has been raised as a concern with the use of RB. In keeping with this, RB has been shown to 
be toxic to corneal epithelial cells and can cause discomfort if not given with topical 
anaesthesia(308, 309). As a result, alternatives to RB for this purpose are often preferred. 
Experimentally, photoactivated RB has been used to deliberately cause tissue damage. 
Intravenous administration of Bose Bengal and subsequent focal laser activation in the brain 
is a well-reported technique used to induce photo-thrombotic stroke in animal models(310-312). 
It has also been used as a topical agent in photodynamic therapy (PDT) for skin cancer 
although no toxic effects to the surrounding normal skin were demonstrated(313). In the 
context of photochemical bonding, the formation of reactive oxygen species from closely 
apposed RB-stained tissue surfaces is believed to result in covalent crosslinking between 
amnion acid residues(242). As with PDT, when used as a sutureless method of wound closure 
following surgical excisions, no toxic effects were demonstrated(314). In the context of 
peripheral nerve repair, both in vitro and in vivo experiments have also confirmed a lack of 
cellular toxicity(314, 315). 
 
Fluence describes the amount of energy delivered per unit area and has the unit joules per 
centimeter squared (J/cm2). Irradiance describes the rate of delivery of this energy and is 
measure in W/cm2. Dose response experiments performed in this study showed that, with a 
constant irradiance of 0.5W/cm2, optimal bond strength was achieved with a fluence of 
60J/cm2. These findings are consistent with previous work(243). Lower fluences led to 
inadequate bonding, with higher fluences leading to excessive illumination times and 
desiccation. These laser settings translate to an illumination time of two minutes which is 
considerably quicker than conventional suture repair time.   
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In addition to potential time saving benefits, the technique of light activated sealing relies less 
on specialist microsurgical equipment, not including the light source. This may make it more 
accessible to those that do not have access to sophisticated equipment or facilities. Reduced 
operative time and a reduced requirement on expensive equipment should translate into 
substantial costs savings for the healthcare provider. The process is technically easier than 
standard microsurgical techniques and should therefore be readily adopted by surgeons that 
are less experienced or who lack classic microsurgical training. 
  
Implications for the future of peripheral nerve repair 
With refinement, light activated sealing could establish itself as an alternative to suture for 
the repair of peripheral nerves. Developing a portable hand held light source in addition to a 
pre-packaged, photo-active dye-stained nerve wrap, may make possible “off-the-shelf” nerve 
repair kits that could be stocked in operating rooms in a similar way to sutures. The ability to 
improve regeneration through ANAs may make the use of nerve autografts obsolete, ridding 
the patient of the morbidity associated with donor nerve harvest. This may have great 
relevance for military reconstructive surgeons who must often manage devastating injuries in 
austere, war torn environments. 
 
Very few clinically translatable interventions have been able to improve outcomes following 
peripheral nerve repair. Electrical stimulation of nerve repair sites may upregulate RAG 
expression and the production of neurotrophic factors(101, 102). Improved rates of regeneration 
have been demonstrated in animal models of immediate and delayed repair(104, 160) and most 
recently, has facilitated full reinnervation of thenar muscles in humans with severe carpal 
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tunnel syndrome(105). The administration of pharmacologics such as acetyl-L-carnitine 
(ALCAR) or N-acetyl cysteine (NAC), both of which are clinically safe, can offer 
neuroprotection to the injured nerve by reducing the effects of axotomy-induced apoptosis in 
the cell body(316). Clinical trials involving both of these compounds are expected in the near 
future. 
 
As more is understood about the neurobiology of nerve injury and regeneration, increasing 
attention is being focused on manipulating the cellular components involved in order to 
prolong a growth permissive environment. The supplementation of exogenous SCs and 
neurotrophic factors at the repair site and in the periphery has the potential to improve rates 
and success of regeneration. However, many pragmatic obstacles exist concerning the 
delivery of these cells and their temporal and spatial regulation. For example, inappropriately 
high concentrations of some neurotrophic factors can be inhibitory to regeneration and can 
even promote cell death(99, 100). The application of these approaches is exciting but is far from 
being realised clinically. Contrary to popular opinion, the results presented in this thesis 
suggest that improvements to the technical aspects of peripheral nerve repair may still be 
possible. This offers a more simplistic and clinically translatable solution at present. If light 
activated sealing can be shown to improve the longevity of SCs and neurotrophic factors at 





Section 5: Conclusions 
Photochemical sealing of nerve graft coaptation sites using crosslinked human amnion nerve 
wraps results in a statistically significant improvement in muscle mass retention and nerve 
histomorphometry in comparison to conventional graft+suture. This observation may be 
related to the creation of a protective seal at nerve graft coaptation sites and the improved 
longevity of this seal as a result of nerve wrap crosslinking. This seal may act to enclose SCs 
and the growth promoting factors they produce. The lack of suture, the effects of low power 
laser irradiation and the presence of amnion at the repair site may all contribute to a reduction 
in inflammation and scar tissue formation. Although unsuitable for small caliber nerves, we 
are optimistic that SIS may represent a viable, commercially available nerve wrap that may 
facilitate the rapid clinical translation of photochemical sealing of larger caliber nerves.  
 
The significantly poorer outcomes observed following ANA+suture in comparison to 
isograft+suture is typical and can be explained by the absence of SCs and their growth 
promoting influence in these grafts. Outcomes in the ANA+PTB group were not significantly 
different in comparison to ANA+suture. It is possible that the attenuation of the previously 
observed photochemical effect is also due to a lack of SCs and neurotrophic factors and the 
inability to contain these at the repair site. Although not significant, greater mean outcome 
values in the ANA+PTB group were statistically comparable to isograft+suture, the current 
standard of care. This could translate into important improvements in peripheral nerve 
recovery in those cases of severe trauma and limb loss where the use of nerve autograft is not 
possible. With refinement, photochemical sealing, when used in conjunction with ANA, has 
the potential to completely supplant the use of autografts following large gap injury.  
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Outcomes of repair following a 30-day delay are significantly poorer in comparison to those 
repairs performed immediately. When performed after a delay, light activated sealing of 
isograft coaptation sites with crosslinked amnion wraps results in significantly better 
outcomes in comparison to sutured repairs. The use of light activated sealing following 
delayed repair results in outcomes that are statistically comparable to those achieved with 
immediate suture. In combination with the potential benefits demonstrated when applied to 
ANA, these findings may have potentially important clinical implications for the future repair 
of large gap nerve injury following periods of delay, particularly when the nature of the 











Section 6: Additional Work 
 
6.1 Assessing nerve revascularization using Optical Frequency Domain 
Imaging: a proof of concept pilot study 
6.1.1 Introduction 
The detrimental effects of hypoperfusion and ischaemia on the structure and function of 
peripheral nerves is well established. Prolonged periods of ischaemia, regardless of aetiology, 
result in conduction block and if prolonged, de-myelination and degeneration. Clinical 
examples of such sequelae include temporary paraesthesia following short periods of limb 
tourniquet use or weakness and muscle wasting following chronic nerve compression. In 
addition to the loss of nerve continuity following transection, investigators have shown that 
stretch and compressive injuries can result in immediate vascular occlusion and latent 
occlusion secondary to increased microvascular permeability and oedema, long after the 
injurious event has passed(317). Due to the rich anastomotic intrinsic vascular system, and the 
segmental extrinsic supply, vascular compromise following transection and end-to-end repair 
is unlikely. However, following nerve grafting, particularly when nerve gaps are large, when 
graft diameter is excessive, when grafts are decellularized, and when the quality of the tissue 
bed is poor, slow or delayed graft revascularization may have a major impact on the success 
of regeneration and recovery. 
 
 
Revascularization of nerve grafts is believed to occur through two mechanisms. Centripetal 
revascularization refers to neovascularization from surrounding tissues and several 
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investigators have claimed the predominance of this process(318-321). In contrast, inosculation 
describes the process by which the longitudinal plexus of blood vessels lying on and within 
the connective tissue layers of the nerve are re-established. Others have shown that this 
process, rather than tissue bed neovascularization, is the primary source of 
revascularization(322, 323). With regards to timing, revascularization of nerve grafts has been 
observed to occur anywhere between 3 days and 3 weeks(323).  The process of centripetal 
revascularization led to predictions that the use of vascularized grafts would result in superior 
rates of revascularization and would therefore out-perform conventional, non-vascularized 
grafts. Although several studies supported this theory(122-126), other investigators were unable 
to show any significant difference(127-130). In addition, no significant differences have been 
observed when comparing nerve autograft with allograft(323, 324).    
 
Several techniques have been used to try and visualize the microvasculature of peripheral 
nerves. Histological techniques(322, 324) provided useful information of vascularity at specific 
times and locations but were unable to provide any useful information on the dynamicity of 
the process. Microangiography using radionuclide labeled microspheres and other washout 
techniques provided a more comprehensive evaluation of blood flow although these 
techniques were limited to regional assessments of flow(318-321, 324). Intravascular tracer 
(Evans blue bovine albumin) provided more information on individual vessel flow 
characteristics(323). The disadvantages of all these approaches is the inability to image in real 
time, the invasive nature of the techniques and the reliance on contrast media for 
visualization.  
 
Most recently, novel optical imaging techniques such as orthogonal polarization spectral 
imaging (OPS) have been applied to peripheral nerves. Emitted light is reflected off 
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erythrocytes and is captured to produce an image. This imaging modality provides real time 
evaluation of microcirculatory blood flow and has suggested that revascularisation is 
primarily through a bi-directional, inosculation-type mechanism(325). An alternative emerging 
technology is optical frequency domain imaging (OFDI). OFDI is an optical imaging 
technique based on very similar principles as its parent technology, optical coherence 
tomography (OCT)(326). Using low-power infrared light, OFDI permits visualization of tissue 
microstructure, allowing in situ image acquisition, precluding the requirement for biopsy. 
This non-invasive (contact only) imaging has a resolution of up to 1-15µm and a depth 
penetration of 2-3 mm(327). OFDI is analogous to ultrasound in that it measures the time-of-
flight of launched waves. However, while ultrasound uses sound waves, OFDI uses light 
waves and has image resolution 1-2 orders of magnitude greater than standard ultrasound(327, 
328). As with ultrasound, OFDI Doppler imaging allows quantitative blood flow 
measurements. Because the optical properties of soft tissues vary significantly, OFDI 
provides excellent contrast between soft tissue structures. Importantly, OFDI is safe to deploy 
in the clinical setting as it operates with near-infrared light and requires no exogenous 
contrast agents. Current OFDI systems also provide images in real-time. In addition to 
displaying these images, OFDI systems archive the acquired data for later post-processing. In 
recent years, our collaborative group at the Wellmen Centre for Photomedicine, The 
Massachusetts General Hospital, have applied OFDI to the study of in vivo tumour biology, 
providing exquisitely detailed, real time images of tumour lymphangiogenesis and the 
response to different therapies(329). Future developments exploring the differences between 
intratumoral and extratumoral vasculature may lead to novel methods of tumour margin 
control. In light of the high resolution, non-invasive, real time capabilities of this modality, it 
is possible that the application of this technology to the study of peripheral nerves may offer 
important insights into the process of revascularization following injury and repair. It was the 
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aim of this proof of concept study to test the efficacy of OFDI when used following various 
different rodent sciatic nerve injuries.  
 
6.1.2 Methods 
6.1.2.1 Animal surgery  
The Institutional Animal Care and Use Committee (IACUC) at the Massachusetts General 
Hospital approved all procedures. Eight male Sprague Dawley rats weighing 250-300g were 
randomized into the following four groups (n=2): (1) crush, (2) transection and end-to-end 
repair (3) transection and repair of 10mm nerve gap using contralateral autograft, (4) 
transection and repair of 10mm nerve gap using acellular nerve allograft (ANA). Induction 
and maintenance anaesthesia was achieved by using ketamine (100mg/kg; Vedco Inc, St 
Joseph, MO)/xylazine (10mg/kg; Akorn Inc, Decatur, IL). All animals had pre- and 
postoperative doses of buprenorphine (0.01mg/kg; Reckitt Benckiser, Richmond, VA). 
Analgesia continued twice daily for 72 hours after surgery or continuously if the interval 
between surgery was less than 72 hours. All animals had dorso-lateral muscle splitting 
incisions on the left hindlimb over the distribution of the sciatic nerve. The sciatic nerve was 
freed from investing connective tissue along the entire length of the nerve from the distal 
trifurcation to a point approximately 25mm proximal to this (figure 40A). Following 
mobilization, baseline images were obtained of uninjured nerves. The aforementioned nerve 
injuries were then created and repaired as described below. All wounds were closed in three 
layers using 4.0 vicryl (muscle and deep dermal) and 4.0 monocryl (subcuticular). Topical 
antibacterial ointment was applied to wounds in order to reduce the incidence of post-
operative infection. Bitter apple was sprayed onto ipsilateral feet to reduce the incidence of 
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automutilation. Rodents were housed in The Massachusetts General Hospital small animal 
facility and had access to food and water as required. 
 
Group 1 – Crush injury 
Following exposure, the sciatic nerve was crushed for 10 seconds using a pair of number 4 
microsurgery forceps. Crush injuries were performed at a site measuring 10mm proximal 
from the site of sciatic nerve trifurcation. In order to facilitate sequential nerve imaging at the 
same site, two Ethilon sutures were inserted into the muscle adjacent to the nerve injury. 
Images were acquired immediately before and after the injury.  
  
Group 2 – Transection and repair 
Following exposure, the sciatic nerve was sharply transected using straight microsurgical 
scissors at a point measuring 10mm proximal from the sciatic trifurcation. Under loupe 
magnification, the nerve ends were immediately repaired using six 10-0 Ethilon suture. 
Images were acquired immediately before and after the repair.  
   
Group 3 – Transection and repair of 10mm nerve gap using contralateral autograft  
In order to harvest the autograft, the right sciatic nerve was exposed as described above. A 
10mm length of nerve was excised from the mid-portion of the sciatic nerve and was stored 
in damp gauze until required. Following exposure of the left sciatic nerve as described above, 
the nerve was sharply transected with straight microsurgery scissors at a point measuring 
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10mm proximal to the trifurcation. The harvested autograft was reversed and sutured into the 
gap created by nerve end retraction using six 10-0 Ethilon sutures at each coaptation site.      
 
Group 4 – Transection and repair of 10mm nerve gap using acellular nerve allograft 
Following exposure, the left sciatic nerve was sharply transected with straight microsurgery 
scissors at a point measuring 10mm proximal to the trifurcation. A 10mm length of ANA was 
reversed and sutured into the gap created by nerve end retraction using six 10-0 Ethilon 
sutures at each coaptation site.      
 
6.1.2.2 Imaging  
OFDI employs a broadband low-coherence light source (beam) that is split to two paths by an 
optical splitter. One of these two beams is directed to a reflecting mirror in a reference arm. 
The second beam is directed to the tissue sample. Both the reference arm reflecting mirror 
and the tissue sample reflect light backward toward the system, and this recollected light 
from the sample and reflecting mirror are mixed to generate a signal. By analyzing this 
interfering signal, the optical scattering properties across tissue depth can be measured. By 
laterally scanning the OFDI beam across the sample, two and three-dimensional OFDI 
images are acquired. An essential pre-requisite for imaging is tissue/animal stabilization. 
Movement artifacts greatly interfere with image acquisition. The main movement artifact 
present in animal preparations is that created and transmitted by respiration. Isolating the 
sciatic nerve from the tissue bed was one solution that was explored. A platform was 
designed and 3D printed. This was attached to posts that could be mounted onto the OFDI 
objective lens. The platform could be slid up or down in the lens tower, allowing regulation 
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of distance between nerve and lens. The platform also contained a groove to accommodate 
the nerve (figure 40B, 40C, 41A). Although effective it was felt that repeatedly elevating the 
nerve out of its tissue bed would be detrimental to healing and neovascularization and as a 














Figure 40. Sciatic nerve exposure and 3D-printed resin platform. (A) Sciatic nerve exposed and mobilized 
along its length. This length extended from the distal trifurcation to a point approximately 25mm proximal to 
this. (B) A custom-made, 3D-printed resin platform containing a groove facilitated nerve elevation from the 
tissue bed. (C) In situ elevation of rodent sciatic nerve from tissue bed.   
 
Instead, following injury and repair, each rodent was firmly secured to a polystyrene platform 
using a combination of Velcro straps and elastic bands (figure 41B and 41C). It was found 
that although movement was not completely abolished, it was sufficiently reduced to enable 
image collection. Image acquisition was obtained immediately pre-injury, immediately post-
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repair and on post-operative days 2, 4 and 7. On each post-operative imaging day, rodents 
were anaesthetized, had nerves exposed and images acquired as described above. 
  
 
Figure 41. OFDI objective lens tower and rodent stabilization method. (A) Objective lens with rig 
permitting attachment of 3D printed platform (subsequently not used). (B/C) Rodent placed on polystyrene 
platform. Left hindlimb placed under traction via elastic band. Rodent pelvis stabilized using Velcro hook-and-




Initial image acquisition  
Initial images from intact, uninjured nerve showed that, despite some residual movement 




Figure 42. Unprocessed longitudinal images acquired from uninjured nerve. (A) Most superficial image. 
Note the extensive vasculature lying on the surface of the nerve. These vessels represent part of the mesoneurial 
and epineurial longitudinal plexus. Note the tortuosity of the vessels, a feature analagous to the bands of 
Fontana, conveying an accordion-like redundancy protecting the nerve against stretching forces during 
movement. (B) A deeper image of the same section of nerve. Note the epineurial vessel at the top left hand 
corner is beginning to disappear out of view. (C) A deeper image showing the complete disappearance of the 
epineurial vessel at the top left hand corner. 
 
Crush Injury 
Following crush injury, the microvasculature at the repair site was clearly visible and 








Figure 43. OFDI images of crush injury. Uninjured nerve is easily distinguishable from the surrounding and 
underlying muscle. Longitudinal vessels on the surface of the epineurium are apparent. A crush injury was 
administered in the mid-portion of the sciatic nerve using number 5 jewelers forceps. Immediately post-crush, 
the longitudinal vessels are still patent. The injury site was easily identified.    
 
Transection and suture repair  
Images were of reasonable quality. The nerve was easily distinguished from underlying 
muscle. Microvasculature was easily visible and could be seen running longitudinally along 
the nerve. At the site of repair, there was an area of relative hypovascularity where the 
vessels were interrupted (figure 44). After 7 days, a florid angiogenic process had occurred 
(figure 45). From the images, it appears that this revascularisation is mainly inosculatory in 












Figure 44. OFDI images of uninjured nerve (left) and immediate neurorrhaphy following transection. The 
markedly different light scattering properties of different tissues allows easy differentiation between uninjured 
nerve and the adjacent muscle bed. Longitudinal vessels can be clearly seen lying on the surface of the nerve 
and on the surface of the muscle. Note the preservation of the longitudinal intrinsic plexus of vessels proximal 
and distal to the repair site, immediately following epineurial suturing. As expected, the actual neurorrhaphy site 








Figure 45. OFDI images of transection and suture repair. The image on the left is immediately post-injury as 
shown in the previous figure. The image on the right shows the florid angiogenic reaction 7-days after suture 
neurorrhaphy. The majority of the vessels seem to be from inosculation of the longitudinal plexus.       
 











Figure 46. OFDI image of nerve autograft reconstruction of 10mm nerve gap. Note improved image quality 
in comparison to original images. Pre-injury image shows excellent resolution of intrinsic supply in addition to 
segmental extrinsic supply. Note the small perpendicular branches penetrating into the core of the nerve forming 
anastomotic connections between epineurium and perineurial plexi. At day 4 following repair, re-establishment 
of longitudinal vessels is apparent.       
 
 
With greater stabilisation, image quality improved. The segmental extrinsic supply and its 
anastomosis with the intrinsic longitudinal plexi could be easily identified (figure 46). Re-
imaging after 4 days showed vessel inosculation across the repair site (figure 46). Some 
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centripetal contribution could also be seen but the majority vessels were longitudinally 
orientated.  
 











Figure 47. OFDI images of uninjured nerve and nerve gap reconstruction using 10mm ANA. As with the 
previous autograft images, note the excellent resolution and image quality. Nerve boundaries and longitudinal 
plexi or vessels are easily visualised in uninjured nerve (left). 7 days after ANA reconstruction of a 10mm nerve 
gap, little to no revascularistion has occurred. There is perhaps some vessel formation at the periphery of the 
graft but this is markedly reduced in comparison to the autograft.    
 
As with autograft repair, the quality of OFDI images was excellent. In comparison to 
autograft, the ANA was hypovascular (figure 47). Very little revascularisation had occurred 
after 7 days, a longer initial time point than used in the autograft rat (figure 47). These 
observations are not surprising and partly explain why axonal regeneration through these 
grafts and the ultimate recovery is inferior to that observed following nerve autograft 
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reconstruction. Software refinements that will allow quantitative measurement of blood flow 
are in progress.       
 
6.1.4 Discussion 
The results of this pilot study have shown that OFDI has the ability to provide high 
resolution, real-time images of nerve microvasculature. Images have been successfully 
acquired from uninjured nerve and in nerves that have been completely transected and 
microsurgcally repaired. The results of these images imply that inosculation of vessels within 
the longitudinal plexi of peripheral nerves may be the predominant mechanism of 
revascularization following injury. These results are consistent with contemporary findings 
showing that, although centripetal neovascularization contributes to the process of 
revascularization, it appears to have a minor, accessory role, particularly following nerve 
grafting(323, 325).  
 
Imaging following autograft and ANA reconstruction, although planned, has not yet been 
performed. This is due to two main obstacles. Repeated anesthesia every 48 hours was found 
to have a deleterious effect on the ability of rodents to recover. Incomplete recovery resulted 
in poor nutritional intake and rehydration to the point where animals were becoming 
moribund towards the latter time points. As a result, protocol amendments were made in 
order to increase the periods between imaging sessions and to introduce nutritional 
supplementation for the rodents. In addition to this, the issue of movement artifact was a 
continual problem. Although movement was considerably reduced by external fixation, 
subtle, transmitted vibrations from respiratory excursion were still present. Rather than devise 
an alternative method of rigid, invasive, skeletal fixation, new software is currently being 
written. This intends to gate the acquisition of images so that image capture only occurs at 
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peaks and troughs of respiration. Once these technical and protocol amendments are in place, 
the remainder of the experiments will be completed. 
 
The limitations of OFDI when applied to peripheral nerve revascularization are generic to all 
in vivo optical imaging techniques. Limited tissue penetration is arguably the most important 
of these. Maximum light penetration is in the region of 2-3mm and this obviously precludes 
use of the technique for percutaneous imaging of deep structures. However, the main clinical 
application of this imaging modality may lie in its ability to provide real time, in vivo 
assessment of nerve vasculature and viability intraoperatively. This would be advantageous 
following traumatic injuries when the viability of nerve tissue is uncertain. This may also 
have important applications in the context of chronic injury when intraneural scar tissue 
obstructs regeneration and recovery. Accurate identification of the extent of these relatively 
avascular portions of nerve would greatly facilitate excision and repair and the avoidance of 
iatrogenic injury to healthy tissue.   
 
The experimental applications for peripheral nerve research are also promising. Methods of 
outcome assessment in peripheral nerve research are notoriously problematic. Several 
methods are usually employed during any particular study. This combinatory approach 
acknowledges the limitations of each individual method and aims to reduce subjectivity, bias 
and error. Common methods include walking track analysis and SFI, muscle weight 
retention, nerve histomorphometry, electrophysiology, retrograde labeling of cell bodies, 
immunohistochemistry and fluorescence microscopy. The routine use of imaging techniques 
to monitor revascularization has not yet been employed although with refinement, it is 
possible that OFDI may make this feasible. The exact relationship between successful 
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revascularization, axonal regeneration and functional recovery is uncertain although with 
further experience, these questions may be answered. The sequential, real-time imaging of 
autograft and ANA revascularization may also help develop other novel strategies that can 
augment regeneration and outcome.    
 
6.1.5 Conclusions              
OFDI is an emerging technology that has proven efficacious for the study of tumour biology. 
The application of this technology to the study of peripheral nerves and their regeneration 
following injury is only now being attempted. This pilot study has confirmed that real-time 
monitoring of nerve microvasculature and revascularization following injury is possible. 
With refinement, high-resolution 3D reconstructions and quantitative assessments of blood 
flow will be possible. This may have useful intraoperative clinical applications when the 
viability of nerves following injury is questionable and also promises to be of use as an 








6.2 Development of a Brain-Body Interface system for limb reanimation 
following high cervical spine injury  
6.2.1 Introduction 
Background  
Annual crude incidence rates of spinal cord injury (SCI) vary between 12.1-57.8 per 
million(330). Most SCI show a bimodal age distribution with the first peak arising in young 
adults between the ages of 15-29 years and the second peak in older adults, mostly over 65 
years(330). Motor vehicle accidents and falls are the commonest mechanisms of injury(330). SCI 
has become more prevalent within the ranks of the armed services as a result of the wars in Iraq 
and Afghanistan. Between 2000-2009, 5928 SCI cases were reported throughout the entire US 
military population(331). Among the 7877 combat-wounded from the years 2005 to 2009, 872 
were classified as SCI, meaning that more than 1 in 10 injuries sustained in the theatre of war 
resulted in SCI(332). During the period from 2001-2009, over 5% of the casualties that required 
battlefield evacuation (598 out of 10,979) were attributable to spine-related trauma(333).  A 
significant fraction of SCI injuries sustained in the military occur at the cervical level, leading 
to severe disability(334). 
 
In cases where spinal cord injury is complete, there is currently very little that can be done to 
restore lost motor control. The treatment options following these injuries are extremely 
limited and largely experimental. The majority of focus is placed on rehabilitation and 
support as the patient accepts and adjusts to their disability. Attempts have been made to 
repair the damaged cord with cell-based therapy such as stem cells and neurotrophic factors. 
Despite promising pre-clinical results, this approach has been unsuccessful clinically. 
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Although patients experience devastating disability, motor intention above and lower motor 
neurons below the level of the injury are intact. As a result, an alternative approach following 
these injuries is to bypass the area of damage. Although nerve transfers are an option, the 
majority of research in this area has focused on neural interface technology. 
 
Neural interface technology aims to restore lost function through the use of neuroprostheses. 
This concept is by no means novel. Cochlear and retinal implants can be traced back to the 
1950s and since then, these devices have helped restore hearing and vision in many 
patients(335, 336). The application of this technology for the restoration of movement is more 
recent. The type of movement restored and the functional gains provided are variable. For 
example, brain-computer interfaces (BCI) use neural signals to control computer cursors. The 
ability to point and click facilitates letter selection, spelling, writing and emailing. This has 
also been linked to various assistive technologies such as light switches and televisions, 
further extending autonomy of the operator. Brain-machine interfaces (BMI) use neural 
signals to control devices such as robotic arms. Demonstrations of non-human primates 
(NHPs) using cortical signals to control computer cursors and robotic arms for reaching and 
grasping(337-339) were followed by similarly impressive clinical demonstrations in 
tetraplegics(340-344), generating a huge amount of scientific and public interest. This represents 
the current limit of BMI capabilities with continued efforts being devoted to increasing 
degrees of freedom and autonomy. Using paralysed muscles as actuators is a challenging 
concept that is receiving increasing attention from researchers in the field(345). Referred to as 
a brain-body interface (BBI), this represents the ultimate integration of neural interface 
technology. The type of cortical signals recorded, the method by which they are recorded, 
and how these signals are processed and delivered to the output actuator are cardinal 
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variables of these interface systems, and are the major points of focus for researchers in the 
field(345).   
 
Cortical signal recording  
Several types of information-carrying neural signal exist although broadly speaking, these 
signals are either action potential spikes or field potentials (FP)(346). Spike rate has emerged 
as a predominant mode of information transfer and is responsible for coding a huge variety of 
motor information such as hand velocity, position and joint torques. This activity can be 
captured from single neurons or from populations of neurons (multi-unit activity (MUA)). 
Single unit or MUA is detectable only by intraparenchymal electrodes. The high spatial 
resolution and superior signal-to-noise ratio of these signals is offset by several limitations. 
Although MUA provides recordings from larger numbers of neurons than single unit activity, 
representative populations remain small. Insertion of intraparenchymal electrodes is highly 
invasive and is associated with potentially devastating risks of bleeding and infection. The 
risk of infection is compounded by the exteriorization of signal recording and transmission 
hardware on the scalp. In addition, implanted electrodes naturally incite a foreign body 
reaction. This results in gliosis, scar tissue formation and encapsulation, all of which can have 
deleterious effects on the function of adjacent cells and the long-term recording ability of 
electrodes. 
 
Field potentials (FPs) represent summed synaptic currents sampled from large numbers of 
neurons with large spatial and functional variation. FPs can be sub-classified into slow, 
medium or fast rhythms or non-rhythm event related potentials (ERPs), all of which have 
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been used to drive BMIs(343, 347). FPs can be recorded intraparenchymally as local field 
potentials (LFPs), from epicortical or epidural locations as electrocorticography (ECoG) 
signals, or from the surface of the scalp as electrencephalography (EEG) signals (345). The 
ability to record FPs extracranially is an advantage over spike recording. However, recording 
from huge populations of neurons through bone and scalp tissues results in poor signal 
resolution. In spite of these limitations, EEG driven BMIs have successfully controlled 
computer cursors in humans(343). Other non-invasive options such as functional MRI (fMRI) 
have recently been investigated. Signals can be recorded from the entire brain with high 
spatial resolution. However, temporal resolution is poor as the signals originate from 
haemodynamic rather than electrical activity(348).  
 
Whilst recognizing the benefits of non-invasive recording, restoration of complex movement 
with multiple degrees of freedom requires a degree of signal resolution that, with current 
technology, can only be provided by invasive methods. Epicortical arrays simply lie on the 
surface of the dura, reducing the complications associated with intraparenchymal electrodes. 
The next generation of recording electrodes strives to improve biocompatibility, prolong the 
duration and reliability of signal recording, allow recording from larger populations of 
neurons, including those from deeper, currently inaccessible locations of the brain, and will 
transmit this information wirelessly, obviating the requirement for exteriorized hardware.   
 
Signal processing  
Cortical signals can be used to control output actuators in a direct or indirect fashion. Indirect 
control (figure 48) is the most commonly applied method for BCIs and BMIs, utilizing neural 
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signals that are not intrinsically related to the intended movement(345). Recorded signals are 
correlated with observed movements and this information is used to build a decoder, the 
purpose of which is to infer movement intention from future recordings. Sophisticated 
computer algorithms are used to formulate a kinematic plan. Decoded signals are delivered to 
an encoder, the purpose of which is to convert decoded signals into a language interpretable 
by the output actuator. The encoded signal may require amplification in order to generate the 
desired output.  
 
There are several limitations of the indirect approach. Firstly, the brain is not actually in 
control. All control occurs at the level of the decoder. Although both brain and decoder are 
adaptable, the two are decoupled. This results in dueling dynamic systems that are unstable 
and unlikely to converge. Decoding algorithms assign coordinates and variables to neuronal 
signals and, without re-calibration, these are fixed. When performing pre-registered 
movements, the system will perform well. However, if asked to perform different movements 
in response to change, the system performs poorly. This inability to generalize is 
compounded by a fundamental lack of understanding of exactly how the motor cortex 
controls hand movement. Understanding has progressed very little since the discovery of the 
motor strip and the construction of motor maps in the late 1800s(349). Rather than controlling 
specific muscles, contemporary opinion is that neurons of the motor cortex encode a state 
vector representation of the hand, with emphasis on kinetic or force-related aspects of 
movement such as joint torque, and kinematic variables such as position and velocity of the 
hand in space(349). Decoders set coordinates and variables according to this entirely assumed 









Figure 48. BMI system based on indirect control  
Direct control uses neural signals that are responsible for desired movements. Unlike the 
indirect approach, signals are fed directly into the actuator, without the involvement of a 
decoder (figure 49). Signals may require amplification to drive the actuator. With this 
arrangement, all learning and control occurs in the brain. Direct control recognizes that the 
intricacies of motor control are beyond current understanding. Rather than relying on a 
decoder that has been constructed around assumed cortical representation, it relies on the 
vastly superior capacity for learning of the brain. Once the brain and actuator have been 















Figure 49. BMI system based on direct control 
theoretically enable the subject to achieve autonomous, generalizable control over 
movement(345). A disadvantage of this approach is that it may take a prolonged period of time 
for a subject to re-learn movement. This limitation is not a feature of indirect control where 
algorithms are used to rapidly infer movement intention.   
 
Neural signal delivery to the output actuator 
Once recorded and processed, signals are delivered to the actuator. In BCIs and BMIs, this 
occurs through external hardware. For BBIs, the successful restoration of autonomous 
movement following SCI will be largely reliant on establishing a reliable method for 
delivering signals subcutaneously, directly into muscle. Functional electrical stimulation 
(FES) is a well established technique that applies electrical currents to neuromuscular tissues 
in order to restore lost function(350). Basic components include a power source, control unit, 
stimulator, lead wires, stimulating electrodes and sensors. Stimulation can be delivered using 
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skin surface, percutaneous, or implantable electrodes(350). Surface electrodes are convenient 
although require repeated replacement, are cosmetically unsightly, are unable to stimulate 
deep muscles and can be painful due to cutaneous pain receptor activation. Percutaneous 
electrodes inserted into muscle provide isolated, repeatable activation and are less painful as 
they do not stimulate cutaneous pain afferents. Longevity of stimulation and tolerance are 
good although for life long use, are inferior to fully implantable systems(351). Implantable 
electrodes can be inserted on the surface of the muscle (epimysial), within the muscle 
(intramuscular), or at the level of the nerve supplying the muscle in question (nerve cuff).  
 
Stimulation is provided by a pulse of electrical current which varies in frequency, amplitude 
and duration. At low frequencies, muscle twitching occurs. As the frequency is increased, the 
fusion threshold is reached where sustained muscle contraction results. Increasing the 
frequency above the fusion threshold increases the force of contraction although also 
increases the rate of muscle fatigue. The force of contraction can also be increased by 
increasing pulse amplitude and duration. Increases in current result in larger electrical fields, 
area of stimulation and therefore motor unit recruitment(350).             
 
In addition to therapeutic applications such as standing, ambulation, breathing, coughing, 
bladder and bowel emptying, penile erection and ejaculation, FES has also been successful at 
restoring reach and grasp movements in paralysed patients(352-354). Arguably the most well 
known example is the Freehand system. First generation systems consist of an eight-channel 
stimulator implanted into a subcutaneous pocket on the chest wall(350, 351). Epimysial or 
intramuscular electrodes implanted into flexors and extensors of the fingers allow lateral and 
palmar grasp. A skin mounted radiofrequency coil overlying the stimulator connects to an 
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external control unit mounted on the contralateral shoulder. Shoulder movements are detected 
and transduced in order to drive the stimulator in a patient controlled fashion. FDA approval 
was granted in 1997 and shortly following this, the system was implanted in excess of 250 
tetraplegic patients. In spite of functional improvements, many patients were disappointed 
with overall performance and subsequently discontinued use. In 2001, the manufacturer 
withdrew from the market. A second-generation system has since been developed consisting 
of twelve stimulating electrodes driven by EMG signals from intact muscle and implantable 
joint sensors situated in the ipsilateral limb. Additional electrodes allow forearm pronation, 
elbow extension and shoulder movements, in addition to lateral and palmar grasp(351, 352, 354). 
The amount of external hardware is reduced and application bilaterally is possible. Although 
intrinsic muscle activation and grasp is reportedly better, dexterity is still poor.  
 
FES has several general limitations. Artificial stimulation of nerves and muscle results in 
reverse recruitment of large motor units first. As a result fine motor control is difficult to 
achieve and the system is susceptible to fatigue. More physiological recruitment has been 
achieved by applying hyperpolarizing, anodal blocking currents that can selectively block 
action potential conduction in large fibres. The application of quasitrapezoidal-shaped pulses 
instead of traditional rectangular pulses has also been showed to recruit small, fatigue-
resistant fibers first(355). Once established, FES performance is fixed with no ability to 
develop over time. The technology is expensive and availability is limited to specialist units 
only. The required surgery is extensive. This includes initial hardware implantation, 
supplementary procedures such as tendon transfers and joint fusions, and also subsequent 
surgeries for equipment failure. Surgical complexity is exacerbated as electrode number 
increases. Stimulating proximally at the level of the nerve reduces electrode number and 
dissection.  
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Implantable nerve electrodes for FES  
Contemporary nerve microelectrodes for use in FES driven neural interface technology aim 
to provide selective stimulation of nerves and graded muscle contraction. Depending on 
design, electrodes can be placed adjacent to the nerve (epineurial), around the nerve (cuff) or 
within the substance of the nerve (intrafascicular and sieve). Cuff electrodes are the most 
commonly applied and thoroughly investigated electrodes for basic and pre-clinical 
research(356). Common designs include the split cylinder and the spiral cuff. The feasibility of 
a second-generation Freehand system using spiral nerve cuffs has recently been demonstrated 
in human tetraplegics(353). Several advantages are associated with cuff electrodes. Stimulation 
currents are considerably less in comparison to muscle and surface electrodes. Cuffs can be 
placed precisely on the nerve and, in comparison to intrafascicular and sieve electrodes, are 
less traumatic. Connecting leads can be carefully orientated in order to reduce mechanical 
deformation and breakage and excessive traction leading to inadvertent nerve compression or 
cuff avulsion. This is of particular relevance in the upper limb when elbow and shoulder 
movements can result in considerable excursion of nerves within the tissues. Compression 
can also occur secondary to nerve oedema and swelling, particularly following encapsulation. 
In addition, compression can occur at cuff edges as the nerve enters and exits. Snug fitting 
cuffs have been shown to result in axonal demyelination and degeneration(357). As a result, 
cuffs are designed to be self-sizing, flexible and are deliberately oversized.  
 
Nerve cuffs must be biocompatible. Any substances released from the cuff must be non-toxic 
and the induced foreign body response must be minor, leading to only mild capsule 
formation. Cuffs must be mechanically and functionally robust to permit chronic use and the 
avoidance of implant failure. They must be biologically stable, resisting corrosion and 
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enzymatic attack. Electrodes must be radiopaque to allow adequate visualization of position. 
Commonly used conducting materials include stainless steel, platinum, iridium and tungsten. 
Insulating materials include silicone, polytetrafluoroethylene and polyimide. Polyimide is a 
flexible polymer and favoured material in precision mechanics due to its suitability for 
micromachining. It has emerged as an excellent material for the manufacture of nerve cuffs 
and has been shown in many studies to be biocompatible with minimal foreign body 
reaction(356, 358). Silicone remains the material of choice for insulating connecting cables(359).  
 
Stimulating electrodes commonly have a bipolar or tripolar arrangement. The latter consists 
of a central cathodic pole and two flanking anodes. These arrangements reduce the spread of 
electrical fields and current, restricting excitation to the vicinity of the cuff(360). Cuffs with 
multiple stimulating channels are now available. Once applied, channels are situated around 
the circumference of the cuff allowing selective fascicular stimulation. The recent 
development of very small nerve cuffs enables placement around fascicles after they have 
branched from the main trunk.  
   
6.2.2 Aims 
The overarching goal of this work is to demonstrate that fully autonomous, generalizable 
control of a paralyzed limb can be achieved using a directly controlled brain-body interface 
(BBI) in a non-human primate model (NHP). The BBI will use ECoG signals to directly re-
animate paralyzed muscles rather than an artificial actuator. Neural signals will be delivered 
to paralyzed muscles by FES using implantable, polyimide nerve cuffs. In order to meet this 
goal, several specific aims have been set: (1) to train a non-human primate to perform a 
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simple behavior (elbow flexion) (2) to perform a highly selective reversible paralysis of 
elbow flexion (3) to demonstrate selective fascicular stimulation of a peripheral nerve using 
an implantable nerve cuff (4) implant a nerve cuff and a cortical recording array into a NHP 
(5) activate the cortically driven FES system and, during reversible limb paralysis, establish 
whether, through operant conditioning and feedback, the NHP can restore movement. The 
experiments performed as part of this thesis were focused on aim 3 although in order to 
provide deeper understanding of the project, a summary of the methods and results for aims 1 
and 2 has been provided.     
  
6.2.3 Methods 
6.2.3.1 Training NHP to perform a simple behaviour 
To assess the success of the reversible nerve block, the NHP was required to reliably perform 
a simple behaviour. The selected task required the NHP to lift a grape up to the mouth and 
involved a single degree of freedom (elbow flexion), across a single joint, in a vertical plane. 
It was essential that the motor task in question was as simple as possible in order to reduce 
the time required for re-learning following paralysis. Two additional tasks were designed 
although have not yet been imposed on the NHP. The second task is a centre-out pointing 
exercise where the NHP grips a joystick mounted on a mobile arm, the movement of which is 
restricted to a single horizontal plane. The joystick moves a cursor on a computer screen 
towards a moving target. This task involves movement in 2 DOF and requires coordination in 
2 DOF (elbow and shoulder). The third task is a crank-turning exercise where the NHP is 
required to turn a handle attached to a rotating wheel. This involves movement in 1 DOF and 
requires coordination of 2 DOF (elbow and shoulder). The first and third tasks involve 
movement in a vertical plane where the effects of gravity alternate between being supportive 
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and inhibitory at different phases of the tasks. The second task involves movement in a 
horizontal plane where the effects of gravity are constant. Alternating the task requirements 
and also the effects of gravity between tasks is a specific design feature permitting the 
assessment of BBI system generalization.  
 
6.2.3.2 Highly selective reversible paralysis of elbow flexion  
In order to thoroughly evaluate the ability of the NHP to assume autonomous control of the 
paralyzed limb, it was imperative that input from the brain and spinal cord along 
physiological pathways was blocked during testing. Irreversible paralysis by cord transection 
or other means in a NHP would almost certainly be declined by an institutional animal care 
and use committee and would also be disadvantageous for several other pragmatic reasons. 
As a result, one of the key features of this experimental strategy was to develop a reversible, 
highly selective, motor paralysis model in the NHP upper limb. Focus was placed on 
reversibly blocking elbow flexion although ultimately, this technique will also be applied to 
elbow extension.    
 
Through several cadaveric dissections of Rhesus Macaque monkeys (Macaca mulatta), it was 
discovered that the neuroanatomy of the upper limb is highly conserved in comparison to 
humans. Elbow flexion is the product of three different muscles – biceps brachii, brachilais 
and brachioradilais. Biceps brachii and brachialis muscles are innervated primarily by the 
musculocutaneous nerve. The brachialis also receives a small contribution from branches of 
the median nerve. The brachioradialis is innervated by branches of the radial nerve. Under 
general anaesthetic, the aforementioned muscles and their motor nerves were exposed 
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through an anteromedial incision in the forelimb. Median nerve branches to the brachialis and 
the radial nerve branches to the brachioradialis were sharply transected and proximal nerve 
ends buried into adjacent muscle. As a result, elbow flexion was entirely reliant on the 










Figure 50. Schematic of neuroanatomy of Rhesus Macaque upper limb and reversible paralysis of elbow 
flexion  
The musculocutaneous nerve was then transposed into a sub-cutaneous position. A metallic 
ligaclip® was placed adjacent to the nerve at the desired block site to facilitate ultrasound 
guided local anaesthetic administration. Wounds were closed in layers using deep dermal 
Vicryl suture and subcuticular Monocryl before returing the animal back to the facility to 
recover. Two weeks later, the NHP was sedated and, under ultrasound guidance, bupivacaine 
hydrochloride was used to selectively block this nerve, whilst preserving all other motor and 
sensory supply. The use of bupivicaine hydrochloride provided sustained paralysis for 6-12 
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hours. The success of the block was apparent when the NHP was unable to perform the pre-












Figure 51. Reversible paralysis of NHP elbow flexion. Images A+B and C+D represent two isolated 
experiments. NHP is unable to flex at the elbow. Note the preservation of hand grasp   
The block was confirmed electrophysiologically by the detection of compound muscle action 
potentials (CMAPS) from relevant muscles before the block compared to a complete absence 




6.2.3.3 Selective fascicular stimulation using implantable nerve cuff - non-survival 
experiments  
The next stage of the study aimed to assess the handling and biocompatibility of an 
implantable polyimide nerve cuff and its ability to selectively stimulate peripheral nerves. 
Under ketamine and xylazine anaesthesia, Sprague Dawley rats (n=5) and C57 Black 6 mice 
(n=5) had dorsolateral incisions made on the thigh. Sciatic nerves were exposed through 
muscle splitting incisions and mobilized free from their investing connective tissue. Incisions 
were extended into the leg in order to expose the gastrocnemius (posterior compartment) and 
tibialis anterior (anterior compartment) muscles. Polyimide nerve cuff electrodes with eight 
stimulating channels (figure 52; Prof Thomas Stieglitz, Department of Microsystems 
Engineering, University of Frieberg) were wrapped around the mid-point of the sciatic nerve 
and were connected to stimulation/recording equipment (Tucker-Davis Technologies (TDT)). 
Once the self-sizing cuffs were applied, stimulating channels were distributed evenly around 
the circumference of the nerve (figure 53 and figure 54). A 1.5mm diameter cuff was used for 
rodent sciatic nerves (approximate nerve diameter 1.2mm) and 1mm cuff for all mouse 
nerves (approximate nerve diameter 0.65mm). Grounding needle electrodes were inserted 
into the upper back muscles of each animal and electromyography (EMG) electrodes were 
inserted into the gastrocnemius and tibialis anterior muscles to record muscle activity (figure 
55). Single pulses and pulse trains were  
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Figure 52. schematic of polyimide nerve cuff electrode. The cuff proper is 8mm in length. The cuff has a 
natural tendency to furl up upon itself and does so along its 7mm width. The eight stimulating channels lie in the 
central portion of the cuff and once furled, are distributed evenly around the circumference of the nerve.      
 
delivered to the various nerve cuff channels whilst pulse frequency, amplitude and width 
were systematically varied. In theory, isolated activation of stimulating channels should allow 
selective fascicular activation and therefore selective activation of anterior and posterior 




Figure 53. Application of nerve cuff around rat sciatic nerve. (A) Sciatic nerve freed from investing 
connective tissue and mobilized along length of nerve. Nerve cuff placed into field adjacent to nerve. (B-C) The 
end of a straightened paper clip was inserted into the furled nerve cuff and by applying light traction, was used 
to unravel the cuff. (D-F) The unfurled cuff was hooked under the sciatic nerve and was allowed to naturally 
recoil back around the nerve.    
 
6.2.3.4 Selective fascicular stimulation using implantable nerve cuff - survival experiment 
Following successful demonstration of selective fascicular stimulation in non-survival 
surgeries, stimulating nerve cuff electrodes and EMG recording electrodes were implanted 
chronically into one rat in order to assess the reliability of the stimulating cuff and recording 
equipment. The cuff was applied in exactly the same fashion as in the acute, non-survival 
experiments.   
 
	 184	
Figure 54. Distribution of stimulating channels around sciatic nerve allowing selective fascicular 
stimulation. In this schematic, stimulating channels 3, 4 and 5 are distributed over the common peroneal 
fascicle. Channels 1, 2, 7 and 8 are distributed over the tibial fascicle. In theory, by activating these channels 
independently, it should be possible to selectively stimulate these fascicles and therefore elicit dorsiflexion and 
plantarflexion respectively.   
 
Intramuscular wire EMG electrodes were used in place of percutaneous needle electrodes to 
facilitate secure fixation into the gastrocnemius and tibialis anterior muscles. All wires and 
connecting cables were buried subcutaneously. Redundant loops were loosely sutured to 
underlying muscle to reduce the risk of displacement of the cuff or EMG electrodes due to 
traction. The connecting ports of the stimulating cuff and EMG electrodes were embedded in  
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Figure 55. Stimulating nerve cuff in situ with needle EMG recording electrodes inserted into tibilais 
anterior and gasrocnemius muscles  
epoxy resin and mounted on nylon mesh. The mesh was subsequently sutured to the muscles 
of the back and the skin closed around the resin to exteriorize the ports (figure 56). At the 
time of implantation, the ports were connected up to the TDT equipment to confirm 
satisfactory selective fascicular activation. Following this, the animal was allowed to recover 
before being returned to the animal facility. Stimulation and recording sessions were repeated 
at weekly intervals for 1-month and then at monthly intervals for up to 6-months. The rat will 
be kept alive for up to 1 year in order to fully assess biocompatibility and durability of the 
hardware. The final aim of the study involving the implantation of the nerve cuff and cortical 















Figure 56. Chronic implantation of polyimide nerve cuff and indwelling EMG electrodes. Once the nerve 
cuff was applied to the nerve, the silicone coated connecting cable was buried subcutaneously in the back. The 
cable was connected to stimulation and recording ports that were embedded in epoxy resin and secured to 
prolene mesh. The ports were exteriorized through the back skin. Mesh was secured to underlying muscle and 
skin closed around the resin using a purse string suture. EMG electode wires were passed through muscles and 





6.2.4.1 Training NHP to perform a simple behavior 
As the movement in question was a natural, instinctive feeding behavior, a small number of 
sessions within the space of one week were sufficient to ensure that the NHP was 
comfortable with the task. The sessions were mainly intended to acclimatise the NHP to the 
experimental environment and the restraints used. The remaining tasks were not imposed 
upon the NHP during these sessions but are planned to take place once the schedule for 
ECoG and nerve cuff implantation has been finalized.  
      
6.2.4.2 Highly selective reversible paralysis of elbow flexion  
As shown in figure 57, a highly selective, reversible paralysis of elbow flexion was achieved 
in the NHP. The NHP was unable to flex the elbow in order to bring a grape up to his mouth 
but importantly, all other motor input and sensory feedback to the limb was preserved. This 
demonstration highlights the feasibility of this approach and will form the basis of future 

















Figure 57. NHP attempting to flex elbow. NHP unable to flex elbow in order to bring grape up to mouth. All 
remaining motor input and sensory feedback was intact.   
 
6.2.4.3 Selective fascicular stimulation using implantable nerve cuff – non-surivival 
Selective activation of nerve cuff channels resulted in muscle activity in all animals. 
Selective stimulation of common peroneal and posterior tibial fascicles was demonstrated in 
9 animals (figure 58 and figure 59). EMG recordings from pulse trains with various different 
simulation parameters (pulse width, pulse amplitude, pulse frequency) allowed the plotting of 
muscle recruitment curves (figure 60). Stimulation of channel 2 resulted in the activation of 
the gastrocnemius muscle with very little EMG signal detected in the tibialis anterior. The 
reverse was observed in channel 3, with primarily tibialis activation and very little 
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gastrocnemius activation. Following 6-months of chronic cuff and EMG implantation, 
successful stimulation and recording was still possible. 
 
Figure 58. Selective fascicular stimulation in a mouse model. Stimulation of different nerve cuff channels 
resulted in plantarflexion and dorsiflexion depending on which channels overlay posterior tibial and common 
peroneal fascicles. Still images obtained from video footage.  
 
Figure 59. Selective fascicular stimulation in a rodent model. Stimulation of different nerve cuff channels 
resulted in plantarflexion and dorsiflexion depending on which stimulating channels overlay posterior tibial and 












Figure 60. Example of CMAP recruitment curves as a function of stimulation pulse amplitude in a single 
rodent. Graphs show CMAP recordings from two of the eight stimulating nerve cuff channels. Activation of 
channel 2 results in the stimulation of the gastrocnemius muscle with very little activity recorded in the tibialis 
anterior muscle. The reverse pattern is seen with activation of channel 3, with mostly tibialis anterior activation 
and very little gastrocnemius activity. This suggests that the cuff was situated around the sciatic nerve in such a 
way that channel 2 overlay the tibial fascicle and channel 3 overlay the common peroneal fascicle.    
 
6.2.4.4 Selective fascicular stimulation using implantable nerve cuff – survival experiment 
Stimulation and recording was possible for 6-months following implantation and, as with the 
non-survival experiments, was successful at showing selective fascicular stimulation. The 
data collection for this phase of the study took place following the authors departure from the 
United States and has not yet been analyzed and released by the Bizzi group. Following 
sacrifice and on gross examination, the sciatic nerve looked healthy with no signs of chronic 
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inflammatory reaction or infection. Cuff encapsulation with fibrous tissue was apparent and 
typical of any foreign material. Unfortunately the cuff had become detached from the 
polyurethane coated wire to which it was attached. This was previously recognized as a 
potential weak point and may necessitate a different method of implantation or even a re-
design of the cuff as the strain will only worsen once implanted into the NHP. Also, when the 
cuff was unrolled, small fragments of the platinum coated stimulation channels adhered to the 
nerve. It is uncertain why this occurred and the significance of this finding for long-term 
recording. There was no evidence of scar tissue between the cuff and the epineurial surface. 
This information was obtained through verbal communication with one of the lead 
investigators (R.A).      
 
6.2.5 Discussion     
This work represents part of an ongoing, collaborative effort between the Department of 
Plastic Surgery and Department of Anaesthesiology at The Massachusetts General Hospital 
and the McGovern Institute for Brain Research at The Massachusetts Institute of Technology. 
Recent experiments have developed a reversible upper limb paralysis model in a NHP. This 
important step involved surgically altering the neuroanatomy of the upper limb so that elbow 
flexion was entirely reliant on the musculocutaneous nerve. Although invasive, the functional 
deficit to the animal as result of this was minimal. Likewise, the injection of local anaesthetic 
temporarily paralysed elbow flexion whilst preserving all other motor and sensory supply. 
This may represent the first description of this highly selective nerve block in a NHP and has 
made feasible the current and planned experiments developing a BBI. Following successful 
demonstration of reversible paralysis, the NHP unfortunately developed an inflammatory 
bowel-type syndrome with associated immunocompromise and thrombocytopaenia. This 
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condition has recurred on several occasions and has been treated successfully with systemic 
steroids. It remains uncertain what the exact diagnosis is and how this will influence future 
implantation of the ECoG recording array and stimulating nerve cuff electrodes.   
 
The experiments performed in mice and rats have demonstrated that polyamide nerve cuffs 
are biocompatible and are electrophysiologically stable. The chronic, survival rodent has 
recently been sacrificed although had nerve stimulation and EMG recordings taken 
successfully up to 6-months post-implantation. Similar studies in the literature have showed 
that after 6-months, polyimide nerve cuffs were surrounded by a well-vascularized, thin, 
fibrous capsule(358). Underlying nerves were grossly normal and free from fibrinous 
adhesions. No evidence of nerve compression was apparent and on histological evaluation, 
axon counts, myelination and histomorphomeric measurements were comparable to the 
contralateral normal nerve. Electron microscopy of the nerve cuff showed no evidence of de-
lamination of micro-fracture.  
 
We also identified no gross abnormality with the sciatic nerve following sacrifice. 
Histological analysis is currently in progress. It was unfortunate that the nerve cuff became 
detached from the wire but we are confident that this problem can be overcome with a 
different implantation technique. This was already being contemplated as, following 
implantation into the NHP, there will need to be considerable “slack” in the connecting wires 
between the cuff and the exteriorized port to compensate for the wide range of movement at 
the shoulder girdle. The evidence of de-lamination of the platinum stimulating channels was 
a surprise and has not yet been observed with this particular cuff. However, the length of 
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follow-up in this study exceeds other reports. We are uncertain what implications this will 
have for the future use of this cuff in the NHP.  
 
The feasibility of selective fascicular stimulation, even in sub-1mm diameter murine sciatic 
nerves, has been confirmed. In future NHP experiments, the BBI system aims to restore 
elbow flexion only. As a result, selective fascicular stimulation is not entirely necessary at 
this time. The restoration of autonomous control of only simple movements would still 
represent a major advance in the field. If this approach proves successful, future attempts to 
increase movement complexity and degrees of freedom will require selective activation of 
individual fascicles and muscles. Grading the strength of muscle contraction and providing 
tactile sensory feedback are additional features that are highly desirable although not a focus 
of this current work.         
 
The next phase of this work aims to implant a polyimide nerve cuff and epicortical ECoG 
recording array into the NHP.  This will be preceded by a short surgical procedure to ensure 
that the previously divided median nerve contribution to the musculocutaneous nerve and the 
radial nerve supply to the brachioradialis remain divided and have not regenerated. This will 
also ensure that the subcutaneous transposition of the musculcutaneous nerve, facilitating 
ultrasound-guided block, is still satisfactory. Optimum positioning of the ECoG array over 
the motor cortex will be achieved by intraoperative stimulation and assessment of motor 
response. The recording array will be connected to an external power source or amplifier. A 
nerve cuff, initially placed around the musculocutaneous nerve, and eventually the radial 
nerve to triceps, will receive the amplified signal from the ECoG array. The silicone 
encapsulated connecting cable will be buried subcutaneously with ample redundant loops 
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positioned in the soft tissues to reduce the likelihood of traction injury and cuff avulsion 
during post-operative limb movements. Once the system is activated during reversible 
paralysis, it is hoped that, through operant conditioning and feedback, the restoration of 
autonomous and generalizable control will be possible.   
 
6.2.6 Conclusion 
This work reports early experiments aimed at developing a directly controlled BBI system, 
the ultimate neural interface for the restoration of limb movements following spinal cord 
injury. Successful demonstration of a reversible, selective upper limb paralysis model in the 
NHP represents a novel solution to a methodological obstacle that has perhaps limited 
progress with this approach in the past. Establishing this technique is a fundamental 
requirement for this experimental approach. With the successful demonstration of selective 
fascicular stimulation, the polyimide nerve cuffs used in this study appear to provide the ideal 
interface for the FES of paralyzed muscles. The approach addresses many of the current 
limitations of indirectly controlled BCIs and BMIs and in our opinion, has the greatest 
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